Sentence,class,file
Published 2010 http://www.health-e.org.za/documents/85d3dad6136e8ca9d02cceb7f4a36145.pdf.,Non-OADS,/arxiv_data1/oa_pdf/68/9e/jech-2014-204535.PMC4345523.pdf
2008. http://www.info.gov.za/view/DownloadFileAction?id=77877.,Non-OADS,/arxiv_data1/oa_pdf/68/9e/jech-2014-204535.PMC4345523.pdf
Available from: http://www.cdc.gov/ncbddd/autism/facts.html.,OADS,/arxiv_data1/oa_pdf/42/4d/yjbm_88_1_37.PMC4345537.pdf
Available from:  http://www.cdc.gov/mmwr/preview/mmwrhtml/ss6302a1.htm.,OADS,/arxiv_data1/oa_pdf/d8/d1/yjbm_88_1_45.PMC4345538.pdf
Available  from: http://iacc.hhs.gov/index.shtml.,OADS,/arxiv_data1/oa_pdf/c2/b4/yjbm_88_1_73.PMC4345541.pdf
Available from: http://www.army.mil/ar - ticle/100408/Latest_Report_Indicates_Autism_is_on_the_Ri  se/.,OADS,/arxiv_data1/oa_pdf/c2/b4/yjbm_88_1_73.PMC4345541.pdf
Available from:  http://www.tricare.mil/TMA/congressionalinformation/dow  nloads/Report%20on%20DoD%20Autism%20Pilot%20Proj  ects.pdf.,OADS,/arxiv_data1/oa_pdf/c2/b4/yjbm_88_1_73.PMC4345541.pdf
Available from: http://www.humana-mili - tary.com/south/bene/TRICAREPrograms/autism/autism.,Non-OADS,/arxiv_data1/oa_pdf/c2/b4/yjbm_88_1_73.PMC4345541.pdf
Available from:  http://www.scribd.com/doc/227164729/A-Guide-for-Mili - tary-Families-Affected-by-Autism.,Non-OADS,/arxiv_data1/oa_pdf/c2/b4/yjbm_88_1_73.PMC4345541.pdf
Available from:  http://www2.ed.gov/about/reports/annual/osep/2008/parts-b-  c/30th-idea-arc.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c2/b4/yjbm_88_1_73.PMC4345541.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comLetter to the Editor Morality and ethics without religion Ludvic Zrinzo Unit of Functional Neurosurgery, UCL Institute of Neurology, and Department of Neurosurgery, National Hospital for Neurology and Neurosurgery, Queen Square,  London, WC1N 3BG, UK E‑mail: *Ludvic Zrinzo ‑ l.zrinzo@ucl.ac.uk   *Corresponding author Received: 12 November 14  Accepted: 25 November 14  Published: 18 February 15 Dear Sir, A man’s ethical behavior should be based effectually on  sympathy, education, and social ties and needs; no religious  basis is necessary.",Non-OADS,/arxiv_data1/oa_pdf/36/72/SNI-6-28.PMC4345550.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/1/28/151609 Copyright: © 2015 Zrinzo L. This is an open‑access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution,  and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/36/72/SNI-6-28.PMC4345550.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Emergent cervical surgical embolectomy to rescue total monocular  blindness due to simultaneous cervical internal and external carotid artery occlusion by cardiogenic emboli Satoshi Kiyofuji, Tomohiro Inoue, Takashi Shigeeda1, Takeshi Sugiura1, Akira Tamura, Isamu Saito Departments of Neurosurgery, Fuji Brain Institute and Hospital, 270‑12 Sugita, Fujinomiya City, Shizuoka, 418‑0021, 1Opthalmology, Sugiura Eye Clinic, 22  Kawanarishinmachi, Fuji City, Shizuoka, 416‑0955, Japan E‑mail:*Satoshi Kiyofuji  ‑ kiyofuji‑tky@umin.ac.jp; T omohiro Inoue  ‑ t.inoue‑fujinsu@beige.plala.or.jp; Takashi Shigeeda  ‑ tshigeed‑tky@umin.org;   Takeshi Sugiura  ‑ sugi‑t@tx.thn.ne.jp; Akira Tamura  ‑ tamura‑nsu@umin.ac.jp; Isamu Saito  ‑ saito‑kyr@umin.ac.jp   *Corresponding author Received: 18 November 14   Accepted: 02 December 14   Published: 18 F ebruary 15 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.151612  Quick Response Code: Abstract Background:  Central retinal artery occlusion  (CRAO) is a stroke of the retina and is  associated with extremely poor prognosis.",Non-OADS,/arxiv_data1/oa_pdf/c1/00/SNI-6-29.PMC4345628.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/1/29/151612 Copyright: © 2015 Kiyofuji S. This is an open‑access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,  distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/c1/00/SNI-6-29.PMC4345628.pdf
"Surgical Neurology International 2015, 6:29  http://www.surgicalneurologyint.com/content/6/1/29this patient with total monocular blindness.",Non-OADS,/arxiv_data1/oa_pdf/c1/00/SNI-6-29.PMC4345628.pdf
"Surgical Neurology International 2015, 6:29  http://www.surgicalneurologyint.com/content/6/1/29judged that we had restored anterograde  ICA flow.",Non-OADS,/arxiv_data1/oa_pdf/c1/00/SNI-6-29.PMC4345628.pdf
"Surgical Neurology International 2015, 6:29  http://www.surgicalneurologyint.com/content/6/1/29home 16  days after surgery.",Non-OADS,/arxiv_data1/oa_pdf/c1/00/SNI-6-29.PMC4345628.pdf
"Surgical Neurology International 2015, 6:29  http://www.surgicalneurologyint.com/content/6/1/29surgical or endovascular clot retrieval with rigid proximal  protection to prevent distal intracranial migration of emboli is ideal.",Non-OADS,/arxiv_data1/oa_pdf/c1/00/SNI-6-29.PMC4345628.pdf
"Surgical Neurology International 2015, 6:29  http://www.surgicalneurologyint.com/content/6/1/29stroke with internal carotid artery occlusion: A  systematic review of clinical  outcomes.",Non-OADS,/arxiv_data1/oa_pdf/c1/00/SNI-6-29.PMC4345628.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comLetter to the Editor The personal and professional legacy of John Edwin Scarff John E. Scarff Jr, Timothy B. Scarff1, Jonathan R. Scarff2 Lexington, North Carolina, 1Fayetteville, Georgia, 2Staff Psychiatrist, Veterans Affairs Outpatient Clinic, 279 North Grove Medical Park Drive, Spartanburg,   South Carolina, 29303, USA E‑mail: John E. Scarff Jr ‑ scarff@lexcominc.net; Timothy B. Scarff ‑ scarfft@bellsouth.net; *Jonathan R. Scarff ‑ Jonathan.Scarff2@va.gov   *Corresponding author Received: 27 October 14  Accepted: 18 November 14  Published: 18 February 15 Dear Sir, We read with appreciation the comprehensive article  by Azab et al .",Non-OADS,/arxiv_data1/oa_pdf/04/a1/SNI-6-27.PMC4345629.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/1/27/151608 Copyright: © 2015 Scarff Jr JE.,Non-OADS,/arxiv_data1/oa_pdf/04/a1/SNI-6-27.PMC4345629.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Prostate dural metastasis presenting as chronic subdural  hematoma.",Non-OADS,/arxiv_data1/oa_pdf/c4/98/SNI-6-30.PMC4345634.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/1/30/151713 Copyright: © 2015 Boukas A.,Non-OADS,/arxiv_data1/oa_pdf/c4/98/SNI-6-30.PMC4345634.pdf
"Surgical Neurology International 2015, 6:30  http://www.surgicalneurologyint.com/content/6/1/30We report a case of prostate cancer metastasising to the  cranial dura mater presenting as a spontaneous chronic  subdural hematoma.",Non-OADS,/arxiv_data1/oa_pdf/c4/98/SNI-6-30.PMC4345634.pdf
"Surgical Neurology International 2015, 6:30  http://www.surgicalneurologyint.com/content/6/1/30 Figure 2: CT head, day 5 postoperative.",Non-OADS,/arxiv_data1/oa_pdf/c4/98/SNI-6-30.PMC4345634.pdf
"Surgical Neurology International 2015, 6:30  http://www.surgicalneurologyint.com/content/6/1/30has gained credence over the years due to the presence  of concomitant vertebral metastases, often multiple and  extensive in the cases reported.",Non-OADS,/arxiv_data1/oa_pdf/c4/98/SNI-6-30.PMC4345634.pdf
"Surgical Neurology International 2015, 6:30  http://www.surgicalneurologyint.com/content/6/1/30or diffuse.",Non-OADS,/arxiv_data1/oa_pdf/c4/98/SNI-6-30.PMC4345634.pdf
"Jae-Yong Park, Tel: +82-2-3290-5637; Fax:  +82-2-917-2388; E-mail: jaeyong68@korea.ac.kr, Eun Mi Hwang,  Tel: +82-2-940-2849, Fax: +82-2-958-7219, E-mail: emhwang@  kist.re.kr http://dx.doi.org/10.5483/BMBRep.2015.48.1.252Received 25 November 2014Keywords: Glycosylation, Heteromerization, Phosphorylation,  SUMOylation, Trafficking, TRPM4, 14-3-3 γ ISSN: 1976-670X (electronic edition) Copyright ⓒ 2015 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Physiological functions of the TRPM4 channels via protein  interactions Chang-Hoon Cho1, Young-Sun Lee2,3, Eunju Kim1,2, Eun Mi Hwang2,4,* & Jae-Yong Park1,* 1School of Biosystem and Biomedical Science, College of Health Science, Korea University, Seoul 136-703, 2Center for Functional  Connectomics, Korea Institute of Science and Technology (KIST), Seoul 136-791, 3Department of Physiology, Institute of Health Science  and Medical Research Center for Neural Dysfunction, Gyeong sang National University School of Medicine, Jinju 660-751, 4Neuroscience  Program, University of Science and Technology (UST), Daejeon 305-350, Korea Transient Receptor Potential, Melastatin-related, member 4  (TRPM4) channels are Ca2+-activated Ca2+-impermeable cati- on channels.",Non-OADS,/arxiv_data1/oa_pdf/c0/e6/BMB-48-1.PMC4345635.pdf
2BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/c0/e6/BMB-48-1.PMC4345635.pdf
"3 http://bmbreports.org BMB Reportsat a conserved site of TRPM4 remains to be explained: wheth- er it is merely species-specific or whether additional regulatory mechanism(s), including additional protein-protein inter- action(s), are required.",Non-OADS,/arxiv_data1/oa_pdf/c0/e6/BMB-48-1.PMC4345635.pdf
"4BMB Reports http://bmbreports.orgPharmacol 179, 269-285 4.",Non-OADS,/arxiv_data1/oa_pdf/c0/e6/BMB-48-1.PMC4345635.pdf
5 http://bmbreports.org BMB Reportsof print] 36.,Non-OADS,/arxiv_data1/oa_pdf/c0/e6/BMB-48-1.PMC4345635.pdf
"Tel: +56452205564; Fax: +56452205564;  E-mail: jparodi@uct.cl http://dx.doi.org/10.5483/BMBRep.2015.48.1.125Received 11 June 2014, Revised 1 July 2014, Accepted 17 July 2014Keywords: Amyloid, Channel, Ethanol, Oocytes, Pore ISSN: 1976-670X (electronic edition) Copyright ⓒ 2015 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Amyloid pore-channel hypothesis: effect of ethanol on  aggregation state using frog oocytes for an Alzheimer’s disease study Jorge Parodi1,*, David Ormeño1 & Lenin D. Ochoa-de la Paz2 1Laboratorio de Fisiología de la Reproducción, Núcleo de Investigaciónen Producción Alimentaria, Facultad de Recursos Naturales,  Escuela  de Medicina Veterinaria, Universidad Católica de Temuco, Temuco, Chile, 2Laboratorio de Fisiología Celular, Departamento de Bioquímica,  Facultad de Medicina, Universidad Nacional Autónoma de México, Ciudad Universitaria, México Alzheimer's disease severely compromises cognitive function.",Non-OADS,/arxiv_data1/oa_pdf/da/52/BMB-48-13.PMC4345636.pdf
14 BMB Reports http://bmbreports.orgmeostasis.,Non-OADS,/arxiv_data1/oa_pdf/da/52/BMB-48-13.PMC4345636.pdf
"15 http://bmbreports.org BMB Reportssented by the group of Rojas in the 90's and new evidence of  the group of Aguayo in 2014, newest and model different to neurons (44, 45).",OADS,/arxiv_data1/oa_pdf/da/52/BMB-48-13.PMC4345636.pdf
16 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/da/52/BMB-48-13.PMC4345636.pdf
17 http://bmbreports.org BMB Reports17.,Non-OADS,/arxiv_data1/oa_pdf/da/52/BMB-48-13.PMC4345636.pdf
18 BMB Reports http://bmbreports.org48.,Non-OADS,/arxiv_data1/oa_pdf/da/52/BMB-48-13.PMC4345636.pdf
"http://dx.doi.org/10.5483/BMBRep.2015.48.1.057Received 4 March 2014, Revised 24 March 2014,  Accepted 24 March 2014 Keywords: E2 ubiquitin conjugating enzyme, hFBH1, Polyubiquiti- nation, SCF , Ubiquitin ISSN: 1976-670X (electronic edition) Copyright ⓒ 2015 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Synergistic effect of two E2 ubiquitin conjugating enzymes in  SCFhFBH1 catalyzed polyubiquitination Jeong-Hoon Kim2,3,#, Jin Sun Choi1,5,#, Sunhong Kim4, Kidae Kim1, Pyung Keun Myung5, Sung Goo Park1,  Yeon-Soo Seo6,* & Byoung Chul Park1,* 1Medical Proteomics Research Center, Korea Research Institute of Bioscience & Biotechnology (KRIBB), Daejeon 305-333, 2Targeted Gene  Regulation Research Center, Korea Research Institute of Bioscience & Biotechnology (KRIBB), Daejeon 305-333, 3Department of Functional  Genomics, University of Science and Technology (UST), Daejeon 305-350, 4Targeted Medicine Research Center, Korea Research Institute of  Bioscience & Biotechnology (KRIBB), Chungbuk 363-883, 5College of Pharmacy, Chungnam National University, Daejeon 305-764,  6Department of Biological Sciences, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 305-701, Korea Ubiquitination is a post translational modification which  mostly links with proteasome dependent protein degradation.",Non-OADS,/arxiv_data1/oa_pdf/94/04/BMB-48-25.PMC4345638.pdf
26 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/94/04/BMB-48-25.PMC4345638.pdf
27 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/94/04/BMB-48-25.PMC4345638.pdf
"28 BMB Reports http://bmbreports.orgtween UbcH5b and UbcH5c, UbcH5b did not promote the  polyubiquitination (Fig.",Non-OADS,/arxiv_data1/oa_pdf/94/04/BMB-48-25.PMC4345638.pdf
29 http://bmbreports.org BMB Reportsisolated as previously described (6).,Non-OADS,/arxiv_data1/oa_pdf/94/04/BMB-48-25.PMC4345638.pdf
"Tel: +86-0951-5920036; Fax: +86-0951-  2063340; E-mail: fanyangnxhospital@163.com http://dx.doi.org/10.5483/BMBRep.2015.48.1.042Received 24 February 2014, Revised 11 March 2014, Accepted 22  April 2014 Keywords: A2780/CP cell, Cisplatin-resistance, Epithelial ovarian  cancer, Fas, Oncotherapy ISSN: 1976-670X (electronic edition) Copyright ⓒ 2015 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Upregulation of Fas in epithelial ovarian cancer reverses the  development of resistance to Cisplatin Fan Yang1,*, Wang Long2, Han Xuechuan1, Liu Xueqin1, Ma Hongyun1& Ding Yonghui3 1Department of Obstetrics and Gynecology, Ningxia People's Hospital, Yinchuan 750002, People’s Republic of China, 2Ningxia Medical  University, Yinchuan 750004, People’s Republic of China, 3Affiliated Hospital of Ningxia Medical University, Yinchuan 750004, People’s  Republic of China This study was to investigate the role of Fas in the develop- ment of Cisplatin-resistant ovarian cancer.",Non-OADS,/arxiv_data1/oa_pdf/e1/b7/BMB-48-30.PMC4345639.pdf
31 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/e1/b7/BMB-48-30.PMC4345639.pdf
32 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/e1/b7/BMB-48-30.PMC4345639.pdf
33 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/e1/b7/BMB-48-30.PMC4345639.pdf
34 BMB Reports http://bmbreports.orgsize and reduce expression of drug resistance gene.,Non-OADS,/arxiv_data1/oa_pdf/e1/b7/BMB-48-30.PMC4345639.pdf
35 http://bmbreports.org BMB Reportsated apoptosis accelerates Helicobacter-induced gastric  cancer in mice.,Non-OADS,/arxiv_data1/oa_pdf/e1/b7/BMB-48-30.PMC4345639.pdf
"Tel: +82-51-510-2809; Fax: +82-51-513-  2801; E-mail: brlee@pusan.ac.kr http://dx.doi.org/10.5483/BMBRep.2015.48.1.080Received 15 April 2014, Revised 30 April 2014, Accepted 30 April 2014Keywords: Anti-peptidoglycan-IgGs, Calcium signaling, Phagocytosis, Phospholiphase C, U937 cells ISSN: 1976-670X (electronic edition) Copyright ⓒ 2015 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Human anti-peptidoglycan-IgG-mediated opsonophagocytosis  is controlled by calcium mobilization in phorbol myristate acetate-treated U937 cells Min Jung Kim1, So-Young Rah2, Jang-Hyun An1, Kenji Kurokawa3, Uh-Hyun Kim2 & Bok Luel Lee1,* 1The Global Research Laboratory of Insect Symbiosis, Co llege of Pharmacy, Pusan National University, Busan 609-735, 2Department of  Biochemistry, Chonbuk National University Medical School, Jeonju 561-180, Korea, 3Faculty of Pharmaceutical Sciences, Nagasaki  International University, Nagasaki 859-3298, Japan Recently, we demonstrated that human serum amyloid P  component (SAP) specifically recognizes exposed bacterial peptidoglycan (PGN) of wall teichoic acid (WTA)-deficient  Staphylococcus aureus  ΔtagO mutant cells and then induces  complement-independent phagocytosis.",Non-OADS,/arxiv_data1/oa_pdf/22/b3/BMB-48-36.PMC4345640.pdf
37 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/22/b3/BMB-48-36.PMC4345640.pdf
38 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/22/b3/BMB-48-36.PMC4345640.pdf
39 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/22/b3/BMB-48-36.PMC4345640.pdf
40 BMB Reports http://bmbreports.orgBacteria and sera  Bacterial strains and functions of deleted genes in  Staphylococcus aureus  mutant strains are summarized as  follows.,Non-OADS,/arxiv_data1/oa_pdf/22/b3/BMB-48-36.PMC4345640.pdf
41 http://bmbreports.org BMB ReportsACKNOWLEDGEMENTS This work was supported for two years by a Pusan National  University Research Grant.,Non-OADS,/arxiv_data1/oa_pdf/22/b3/BMB-48-36.PMC4345640.pdf
"Soon Young Paik, Tel: +82-2-2258-7342;  Fax: +82-2-2258-7353; E-mail: paik@catholic.ac.kr, Jaehong Kim,  Tel: +82-32-899-6339; Fax: +82-32-899-6039; E-mail: geretics@  gachon.ac.kr http://dx.doi.org/10.5483/BMBRep.2015.48.1.090Received 29 April 2014, Revised 8 May 2014, Accepted 8 May 2014Keywords: Antibacterial activity, Cetylpyridinium chloride,  Mouthwashes, Streptococcus mutans ISSN: 1976-670X (electronic edition) Copyright ⓒ 2015 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Evaluation of antimicrobial effects of commercial mouthwashes  utilized in South Korea Su-Jeong Yang1, Sang-Ha Han1, Ah-Ra Lee1, Joon-Ho Jun2, Mi-Won Son2, Se-Hwan Oh3, Jaehong Kim4,*& Soon-Young Paik1,* 1Department of Microbiology, College of Medicine, The Catholic University of Korea, Seoul 137-701, 2Pharmaceutical Product Research  Aboratories, Dong-A ST Research Institute, Yonin 449-905, 3Apgugeong St. Mary’s Eye Center, Seoul 135-894, 4Department of  Biochemistry, School of Medicine, Gachon University, Incheon 406-799, Korea Streptococcus mutans  is frequently associated with dental  caries.",Non-OADS,/arxiv_data1/oa_pdf/b9/61/BMB-48-42.PMC4345641.pdf
43 http://bmbreports.org BMB ReportsPBS Product A+Product B+Product C+Product D+Product E+Product F Biofilm PlanktonicCFU (SD)* % KillLog reduction CFU (SD)* % KillLog reduction5.54±0.05    7.56±0.20   0.00±0.00 100     5.54 † 0.00±0.00 100     7.56†5.46±0.03 16.82     0.08† 1.24±0.14 99.99     6.33†5.00±0.05 71.61      0.54† 1.06±0.14 99.99      6.50†5.42±0.10 24.14      0.12† 6.27±0.12 94.87      1.29†5.49±0.02 10.87     0.05‡ 6.54±0.21 90.45     1.02†5.48±0.02 12.90      0.06† 6.33±0.26 94.11      1.23† *Mean (SD) Log-transformed counts to test solution.,Non-OADS,/arxiv_data1/oa_pdf/b9/61/BMB-48-42.PMC4345641.pdf
44 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/b9/61/BMB-48-42.PMC4345641.pdf
45 http://bmbreports.org BMB ReportsFormula Components Concentration (%) A B C D E FCetylpyridinium chloride Sodium fluoride Sodium fluoride Methyl salicylateThymol Eucalyptol LevomentholEthanol Isopropylene methyl phenol Sodium fluorideEthanol Ethanol  0.05   0.02   0.02   0.06  0.06   0.09   0.0427   0.02   0.0210 20Table 2.,Non-OADS,/arxiv_data1/oa_pdf/b9/61/BMB-48-42.PMC4345641.pdf
46 BMB Reports http://bmbreports.orgenumeration of viable bacteria.,OADS,/arxiv_data1/oa_pdf/b9/61/BMB-48-42.PMC4345641.pdf
47 http://bmbreports.org BMB ReportsEvaluation of the antiplaque efficacy of two cetylpyr- idinium chloride-containing mouthwashes.,Non-OADS,/arxiv_data1/oa_pdf/b9/61/BMB-48-42.PMC4345641.pdf
"Tel: +82-2-2650-5733; Fax: +82-2-2650-  5733; E-mail: parkym@ewha.ac.kr http://dx.doi.org/10.5483/BMBRep.2015.48.1.186Received 2 September 2014, Revised 23 September 2014,  Accepted 16 October 2014 Keywords: Atherosclerosis, CD36, Macrophage, Non-muscle my- osin, Oxidized LDL ISSN: 1976-670X (electronic edition) Copyright ⓒ 2015 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Oxidized LDL induces phosphorylation of non-muscle myosin  IIA heavy chain in macrophages Young Mi Park1,2,* 1Department of Molecular Medicine, Ewha Womans University School of Medicine, 2Global Top 5 Research Program, Ewha Womans  University, Seoul 158-710, Korea Oxidized LDL (oxLDL) performs critical roles in atherosclerosis  by inducing macrophage foam cell formation and promoting inflammation.",Non-OADS,/arxiv_data1/oa_pdf/25/ff/BMB-48-48.PMC4345642.pdf
Oxidized LDL induces phosphorylation of non-muscle myosin IIA heavy chain in macrophages Young Mi Park 49 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/25/ff/BMB-48-48.PMC4345642.pdf
Oxidized LDL induces phosphorylation of non-muscle myosin IIA heavy chain in macrophages Young Mi Park 50 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/25/ff/BMB-48-48.PMC4345642.pdf
Oxidized LDL induces phosphorylation of non-muscle myosin IIA heavy chain in macrophages Young Mi Park 51 http://bmbreports.org BMB Reportsendocytosis.,Non-OADS,/arxiv_data1/oa_pdf/25/ff/BMB-48-48.PMC4345642.pdf
Oxidized LDL induces phosphorylation of non-muscle myosin IIA heavy chain in macrophages Young Mi Park 52 BMB Reports http://bmbreports.orgtensively washed and boiled in SDS-PAGE loading buffer and  the bound material was analyzed by immunoblot using an anti-body for PKC- βII.,Non-OADS,/arxiv_data1/oa_pdf/25/ff/BMB-48-48.PMC4345642.pdf
Oxidized LDL induces phosphorylation of non-muscle myosin IIA heavy chain in macrophages Young Mi Park 53 http://bmbreports.org BMB Reports26.,Non-OADS,/arxiv_data1/oa_pdf/25/ff/BMB-48-48.PMC4345642.pdf
"http://dx.doi.org/10.5483/BMBRep.2015.48.1.213Received 17 October 2014, Revised 23 October 2014,  Accepted 23 October 2014 Keywords: Autocrine, CD5, CD40, Interleukin-10, Regulatory B cells ISSN: 1976-670X (electronic edition) Copyright ⓒ 2015 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Autocrine stimulation of IL-10 is critical to the enrichment of  IL-10-producing CD40hiCD5+ regulatory B cells in vitro  and in vivo Hyuk Soon Kim1,#, Jun Ho Lee2,#, Hee Dong Han1,#, A-Ram Kim1, Seung Taek Nam1, Hyun Woo Kim1, Young Hwan Park1,  Dajeong Lee1, Min Bum Lee1, Yeong Min Park1, Hyung Sik Kim3, Young Mi Kim4, Ji Chang You5,*& Wahn Soo Choi1,* 1School of Medicine, Konkuk University, Chungju 380-701, 2College of Medicine, Korea University, Seoul 136-701, 3College of Pharmacy,  Sungkyunkwan University, Suwon 440-746, 4College of Pharmacy, Duksung Women’s University, Seoul 132-714, 5National Research  Laboratory of Molecular Virology, Department of Pathology, Scho ol of Medicine, The Catholic University of Korea, Seoul 137-701,  Korea IL-10-producing B (Breg) cells regulate various immune res- ponses.",Non-OADS,/arxiv_data1/oa_pdf/8c/db/BMB-48-54.PMC4345643.pdf
55 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/8c/db/BMB-48-54.PMC4345643.pdf
56 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/8c/db/BMB-48-54.PMC4345643.pdf
57 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/8c/db/BMB-48-54.PMC4345643.pdf
58 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/8c/db/BMB-48-54.PMC4345643.pdf
"MATERIALS AND METHODS Material and Methods are described in the online data supple- ment, available at http://www.bmbreports.org/.",OADS,/arxiv_data1/oa_pdf/8c/db/BMB-48-54.PMC4345643.pdf
59 http://bmbreports.org BMB Reportsflammatory responses.,Non-OADS,/arxiv_data1/oa_pdf/8c/db/BMB-48-54.PMC4345643.pdf
"Tel: +82-2-2077-7627; Fax: +82-303-0799-  0396; E-mail: klim@sm.ac.kr http://dx.doi.org/10.5483/BMBRep.2015.48.1.165Received 4 August 2014Keywords: Customized gene targeting, Cytotoxicity, DNA binding  domains, Genome engineering, Nucleases ISSN: 1976-670X (electronic edition) Copyright ⓒ 2015 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Recent advances in developing  molecular tools for targeted  genome engineering of mammalian cells Kwang-il Lim * Department of Medical and Pharmaceutical Sciences, College of Science, Sookmyung Women’s University, Seoul 140-742, Korea Various biological molecules naturally existing in diversified  species including fungi, bacteria, and bacteriophage have functionalities for DNA binding and processing.",Non-OADS,/arxiv_data1/oa_pdf/77/9e/BMB-48-6.PMC4345644.pdf
Recent advances in developing molecular tools for targeted genome engineering of mammalian cells Kwang-il Lim 7 http://bmbreports.org BMB ReportsZINC FINGER NUCLEASES Zinc finger nucleases (ZFNs) are generally constructed by fu- sion of a nuclease that works as a dimer for DNA cleavage re- action and multiple zinc fingers that play the guide role to-ward the intended genomic target locus.,Non-OADS,/arxiv_data1/oa_pdf/77/9e/BMB-48-6.PMC4345644.pdf
"Recent advances in developing molecular tools fo r targeted genome engineering of mammalian cells Kwang-il Lim 8BMB Reports http://bmbreports.orgengineering, this new method also has some limitations to  overcome.",Non-OADS,/arxiv_data1/oa_pdf/77/9e/BMB-48-6.PMC4345644.pdf
"Recent advances in developing molecular tools for targeted genome engineering of mammalian cells Kwang-il Lim 9 http://bmbreports.org BMB Reportshoming endonucleases, such as I-SceI and I-AniI, do not re- quire the formation of dimer of the enzymes for DNA cleav-age reactions (42, 43).",Non-OADS,/arxiv_data1/oa_pdf/77/9e/BMB-48-6.PMC4345644.pdf
"Recent advances in developing molecular tools fo r targeted genome engineering of mammalian cells Kwang-il Lim 10 BMB Reports http://bmbreports.orgZFN TALEN CRISPR-Cas9 Origin of DNA recognition unit Molecular type of DNA  recognition unit Size of DNA recognition unit Modular assembly of DNA  recognition units Targeting mechanism Presence of repeated unitsPresence of DNA cleavage activityDNA binding motifs within  transcription factors Proteins Around 30 amino acids per unit  targeting a 3 bp sequencePossbile, but limited by the  interactions between neighboring  unitsProtein-DNA interactions Yes, as zinc finger domains  in tandem YesStructural repeats within the  secreted transcriptional regulatory proteins from plant pathogenic  bacteria Proteins Around 34 amino acids per unit  targeting a single basePossible Protein-DNA interactions Yes, as TALE DNA binding domains  in tandem YesPathogen-targeting RNAs of the  adaptive immune systems of prokaryotes RNAsAround 20 bases targeting the  equivalent size of DNA sequenceNot relevant, use of a single guide  RNA in general  Watson-Crick base paring between  guide RNA and target DNA No YesTable 1.",Non-OADS,/arxiv_data1/oa_pdf/77/9e/BMB-48-6.PMC4345644.pdf
Recent advances in developing molecular tools for targeted genome engineering of mammalian cells Kwang-il Lim 11 http://bmbreports.org BMB Reportsnucleases by in vitro selection.,Non-OADS,/arxiv_data1/oa_pdf/77/9e/BMB-48-6.PMC4345644.pdf
Recent advances in developing molecular tools fo r targeted genome engineering of mammalian cells Kwang-il Lim 12 BMB Reports http://bmbreports.org48.,Non-OADS,/arxiv_data1/oa_pdf/77/9e/BMB-48-6.PMC4345644.pdf
"Microfil was used to fill vascular  and other spaces of non -surviving animals  (http://www.flowtech-inc.com, Flow Tech, Carver, MA ,  USA).",Non-OADS,/arxiv_data1/oa_pdf/11/ff/NRR-7-766.PMC4345659.pdf
"Retrieved from UK, Sexual health for non-experts, http://www.rcn.org.uk/ development/practice/cpd_online_learning/sexual_health_for_non-experts 14) Ivarsson B, Fridlund B, Sjöberg T. Information from health care professionals about sexual function and coexistence after myocardial infarction: a Swedish national survey.",OADS,/arxiv_data1/oa_pdf/e8/60/2186-3326-76-273.PMC4345689.pdf
"5) http://www.mhlw.go.jp/toukei/saikin/hw/k-tyosa/k-tyosa10/toukei.html (accessed Mar 2nd, 2014)  6) Saag KG, Mikuls TR.",Non-OADS,/arxiv_data1/oa_pdf/5e/39/2186-3326-76-333.PMC4345695.pdf
"24) http://apps.who.int/bmi/index.jsp?introPage=intro_3.html (accessed Dec 2nd, 2013) 25) Hak AE, Choi HK.",Non-OADS,/arxiv_data1/oa_pdf/5e/39/2186-3326-76-333.PMC4345695.pdf
"Carboplatin dosing; http://www.fda.gov/AboutFDA/CentersOffices/Officeof- MedicalProductsandTobacco/CDER/ucm228974.htm (accessed 26 August 2013) 14) Stevens LA, Manzi J, Levey AS, Chen J, Deysher AE, Greene T, Poggio ED, Schmid CH, Steffes MW,  Zhang YL, Van Lente F, Coresh J.",Non-OADS,/arxiv_data1/oa_pdf/4f/39/2186-3326-76-0001.PMC4345715.pdf
"Available from: 6. http://icmr.nic.in/art/art_clinics.ht m, accessed  on January 14, 2013.",Non-OADS,/arxiv_data1/oa_pdf/d3/bb/IJMR-140-106.PMC4345740.pdf
"Available from: 9. http://www.latin- dictionary.org/surrogatus, http://en.wiktionary.org/wiki/ surrogatus , accessed  on October 10, 2014.",Non-OADS,/arxiv_data1/oa_pdf/c2/d8/IJMR-140-13.PMC4345743.pdf
"Surrogacy in New Encyclopedia, Britannica, Available 11.  from: http://www.britannica.com/EBchecked/topic/575390/   surrogate-motherhood , accessed on October 10, 2014.",Non-OADS,/arxiv_data1/oa_pdf/c2/d8/IJMR-140-13.PMC4345743.pdf
"Available from: http://www.un.org/ga/ search /view_doc.asp?symbol=E/CN.6/2014/L.7 , accessed on  September 11, 2014.",Non-OADS,/arxiv_data1/oa_pdf/df/87/IJMR-140-147.PMC4345746.pdf
"Available from: http://science.jrank.org/ pages/7694/Family-Planning.htm l, accessed on March 20,  2014.Bongaa 6. rts J,  Cleland J. Townsend JW, Bertrand JT, Das Gupta  M. Family planning programs for the 21st century.",Non-OADS,/arxiv_data1/oa_pdf/df/87/IJMR-140-147.PMC4345746.pdf
"Available from: http://tcw.nic.in/Acts/MTP-Act- 1971.pd f, accessed on September 12, 2014.",Non-OADS,/arxiv_data1/oa_pdf/df/87/IJMR-140-147.PMC4345746.pdf
"Available from: http://planningcommission.nic.in/aboutus/ committee/strgrp/stgp_fmlywel/sgfw_ch3.pd f, accessed on  March 21, 2014.",Non-OADS,/arxiv_data1/oa_pdf/df/87/IJMR-140-147.PMC4345746.pdf
"Available from: 16.  http://www.searo.who.int/LinkFiles/Family_Planning_Fact_ Sheets_india.pd f, accessed on March 21, 2014.",Non-OADS,/arxiv_data1/oa_pdf/df/87/IJMR-140-147.PMC4345746.pdf
"Available from: http://www.measuredhs.com/ pubs/pdf/AS25/AS25[12June2012].pd f, accessed on March  25, 2014.",Non-OADS,/arxiv_data1/oa_pdf/df/87/IJMR-140-147.PMC4345746.pdf
"Available from: http://www.promundo.org.br/Pesquisa/150  INDIAN J MED RES, NOVEMBER (SUPPL.)",Non-OADS,/arxiv_data1/oa_pdf/df/87/IJMR-140-147.PMC4345746.pdf
"Available from: http://www.censusindia.gov.in/2011- prov-results/data_files/india/Final_PPT_2011_chapter5.pdf ,  accessed on March 24, 2014.",OADS,/arxiv_data1/oa_pdf/df/87/IJMR-140-147.PMC4345746.pdf
"Available from:  http://pdf.usaid.gov/pdf_docs/PNACG652.pd f, accessed on  April 18, 2014.",Non-OADS,/arxiv_data1/oa_pdf/df/87/IJMR-140-147.PMC4345746.pdf
Available from: https://www.unfpa.,Non-OADS,/arxiv_data1/oa_pdf/4d/4c/IJMR-140-152.PMC4345747.pdf
"Available from: http://www.unfpa.org/webdav/ site/global/shared/documents/publications/2009/2008_donor_ support_report.pd f, accessed on May 12, 2012.",Non-OADS,/arxiv_data1/oa_pdf/4d/4c/IJMR-140-152.PMC4345747.pdf
"Available 6.  from: http://www.lifecarehll.com/page/render/reference/_ Milestone s, accessed on May 12, 2012.",Non-OADS,/arxiv_data1/oa_pdf/4d/4c/IJMR-140-152.PMC4345747.pdf
"Available  from: http://shopsproject.org/resource-center/yahi-hai-sahi- growing-condom-market-north-india-throughprivate-secto r,  accessed on May 12, 2012.",Non-OADS,/arxiv_data1/oa_pdf/4d/4c/IJMR-140-152.PMC4345747.pdf
Available from: http://centers.iub.edu.bd/chpdnew/ chpd/download/publications/WorkPap2017NKamal-FHuda.,Non-OADS,/arxiv_data1/oa_pdf/4d/4c/IJMR-140-152.PMC4345747.pdf
"Available from: http://www.naco.gov.in/ upload/IEC%20Division/NACO%20monographs%20for%20 Vienna/Final%20NACO%20Monograph%201.pdf , accessed  on May 12, 2012.",Non-OADS,/arxiv_data1/oa_pdf/4d/4c/IJMR-140-152.PMC4345747.pdf
"Available from: http://data.unaids.org/  Publications/IRC-pub01/ JC003-Mal eCondom-FactSheets_ en.pdf , accessed on May 12, 2012.",OADS,/arxiv_data1/oa_pdf/4d/4c/IJMR-140-152.PMC4345747.pdf
"Available from: 20. http://www.iipsindia.org/index.htm , accessed  on April 1, 2013.",Non-OADS,/arxiv_data1/oa_pdf/7b/e5/IJMR-140-17.PMC4345748.pdf
"Available from: http://apps.who.int/ hpvcentre/statistics/dynamic/ico/country_pdf/IND.pd f, accessed  on November 1, 2013.",OADS,/arxiv_data1/oa_pdf/6d/76/IJMR-140-36.PMC4345751.pdf
"Available from: 18.  http://www.rchiips.org/nfhs/pdf/India.pdf , accessed on January  2, 2014.",Non-OADS,/arxiv_data1/oa_pdf/6f/87/IJMR-140-45.PMC4345752.pdf
"Available from: 18. http://conrad.org/contraception-trials.htm l,  accessed on September 21, 2012.",Non-OADS,/arxiv_data1/oa_pdf/d1/de/IJMR-140-58.PMC4345754.pdf
"12 ed, U.S. Department of Health and  Human Services, Public Health Service, NC, USA: National  Toxicology Program; 2011. p. 1-499.Available from: 17. http://toxnet.nlm.nih.gov/cgi-bin/sis/ htmlgen?HSDB , accessed on September 5, 2014.",OADS,/arxiv_data1/oa_pdf/44/55/IJMR-140-63.PMC4345756.pdf
"It is possible, given proper research evaluations and  outcomes, that safe functional food products could be  manufactured based on epidemiolog ical information.Acknowledgment  The authors thank the Wolfson Research Institute for Health  and Wellbeing, Durham University; and the Cheminformatics  Team, ChemSpider, ( http://www.chemspider.com ), Royal Society  of Chemistry Burlington House , Piccadilly , London ; for support in  various studies, and David Griffiths, Castleton, Gwent, UK, for his  graphics skills with respect to Figure 5.",Non-OADS,/arxiv_data1/oa_pdf/17/7b/IJMR-140-82.PMC4345759.pdf
"Available  from: http://www.fda.gov/NewsEvents/PublicHealthFocus/ ucm197739.htm , accessed on August 31, 2012.",Non-OADS,/arxiv_data1/oa_pdf/17/7b/IJMR-140-82.PMC4345759.pdf
"Available  from: http://www.austlii.edu.au , accessed on September 24,  2014.",Non-OADS,/arxiv_data1/oa_pdf/35/2f/IJMR-140-9.PMC4345760.pdf
Available from: 53. http://yourfertility.org.au/factor/age-and- fertility?activeIndex=1 .,Non-OADS,/arxiv_data1/oa_pdf/35/2f/IJMR-140-9.PMC4345760.pdf
Available from: http://stemcells.nih.,OADS,/arxiv_data1/oa_pdf/e5/ee/IJMR-140-98.PMC4345762.pdf
"To view please visit the journal online (http://dx.doi.org/10.1136/thoraxjnl-2014-205278) 1Department of Respiratory Medicine, Barts Health NHS Trust, London, UK 2Department of Medicines Management and PharmacyServices, Leeds University Hospitals Trust, Leeds, UK 3Department of Respiratory Medicine, The WhittingtonHospital, London, UK 4Department of Respiratory Medicine, Queen AlexandraHospital, Portsmouth, UK 5Imperial College London, Chest and Allergy Clinic, London, UK Correspondence to Dr Jessica Louise Potter,Department of Respiratory Medicine, London Chest Hospital, Bonner Road,London E2 9JX, UK;Jessica.keal@gmail.com, Jessica.potter@ bartshealth.nhs.uk Received 13 February 2014 Revised 29 April 2014 Accepted 21 May 2014 Published Online First13 June 2014 To cite: Potter JL, Capstick T, Ricketts WM, et al.Thorax 2015; 70: 297 –298.ABSTRACT Using the best available evidence and expert consensus,this document provides guidance for adverse effectmonitoring in multidrug-resistant TB (MDR-TB).",Non-OADS,/arxiv_data1/oa_pdf/1a/93/thoraxjnl-2014-205278.PMC4345768.pdf
The guidance has beenpublished online at http://www.tbdrugmonographs.co.uk andwill be freely accessible to all.,Non-OADS,/arxiv_data1/oa_pdf/1a/93/thoraxjnl-2014-205278.PMC4345768.pdf
Competing interests JLP owns the web domain http://www.tbdrugmonographs.,Non-OADS,/arxiv_data1/oa_pdf/1a/93/thoraxjnl-2014-205278.PMC4345768.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 World Health Organisation.,Non-OADS,/arxiv_data1/oa_pdf/1a/93/thoraxjnl-2014-205278.PMC4345768.pdf
"See: http://creativecommons.org/licenses/ by-nc/4.0/ To cite Shimshoni E, Yablecovitch D, Baram L, et al.",Non-OADS,/arxiv_data1/oa_pdf/93/18/gutjnl-2014-308048.PMC4345769.pdf
World J Gastrointest Pathophysiol 2014;5:48 – 53. http://www.wjgnet.com/2150-5330/ pdf/v5/i1/48.pdf (accessed 22 Jun 2014).,Non-OADS,/arxiv_data1/oa_pdf/93/18/gutjnl-2014-308048.PMC4345769.pdf
"http://www.ncbi.nlm.nih.gov/ pubmed/14669348 24 Ko ﬂa-Dlubacz A, Matusiewicz M, Krzystek-Korpacka M,et al.",OADS,/arxiv_data1/oa_pdf/93/18/gutjnl-2014-308048.PMC4345769.pdf
http://www.ncbi.nlm.nih.gov/ pubmed/11222550 (accessed 16 Jun 2014).,Non-OADS,/arxiv_data1/oa_pdf/93/18/gutjnl-2014-308048.PMC4345769.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ References ALARCON, P ., RUSHTON, J., & WIELAND, B.",Non-OADS,/arxiv_data1/oa_pdf/d6/04/vetrec-2014-102755.PMC4345771.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Information Services Division, NHS National Services Scotland.",Non-OADS,/arxiv_data1/oa_pdf/76/80/emermed-2013-203200.PMC4345772.pdf
September 2012. http://www.isdscotland.org/Health-Topics/Hospital-Care/Inpatient-and-Day-Case-Activity/ (accessed 18 Jan 2013).,Non-OADS,/arxiv_data1/oa_pdf/76/80/emermed-2013-203200.PMC4345772.pdf
http://www.dh.gov.uk/en/Publicationsandstatistics/ Statistics/Performancedataandstatistics/ AccidentandEmergency/DH_077485 (accessed 18 Jan 2013).,OADS,/arxiv_data1/oa_pdf/76/80/emermed-2013-203200.PMC4345772.pdf
"ISBN: 3-900051-07-0. http://www.R-project.org/ 25 Robin X, Turck N, Hainard A, et al.",Non-OADS,/arxiv_data1/oa_pdf/76/80/emermed-2013-203200.PMC4345772.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/ bmjspcare-2014-000770).,Non-OADS,/arxiv_data1/oa_pdf/d8/3c/bmjspcare-2014-000770.PMC4345773.pdf
"See: http://creativecommons.org/licenses/by- nc/4.0/ REFERENCES 1 Tsim S, Davidson S. End-of-life care in a general respiratory ward in the United Kingdom.",Non-OADS,/arxiv_data1/oa_pdf/d8/3c/bmjspcare-2014-000770.PMC4345773.pdf
Secondary living and dying well: building onprogress 2011. http://www.scotland.gov.uk/Resource/Doc/340076/0112559.pdf 3 Hillman K. Dying safely.,Non-OADS,/arxiv_data1/oa_pdf/d8/3c/bmjspcare-2014-000770.PMC4345773.pdf
"Available from:http://virtualmentor.ama-assn.org/2003/01/pfor2-0301.htmlReview Cardona-Morrell M, et al.BMJ Supportive & Palliative Care 2015; 5:78–90.",Non-OADS,/arxiv_data1/oa_pdf/d8/3c/bmjspcare-2014-000770.PMC4345773.pdf
"July 2008. http://webarchive.nationalarchives.gov.uk/20130107105354/http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_086345.pdf 22 van W eel C, Michels J.",OADS,/arxiv_data1/oa_pdf/d8/3c/bmjspcare-2014-000770.PMC4345773.pdf
Factors Associated within 28 Days In-Hospital Mortality of Patients with AcuteRespiratory Distress Syndrome BioMed Research International2013; Article ID 564547:5 pages doi: http://dx.doi.org/10.1155/2013/564547 [published Online First: Epub Date]|.,Non-OADS,/arxiv_data1/oa_pdf/d8/3c/bmjspcare-2014-000770.PMC4345773.pdf
1981 https://bioethicsarchive.georgetown.edu/pcbe/reports/past_commissions/defining_death.pdf(accessed Mar 2013).,Non-OADS,/arxiv_data1/oa_pdf/d8/3c/bmjspcare-2014-000770.PMC4345773.pdf
"Guidelines for a Palliative Approach in Residential Aged Care.Secondary Guidelines for a Palliative Approach in ResidentialAged Care 2006. http://www.nhmrc.gov.au/_files_nhmrc/publications/attachments/pc29.pdf 52 Schmidt RJ, Moss AH.",Non-OADS,/arxiv_data1/oa_pdf/d8/3c/bmjspcare-2014-000770.PMC4345773.pdf
http://dx.doi.org/10.1016/j.resuscitation.,OADS,/arxiv_data1/oa_pdf/d8/3c/bmjspcare-2014-000770.PMC4345773.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Blencowe H, Cousens S, Oestergaard M, et al.",Non-OADS,/arxiv_data1/oa_pdf/33/bf/fetalneonatal-2013-305877.PMC4345791.pdf
"http://www.data.worldbank.org/country/malawi June 2013.5 Hogan MC, Foreman KJ, Naghavi M, et al.",Non-OADS,/arxiv_data1/oa_pdf/33/bf/fetalneonatal-2013-305877.PMC4345791.pdf
See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Centers for Disease Control and Prevention.,Non-OADS,/arxiv_data1/oa_pdf/6e/44/tobaccocontrol-2014-052038.PMC4345792.pdf
"Last Updated: May, 2014. http://airnow.gov/index.cfm?action=aqibasics.aqi (accessed 17 Sep 2014).",OADS,/arxiv_data1/oa_pdf/6e/44/tobaccocontrol-2014-052038.PMC4345792.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ thoraxjnl-2014-205248).,Non-OADS,/arxiv_data1/oa_pdf/d2/6c/thoraxjnl-2014-205248.PMC4345793.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Connors AF Jr, Dawson NV, Thomas C, et al.",Non-OADS,/arxiv_data1/oa_pdf/d2/6c/thoraxjnl-2014-205248.PMC4345793.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Gatrad R, Gatrad A, Sheikh A. Hookah smoking.",Non-OADS,/arxiv_data1/oa_pdf/70/36/tobaccocontrol-2014-051908.PMC4345795.pdf
"74 Global Strategy for the Diagnosis, Management, and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2014. http://www.goldcopd.org/ 75 Waked M, Khayat G, Salameh P. Chronic obstructive pulmonary disease prevalence in Lebanon: a cross-sectional descriptive study.",Non-OADS,/arxiv_data1/oa_pdf/70/36/tobaccocontrol-2014-051908.PMC4345795.pdf
"2010. http://www.cdc.gov/tobacco/data_statistics/by_topic/health_effects/index.htm 98 Dar NA, Bhat GA, Shah IA, et al.",OADS,/arxiv_data1/oa_pdf/70/36/tobaccocontrol-2014-051908.PMC4345795.pdf
"Geneva, Switzerland, 2005. http://www.who.int/tobacco/global_interaction/tobreg/Waterpipe%20recommendation_Final.pdf?ua=1 El-Zaatari ZM, et al.Tob Control 2015; 24:i31–i43.",Non-OADS,/arxiv_data1/oa_pdf/70/36/tobaccocontrol-2014-051908.PMC4345795.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Avila MP, Weiter JJ, Jalkh AE, et al.",Non-OADS,/arxiv_data1/oa_pdf/ad/1d/bjophthalmol-2014-305131.PMC4345796.pdf
2011. http://www.cebm.net/index.aspx?o=5653 (accessed 13 Nov 2013).,Non-OADS,/arxiv_data1/oa_pdf/ad/1d/bjophthalmol-2014-305131.PMC4345796.pdf
2011. http://www.fda.gov/Drugs/DrugSafety/ ucm270296.htm (accessed 11 Jul 2013).,Non-OADS,/arxiv_data1/oa_pdf/ad/1d/bjophthalmol-2014-305131.PMC4345796.pdf
2012. http://clinicaltrials.gov/ct2/show/ NCT01249664?term=a ﬂibercept+AND+myopia&rank=1 (accessed 1 Jul 2013).,Non-OADS,/arxiv_data1/oa_pdf/ad/1d/bjophthalmol-2014-305131.PMC4345796.pdf
2013. http://press.healthcare.bayer.,Non-OADS,/arxiv_data1/oa_pdf/ad/1d/bjophthalmol-2014-305131.PMC4345796.pdf
2012. http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/ad/1d/bjophthalmol-2014-305131.PMC4345796.pdf
See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 World Health Organization.,Non-OADS,/arxiv_data1/oa_pdf/42/f4/tobaccocontrol-2014-051910.PMC4345797.pdf
"Retrieved June, 7, 2011. http://www.who.int/tobacco/framework/download/en/ 130 Nakkash R, Khalil J.",Non-OADS,/arxiv_data1/oa_pdf/42/f4/tobaccocontrol-2014-051910.PMC4345797.pdf
See: http://creativecommons.org/licenses/ by-nc/4.0/ To cite Ward KD.,Non-OADS,/arxiv_data1/oa_pdf/fe/31/tobaccocontrol-2014-052203.PMC4345809.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/ bmjspcare-2013-000473).,Non-OADS,/arxiv_data1/oa_pdf/2c/1a/bmjspcare-2013-000473.PMC4345810.pdf
"Theopinion poll was commissioned by CARENET (Canadian Researchers at the End of Life Network, http://www.thecarenet.ca), the FHA, the CanadianHospice and Palliative Care Association, and the Speak Up Campaign and was conducted by Ipsos Reid.",Non-OADS,/arxiv_data1/oa_pdf/2c/1a/bmjspcare-2013-000473.PMC4345810.pdf
"Some of these resources included a provin- cial toll-free telephone line, a website and a numberof documents, most notably an ACP workbook ( My Voice Workbook ) that could be used by patients and the public to help them develop an advance care plan,or approach a HCP around healthcare decision making at the EOL (http://www.fraserhealth.ca/your_ care/advance-care-planning/).",Non-OADS,/arxiv_data1/oa_pdf/2c/1a/bmjspcare-2013-000473.PMC4345810.pdf
"Funding This study used a dataset commissioned by CARENET (Canadian Researchers at the End of Life Network, http://www.thecarenet.ca), the Fraser Health Authority (http://www.",Non-OADS,/arxiv_data1/oa_pdf/2c/1a/bmjspcare-2013-000473.PMC4345810.pdf
"fraserhealth.ca), the Canadian Hospice and Palliative Care Association (http://chpca.net), and the Speak Up Campaign andconducted by Ipsos Reid.",Non-OADS,/arxiv_data1/oa_pdf/2c/1a/bmjspcare-2013-000473.PMC4345810.pdf
"See: http://creativecommons.org/licenses/by- nc/3.0/ REFERENCES 1 Heyland DK, Barwich D, Pichora D, et al.",Non-OADS,/arxiv_data1/oa_pdf/2c/1a/bmjspcare-2013-000473.PMC4345810.pdf
"Canadian Hospices Palliative Care Association, 2010. http://akeresourcecentre.org/files/ACP/ACP_National%20Framework_Full.pdf (accessed 13Aug 2012).",Non-OADS,/arxiv_data1/oa_pdf/2c/1a/bmjspcare-2013-000473.PMC4345810.pdf
"Pew Research Center for the People and the Press, 2006. http://www.people-press.org/2006/01/05/strong-public-support-for-right-to-die/#summary-of-findings(accessed 31 Aug 2012).",Non-OADS,/arxiv_data1/oa_pdf/2c/1a/bmjspcare-2013-000473.PMC4345810.pdf
"Prepared for Office of Disability , Aging and Long-T erm Care Policy, U.S. Department of Health andHuman Services, 2007. http://aspe.hhs.gov/daltcp/reports/2007/advdirlr.htm (accessed 22 Aug 2012).",Non-OADS,/arxiv_data1/oa_pdf/2c/1a/bmjspcare-2013-000473.PMC4345810.pdf
"Secretariat on Palliative and End-of-Life Care, Primary and Continuing Health Care Division of theHealth Care Policy Directorate, Health Canada, 2007. http://www.bccancer.bc.ca/NR/rdonlyres/E17D408A-C0DB-40FA-9682 –9DD914BB771F/28582/ COLOUR030408_Con.pdf (accessed Aug 2012).",Non-OADS,/arxiv_data1/oa_pdf/2c/1a/bmjspcare-2013-000473.PMC4345810.pdf
"California Healthcare Foundation, 2012. http://www.chcf.org/~/media/MEDIA%20LIBRARY%20Files/PDF/F/PDF%20FinalChapterDeathDying.pdf (accessed Aug 2012).",Non-OADS,/arxiv_data1/oa_pdf/2c/1a/bmjspcare-2013-000473.PMC4345810.pdf
"London: RCP , 2009. http://www.rc- plondon.ac.uk/pubs/contents/9c95f6ea-c57e-4db8-bd98-fc12ba31c8fe.pdf (accessed 3 Jan 2013).",Non-OADS,/arxiv_data1/oa_pdf/2c/1a/bmjspcare-2013-000473.PMC4345810.pdf
"http://www.statcan.gc.ca/pub/89-582-x/index-eng.htm (accessed 20 Nov2012).Research Teixeira AA, et al.BMJ Supportive & Palliative Care 2015; 5:40–47.",Non-OADS,/arxiv_data1/oa_pdf/2c/1a/bmjspcare-2013-000473.PMC4345810.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/annrheumdis-2013-204355).,Non-OADS,/arxiv_data1/oa_pdf/8b/d3/annrheumdis-2013-204355.PMC4345811.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Abramson SB, Attur M. Developments in the scienti ﬁc understanding of osteoarthritis.",Non-OADS,/arxiv_data1/oa_pdf/8b/d3/annrheumdis-2013-204355.PMC4345811.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the workis properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d4/f0/ciu912.PMC4345816.pdf
Available at: http://dtxtq4w60xqpw.cloudfront.net/sites/all/ ﬁles/pdf/unwto_barom13_ 04_august_excerpt.pdf .,Non-OADS,/arxiv_data1/oa_pdf/74/57/ciu957.PMC4345818.pdf
Available at: http://www.who.int/topics/diarrhoea/en/ .,Non-OADS,/arxiv_data1/oa_pdf/74/57/ciu957.PMC4345818.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Agelopoulos N, T ate T .",Non-OADS,/arxiv_data1/oa_pdf/aa/fc/bmjspcare-2012-000285.PMC4345830.pdf
"http://www.mariecurie.orguk/en-gb/press-media/news-comment/marie-curie-welcomes-palliative-care-funding-review/Research Round J, et al.BMJ Supportive & Palliative Care 2015; 5:26–33.",Non-OADS,/arxiv_data1/oa_pdf/aa/fc/bmjspcare-2012-000285.PMC4345830.pdf
Cirrhotic patients should have a dual x-ray absorptiometry scan to assess bone mineral density and have their fracture risk assessed using the FRAX tool (http://www.shef.ac.uk/FRAX/tool).,Non-OADS,/arxiv_data1/oa_pdf/53/db/postgradmedj-2013-100404rep.PMC4345831.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Bedogni G, Miglioli L, Masutti F, et al.",Non-OADS,/arxiv_data1/oa_pdf/53/db/postgradmedj-2013-100404rep.PMC4345831.pdf
"Hepatology 2010;51:121 –9.Table 4 Managing the complications of cirrhosis Complication Risk Management Hepatocellular carcinomaYearly cumulative incidence 2.6% per year506 monthly abdominal USS± α-fetoprotein Varices 40% –44% if Child –Pugh grade A 75% –85% if Child –Pugh grade C92Endoscopic surveillance and management according to BSG or AASLD guidelines94 93 Osteoporosis Cirrhotic patients are at increased risk of osteoporosis and fractures Larger studies assessing the effects of vitamin D supplementation on BMD are lackingCorrection of vitamin D insufficiency with oral daily vitamin D 3 and calcium95 Dual x-ray absorptiometry scan to assess BMD Assess fracture risk using FRAX tool (http://www.shef.ac.uk/ FRAX/tool) AASLD, American Association for the Study of Liver Diseases; BMD, bone mineral density; BSG, British Society of Gastroenterology; USS, ultrasonogr aphy.",Non-OADS,/arxiv_data1/oa_pdf/53/db/postgradmedj-2013-100404rep.PMC4345831.pdf
"Correspondence to Professor Frank J Chaloupka, Department of Economics,Institute for Health Researchand Policy, University of Illinois at Chicago, Chicago, IL 60608, USA;fjc@uic.edu Received 1 October 2014 Accepted 28 November 2014 Published Online First30 December 2014 ▸http://dx.doi.org/10.1136/ tobaccocontrol-2014-052095 ▸http://dx.doi.org/10.1136/ tobaccocontrol-2014-052100 To cite: Chaloupka FJ, Warner KE, Acemo ğlu D, et al.Tob Control 2015; 24:112–119.ABSTRACT The Family Smoking Prevention and Tobacco Control Actof 2009 gave the Food and Drug Administration (FDA)regulatory authority over cigarettes and smokelesstobacco products and authorised it to assert jurisdictionover other tobacco products.",Non-OADS,/arxiv_data1/oa_pdf/a7/b5/tobaccocontrol-2014-052022.PMC4345832.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 White House.,Non-OADS,/arxiv_data1/oa_pdf/a7/b5/tobaccocontrol-2014-052022.PMC4345832.pdf
Manuscript 2010: http://people.rwj.harvard.edu/~mlevy/cigarettes.pdf 26 Laux F. Addiction as a market failure: using rational addiction results to justify tobacco regulation.,Non-OADS,/arxiv_data1/oa_pdf/a7/b5/tobaccocontrol-2014-052022.PMC4345832.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/gutjnl-2013-306155).,Non-OADS,/arxiv_data1/oa_pdf/bc/99/gutjnl-2013-306155.PMC4345833.pdf
"Received 2 October 2013 Revised 20 March 2014Accepted 8 April 2014Published Online First 21 May 2014 ▸http://dx.doi.org/10.1136/ gutjnl-2014-307452 To cite: Xiao F, Fofana I, Thumann C, et al.Gut 2015; 64:483–494.ABSTRACT Objective Although direct-acting antiviral agents (DAAs) have markedly improved the outcome oftreatment in chronic HCV infection, there continues to be an unmet medical need for improved therapies in difﬁcult-to-treat patients as well as liver graft infection.",Non-OADS,/arxiv_data1/oa_pdf/bc/99/gutjnl-2013-306155.PMC4345833.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Dabbouseh NM, Jensen DM.",Non-OADS,/arxiv_data1/oa_pdf/bc/99/gutjnl-2013-306155.PMC4345833.pdf
"19Much of that promotion on the internet and social media is organisedaround Interest groups, but in fact disguise waterpipe sellers andmarketers 18–20(see eg, http://www.hookahblogger.tumblr.com/ and http://www.hookah-shisha.com/hookahlove/).",Non-OADS,/arxiv_data1/oa_pdf/17/be/tobaccocontrol-2014-051903.PMC4345835.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Maziak W, Ward K, Soweid RAA, et al .",Non-OADS,/arxiv_data1/oa_pdf/17/be/tobaccocontrol-2014-051903.PMC4345835.pdf
http://www.lungusa2.org/embargo/slati/Trendalert_ Waterpipes.pdf (accessed 5 Jul 2014).,Non-OADS,/arxiv_data1/oa_pdf/17/be/tobaccocontrol-2014-051903.PMC4345835.pdf
http://www.thehookahlounge.org/how-to-make- your-own-shisha/ (accessed 5 Jul 2014).,Non-OADS,/arxiv_data1/oa_pdf/17/be/tobaccocontrol-2014-051903.PMC4345835.pdf
http://nccd.cdc.gov/ gtssdata/Ancillary/DataReports.aspx?CAID=2 (accessed 28 Jun 2014).,OADS,/arxiv_data1/oa_pdf/17/be/tobaccocontrol-2014-051903.PMC4345835.pdf
Available at: http://www.cms.gov/Medicare/Medicare-Fee-for-Service- Payment/InpatientRehabFacPPS/index.html?redirect=/InpatientRehabFacPPS/LIRFF/list.asp.,Non-OADS,/arxiv_data1/oa_pdf/de/7a/jah3-4-e001038.PMC4345857.pdf
"Dr Jia is currently located at the University of Hawaii Cancer Center, Honolulu, HI.Dr Ellis is currently located at the Purdue University, West Lafayette, IN.An accompanying Table S1 is available at http://jaha.ahajournals.org/ content/4/2/e001136/suppl/DC1.",Non-OADS,/arxiv_data1/oa_pdf/b4/03/jah3-4-e001136.PMC4345858.pdf
"XCMS package (v1.24.1) (http://metlin.scripps.edu), which runs in the statistical package R (v.2.12.1) (http://www.r- project.org), to pick, align, and quantify features (chromato- graphic events corresponding to speci ﬁc m/z values and retention times).",OADS,/arxiv_data1/oa_pdf/b4/03/jah3-4-e001136.PMC4345858.pdf
Metabolite annotation was performed by comparing the accurate mass (m/z) and retention time (Rt) of reference standards in our in-house library and the accurate mass ofcompounds obtained from the web-based resources such as the Human Metabolome Database (http://www.hmdb.ca/).,OADS,/arxiv_data1/oa_pdf/b4/03/jah3-4-e001136.PMC4345858.pdf
An accompanying Data S1 is available at http://jaha.ahajournals.org/ content/4/1/e001288/suppl/DC1 *A list of LIFE Study investigators is provided in the online appendix.,Non-OADS,/arxiv_data1/oa_pdf/5c/1f/jah3-4-e001288.PMC4345863.pdf
"†The China PEACE-Retrospective AMI Study Site Investigators are listed in an Appendix available at http://jaha.ahajournals.org/content/4/2/e001343/ suppl/DC1 Correspondence to: Lixin Jiang, MD, PhD, National Clinical Research Center of Cardiovascular Diseases, Fuwai Hospital, 167 Beilishi Rd, Beijing 100037,China.",Non-OADS,/arxiv_data1/oa_pdf/72/ea/jah3-4-e001343.PMC4345866.pdf
Available at: http://www.stats.gov.cn/tjsj/ndsj/2011/indexch.htm.,OADS,/arxiv_data1/oa_pdf/72/ea/jah3-4-e001343.PMC4345866.pdf
Available at: http://www.cms.gov/medicare/medicare-fee-for-service-pay-ment/acuteinpatientpps/readmissions-reduction-program.html.,Non-OADS,/arxiv_data1/oa_pdf/ed/7e/jah3-4-e001352.PMC4345868.pdf
"Accompanying Tables S1 through S3 are available at http://jaha.ahajour nals.org/content/4/2/e001477/suppl/DC1 Correspondence to: Robert L. Wilensky, MD, Hospital of the University of Pennsylvania, 3400 Spruce St, 9 Gates, Philadelphia, PA 19104.",Non-OADS,/arxiv_data1/oa_pdf/58/0a/jah3-4-e001477.PMC4345873.pdf
"Accompanying Tables S1 through S3 are available at http://jaha.ahajour- nals.org/content/1/5/e001568/suppl/DC1 Correspondence to: Hui-Ju Tsai, MPH, PhD, Division of Biostatistics and Bioinformatics, Institute of Population Health Sciences, National Health Research Institutes, 35 Keyan Road Zhunan, Miaoli County 350, Taiwan.E-mails: tsaihj@nhri.org.tw, h-tsai@northwestern.edu Received December 23, 2014; accepted January 24, 2015.ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/14/aa/jah3-4-e001568.PMC4345877.pdf
See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Argon Laser Photocoagulation for Macular Edema in Branch Vein Occlusion.,Non-OADS,/arxiv_data1/oa_pdf/26/a6/bjophthalmol-2014-305041.PMC4345884.pdf
2010. http://www.gene.com/media/press-releases/12827/2010-06-22/fda-approves-lucentis-ranibizumab-inject (accessed 13 May 2014) 12 Novartis Europharm Limited.,Non-OADS,/arxiv_data1/oa_pdf/26/a6/bjophthalmol-2014-305041.PMC4345884.pdf
2011. http://www.novartis.,Non-OADS,/arxiv_data1/oa_pdf/26/a6/bjophthalmol-2014-305041.PMC4345884.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ To cite Mori S, Yoshitama T, Hidaka T, et al.Ann Rheum Dis 2015; 74:627–630.",Non-OADS,/arxiv_data1/oa_pdf/07/f2/annrheumdis-2014-206695.PMC4345886.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/annrheumdis-2013-204867).,Non-OADS,/arxiv_data1/oa_pdf/54/4b/annrheumdis-2013-204867.PMC4345887.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/Figure 4 Time from symptom onset to diagnosis from the year 2000 to theyear 2011 in 10 416 patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis adjusted for gender, birth year and year of entry into DANBIO.",Non-OADS,/arxiv_data1/oa_pdf/54/4b/annrheumdis-2013-204867.PMC4345887.pdf
"413, 4700 Keele Street, Toronto, Ontario, Canada M3J 1P3; lgins@yorku.ca Received 5 June 2014 Revised 15 October 2014 Accepted 28 October 2014 Published Online First 14 November 2014 ▸http://dx.doi.org/10.1136/ bmjqs-2015-003928 To cite: Ginsburg LR, Tregunno D, Norton PG, et al.",Non-OADS,/arxiv_data1/oa_pdf/2a/44/bmjqs-2014-003277.PMC4345888.pdf
See: http://creativecommons.org/licenses/by- nc/4.0/ REFERENCES 1 Lucian Leape Institute.,Non-OADS,/arxiv_data1/oa_pdf/2a/44/bmjqs-2014-003277.PMC4345888.pdf
http://mcc.ca/ examinations/nac-overview/ (accessed 13 May 2014).,Non-OADS,/arxiv_data1/oa_pdf/2a/44/bmjqs-2014-003277.PMC4345888.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/gutjnl-2014-307213).,Non-OADS,/arxiv_data1/oa_pdf/84/97/gutjnl-2014-307213.PMC4345889.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Fearon ER.,Non-OADS,/arxiv_data1/oa_pdf/84/97/gutjnl-2014-307213.PMC4345889.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Rodriguez-Paredes M, Esteller M. Cancer epigenetics reaches mainstream oncology.",Non-OADS,/arxiv_data1/oa_pdf/98/5a/gutjnl-2014-307094.PMC4345890.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/70/b8/amep-6-135.PMC4345894.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pAdvances in Medical Education and Practice 2015:6 135–141Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  135OriginAl rEsEArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S7745 9Do medical students’ scores using different  assessment instruments predict their scores  in clinical reasoning using a computer-based  simulation?,Non-OADS,/arxiv_data1/oa_pdf/70/b8/amep-6-135.PMC4345894.pdf
Available from: https://members.aamc.org/eweb/DynamicPage.,Non-OADS,/arxiv_data1/oa_pdf/70/b8/amep-6-135.PMC4345894.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/70/b8/amep-6-135.PMC4345894.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/70/b8/amep-6-135.PMC4345894.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/37/17/amep-6-149.PMC4345895.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pAdvances in Medical Education and Practice 2015:6 149–152Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  149OriginAl rEsEArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S6780 4students’ knowledge of, and attitudes toward,  mentoring: a case study at the Master’s Program  in health and hospital Administration saad Al Qahtani King saud bin Abdulaziz University for  health sciences, riyadh, saudi Arabia correspondence: saad Al Qahtani   King saud Bin Abdulaziz University for  health sciences, college of Medicine,   riyadh, PO Box 22490, Postal code  11426, saudi Arabia   Email mcmasterer@hotmail.co mIntroduction:  Mentoring has been defined as a process whereby the mentor guides the mentee  in personal or professional development.",Non-OADS,/arxiv_data1/oa_pdf/37/17/amep-6-149.PMC4345895.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/37/17/amep-6-149.PMC4345895.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/37/17/amep-6-149.PMC4345895.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8b/72/amep-6-143.PMC4345897.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pAdvances in Medical Education and Practice 2015:6 143–148Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  143OriginAl rEsEArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S7731 5Influence of predicting the diagnosis from history  on the accuracy of physical examination Kiyoshi Shikino Masatomi Ikusaka Y oshiyuki Ohira Masahito Miyahara Shingo Suzuki Misa Hirukawa Kazutaka Noda T omoko Tsukamoto Takanori Uehara Department of General Medicine,   Chiba University Hospital, Chiba,   Chiba Prefecture, Japan Correspondence: Kiyoshi Shikino   Department of General Medicine,   Chiba University Hospital, 1-8-1, Inohana,  Chuo-ku, Chiba, Chiba Prefecture, Japan   Tel +81 43 222 7171 (ext 6438);   +81 43 224 4758 (direct line)   Fax +81 43 224 4758   Email kshikino@gmail.co mBackground:  This study aimed to clarify the influence of predicting a correct diagnosis from  the history on physical examination by comparing the diagnostic accuracy of auscultation with  and without clinical information.",Non-OADS,/arxiv_data1/oa_pdf/8b/72/amep-6-143.PMC4345897.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/8b/72/amep-6-143.PMC4345897.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8b/72/amep-6-143.PMC4345897.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Corrado D, Pelliccia A, Heidbuchel H, et al.",Non-OADS,/arxiv_data1/oa_pdf/4c/96/heartjnl-2014-306437.PMC4345900.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/annrheumdis-2014-205743).,Non-OADS,/arxiv_data1/oa_pdf/83/02/annrheumdis-2014-205743.PMC4345902.pdf
"Correspondence to Dr Mohit Kapoor, The TorontoWestern Research Institute, Toronto Western Hospital, The University Health Network(UHN), 60 Leonard Avenue,Toronto, Ontario, M5T 2S8, Canada; mkapoor@uhnresearch.ca Received 14 April 2014 Revised 18 November 2014Accepted 7 December 2014 Published Online First 8 January 2015 ▸http://dx.doi.org/10.1136/ annrheumdis-2014-206884 To cite: Vasheghani F, Zhang Y, Li Y-H, et al.Ann Rheum Dis 2015; 74:569– 578.ABSTRACT Objectives We have previously shown that peroxisome proliferator-activated receptor gamma (PPAR γ), a transcription factor, is essential for the normal growthand development of cartilage.",Non-OADS,/arxiv_data1/oa_pdf/83/02/annrheumdis-2014-205743.PMC4345902.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Kuettner KE, Cole AA.",Non-OADS,/arxiv_data1/oa_pdf/83/02/annrheumdis-2014-205743.PMC4345902.pdf
See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 NICE: CG85 —Glaucoma: diagnosis and management of chronic open angle glaucoma and ocular hypertension.,Non-OADS,/arxiv_data1/oa_pdf/d0/39/bjophthalmol-2014-305588.PMC4345905.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Singh JA, Furst DE, Bharat A, et al.",Non-OADS,/arxiv_data1/oa_pdf/0f/30/annrheumdis-2014-206149.PMC4345907.pdf
2013. http://packageinserts.bms.com/pi/pi_orencia.,Non-OADS,/arxiv_data1/oa_pdf/0f/30/annrheumdis-2014-206149.PMC4345907.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/annrheumdis-2013-204195).,Non-OADS,/arxiv_data1/oa_pdf/c8/5a/annrheumdis-2013-204195.PMC4345908.pdf
See: http://creativecommons.org/ licenses/by-nc/3.0/REFERENCES 1 Abbott Laboratories.,Non-OADS,/arxiv_data1/oa_pdf/c8/5a/annrheumdis-2013-204195.PMC4345908.pdf
Last revised September 2012. http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/125057s232lbl.pdf (accessed 17 Apr 2013).,Non-OADS,/arxiv_data1/oa_pdf/c8/5a/annrheumdis-2013-204195.PMC4345908.pdf
Last revised November 2012. http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/ 125160s189lbl.pdf (accessed 17 Apr 2013).,Non-OADS,/arxiv_data1/oa_pdf/c8/5a/annrheumdis-2013-204195.PMC4345908.pdf
Last revised December 2012. http://www.accessdata.fda.,OADS,/arxiv_data1/oa_pdf/c8/5a/annrheumdis-2013-204195.PMC4345908.pdf
Last revised March 2013. http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/103772s5345lbl.pdf (accessed 17 Apr 2013).,Non-OADS,/arxiv_data1/oa_pdf/c8/5a/annrheumdis-2013-204195.PMC4345908.pdf
Last revised November 2012. http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/125289s070lbl.pdf (accessed 17 Apr 2013).,Non-OADS,/arxiv_data1/oa_pdf/c8/5a/annrheumdis-2013-204195.PMC4345908.pdf
http://SEER.cancer.gov/about/overview.html (accessed 17 Apr2013).,Non-OADS,/arxiv_data1/oa_pdf/c8/5a/annrheumdis-2013-204195.PMC4345908.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ annrheumdis-2014-206624).,OADS,/arxiv_data1/oa_pdf/a1/d1/annrheumdis-2014-206624.PMC4345910.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Nicola PJ, Maradit-Kremers H, Roger VL, et al.",Non-OADS,/arxiv_data1/oa_pdf/a1/d1/annrheumdis-2014-206624.PMC4345910.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/REFERENCES 1 Akl EA, Gaddam S, Gunukula SK, et al .",Non-OADS,/arxiv_data1/oa_pdf/60/8c/tobaccocontrol-2014-051907.PMC4345918.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Horsley T, Grimshaw J, Campbell C. Maintaining the competence of Europe ’s workforce.",Non-OADS,/arxiv_data1/oa_pdf/af/a7/postgradmedj-2014-132965.PMC4345919.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ heartjnl-2014-306389).,Non-OADS,/arxiv_data1/oa_pdf/3f/43/heartjnl-2014-306389.PMC4345920.pdf
"4,Commercial Complex, Sector-C, Pocket-9, Vasant Kunj, New Delhi 110070, India;dprabhakaran@ccdcindia.org Received 19 June 2014 Revised 31 October 2014 Accepted 3 November 2014 Published Online First23 December 2014 ▸http://dx.doi.org/10.1136/ heartjnl-2014-306946 To cite: Roy A, Roe MT, Neely ML, et al.Heart 2015; 101:279 –286.ABSTRACT Objective To study the impact of national economic and human development status on patient pro ﬁles and outcomes in the setting of acute coronary syndrome (ACS).Methods We conducted a retrospective analysis of the Targeted Platelet Inhibition to Clarify the Optimal Strategyto Medically Manage Acute Coronary Syndromes trial(TRILOGY ACS) population (51 countries; 9301 patients).Outcome measures compared baseline characteristics andclinical outcomes through 30 months by 2010 country-level United Nations Human Development Indices (HDIs)and per-capita gross national income.Results TRILOGY ACS enrolled 3659 patients from 27 very-high HDI countries, 3744 from 18 high-HDI countriesand 1898 from 6 medium-HDI countries.",Non-OADS,/arxiv_data1/oa_pdf/3f/43/heartjnl-2014-306389.PMC4345920.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Glickman SW, McHutchison JG, Peterson ED, et al.",Non-OADS,/arxiv_data1/oa_pdf/3f/43/heartjnl-2014-306389.PMC4345920.pdf
http://hdr.undp.org/en/ reports/global/hdr2010/ (accessed 23 Sep 2013).,OADS,/arxiv_data1/oa_pdf/3f/43/heartjnl-2014-306389.PMC4345920.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/sextrans-2014-051674).,Non-OADS,/arxiv_data1/oa_pdf/b4/1c/sextrans-2014-051674.PMC4345922.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Sarkar K, Bal B, Mukherjee R, et al.",Non-OADS,/arxiv_data1/oa_pdf/b4/1c/sextrans-2014-051674.PMC4345922.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/11/27/ccid-8-105.PMC4345923.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical, Cosmetic and Investigational Dermatology 2015:8 105–111Clinical, Cosmetic and Investigational Dermatology Dove press submit your manuscript | www.dovepress.co m Dove press  105OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CCID.S7828 7scabies among primary schoolchildren in egypt:  sociomedical environmental study in Kafr   el-sheikh administrative area Doaa salah hegab1 abdullah Mahfouz Kato1 Ibrahim ali Kabbash2 ghada Maged Dabish3 1Department of Dermatology and  Venereology, Faculty of Medicine,   2Department of Public health and  Community, Faculty of Medicine,   3Faculty of Medicine, Tanta University,   Tanta, egypt Correspondence: Doaa salah hegab   Department of Dermatology and  Venereology, Faculty of Medicine,   Tanta University hospitals,   el geish street, Tanta 31111, egypt   Tel +20 12 2450 0857   email doaasalahhegab@yahoo.co mBackground/objectives:  Scabies is a major global public health issue that might affect people  from all socioeconomic levels.",Non-OADS,/arxiv_data1/oa_pdf/11/27/ccid-8-105.PMC4345923.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/11/27/ccid-8-105.PMC4345923.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/11/27/ccid-8-105.PMC4345923.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/17/77/cia-10-491.PMC4345924.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 491–497Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  491OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S7045 2Inertial sensors as measurement tools of elbow  range of motion in gerontology g sacco1–3,* JM T urpin3,4,* A Marteu5 C sakarovitch6 B T eboul2 l Boscher4,5 P Brocker4 P robert1–3 O guerin2,3,7 1Memory Center, Claude Pompidou  Institut, Department of geriatrics,   University hospital of nice, nice,   France; 2Centre d’Innovation  et d’Usages en santé (CIU-s),   University hospital of nice, Cimiez  hospital, nice, France; 3CoBTeK  Cognition Behaviour Technology  eA 7276, research Center edmond  and lily safra, nice sophia- Antipolis University, nice, France;   4rehabilitation Unit, Department  of geriatrics, University hospital  of nice, Cimiez hospital, nice, France;   5rehabilitation Unit, Department  of neurosciences, University hospital  of nice, l’Archet hospital, nice,   France; 6Department of Clinical  research and Innovation, University  hospital of nice, Cimiez hospital,   nice, France; 7Acute geriatrics Unit,   Department of geriatrics, University  hospital of nice, Cimiez hospital,   nice, France *These authors contributed equally  to this workBackground and purpose:  Musculoskeletal system deterioration among the aging is a major  reason for loss of autonomy and directly affects the quality of life of the elderly.",Non-OADS,/arxiv_data1/oa_pdf/17/77/cia-10-491.PMC4345924.pdf
"Within  a clinical setting, physiotherapists do have technical references: the goniometer and  inclinometer are valid instruments;5–7 however, positioning of these tools is not easy  with some joints.8–10 Other techniques are also used in tests: the meter ribbon (easy use  for estimating improvement in range of motion [ROM] but not adapted to a unique  assessment) and visual assessment (often practiced in clinical tests but subjective and  not entirely replicable).11,12 It seemed necessary to find an instrument that would allow  a combination of all the assets of those reference techniques – that is, an instrument  that is reliable and replicable but also simple, fast, and easy to use.Correspondence: g sacco Memory Center, Institut Claude  Pompidou, Department of geriatrics,  University hospital of nice, 10 rue  Molière, 06100 nice, France Tel +33 6 0973 3254 email sacco.g@chu-nice.f r Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Sacco et al Running head recto: An inertial sensor for measuring elbow range of motion DOI: http://dx.doi.org/10.2147/CIA.S70452",Non-OADS,/arxiv_data1/oa_pdf/17/77/cia-10-491.PMC4345924.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/17/77/cia-10-491.PMC4345924.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/17/77/cia-10-491.PMC4345924.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/53/b6/ceor-7-123.PMC4345925.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinicoEconomics and Outcomes Research 2015:7 123–132ClinicoEconomics and Outcomes Research Dove press submit your manuscript | www.dovepress.co m Dove press  123ORiginal REsEaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEOR.S7552 3Medical resource utilization and costs associated  with autosomal dominant polycystic kidney  disease in the Usa: a retrospective matched  cohort analysis of private insurer data Tyler Knight1 Caroline schaefer1 holly Krasa2 Dorothee Oberdhan2 arlene Chapman3 Ronald D Perrone4 1Covance Market access services  inc., gaithersburg, MD,  2Otsuka  Pharmaceutical Development and  Commercialization, inc., Rockville,   MD, 3Emory University, atlanta,    ga, 4T ufts Medical Center and T ufts  University school of Medicine,    Boston, M a, Usa Correspondence: Tyler Knight   Covance Market access services   inc., 9800 Washingtonian Blvd,   gaithersburg, MD 20878, Usa   Tel +1 240 632 3000  Fax +1 240 632 3001  Email tyler.knight@covance.co mBackground:  Autosomal dominant polycystic kidney disease (ADPKD) results in kidney cyst  development and enlargement, resulting in chronic kidney disease (CKD) leading to renal failure.",Non-OADS,/arxiv_data1/oa_pdf/53/b6/ceor-7-123.PMC4345925.pdf
"ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinicoeconomics-and-outcomes-research-journa lClinicoEconomics & Outcomes Research is an international, peer- reviewed open-access journal focusing on Health Technology Assess - ment, Pharmacoeconomics and Outcomes Research in the areas of  diagnosis, medical devices, and clinical, surgical and pharmacological  intervention.",Non-OADS,/arxiv_data1/oa_pdf/53/b6/ceor-7-123.PMC4345925.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/53/b6/ceor-7-123.PMC4345925.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e1/31/copd-10-389.PMC4345936.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 389–397International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  389OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S7584 0self-reported sleep quality and acute exacerbations  of chronic obstructive pulmonary disease Jeanne geiger-Brown1 sarah lindberg2 samuel Krachman3 Charlene e Mcevoy4 gerard J Criner3 John e Connett2 richard K albert5 steven M scharf6 1Center for health Outcomes  research, University of Maryland  school of nursing, Baltimore,  MD, 2University of Minnesota  school of Public health, Division  of Biostatistics, Minneapolis, M n,  3Pulmonary and Critical Care  Medicine, Department of Medicine,  T emple University school of Medicine,  Philadelphia, P a, 4health Partners  Institute of education and research,  st Paul, M n, 5The Medicine service,  Denver health and Department  of Medicine, the University  of Colorado Denver health sciences  Center, Denver, CO, 6Department of  Medicine, Pulmonary and Critical Care  Division, University of Maryland school  of Medicine, Baltimore, MD, UsaBackground:  Many patients with chronic obstructive pulmonary disease (COPD) suffer from  poor sleep quality.",Non-OADS,/arxiv_data1/oa_pdf/e1/31/copd-10-389.PMC4345936.pdf
"In this secondary analysis Correspondence: steven M scharf sleep Disorders Center, University  of Maryland, 100 n greene  street, 2nd Floor, Baltimore,  MD 21201-1192, Usa Tel +1 410 706 4771 Fax +1 410 706 0345 email sscharf@medicine.umaryland.ed u Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Geiger-Brown et al Running head recto: Sleep quality and exacerbations DOI: http://dx.doi.org/10.2147/COPD.S75840",Non-OADS,/arxiv_data1/oa_pdf/e1/31/copd-10-389.PMC4345936.pdf
Avail - able from: http://www.goldcopd.org /.,Non-OADS,/arxiv_data1/oa_pdf/e1/31/copd-10-389.PMC4345936.pdf
Available from: http://www.whocc.,Non-OADS,/arxiv_data1/oa_pdf/e1/31/copd-10-389.PMC4345936.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/e1/31/copd-10-389.PMC4345936.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e1/31/copd-10-389.PMC4345936.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b3/f4/clep-7-213.PMC4345937.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Epidemiology 2015:7 213–223Clinical Epidemiology Dove press submit your manuscript | www.dovepress.co m Dove press  213Original rEsEarChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CLEP .S7814 5statin prescription patterns, adherence,   and attainment of cholesterol treatment   goals in routine clinical care: a Danish   population-based study Elisabeth svensson1 rikke Beck nielsen1 Pål hasvold2 Pernilla aarskog2 reimar W Thomsen1 1Department of Clinical Epidemiology,  institute of Clinical Medicine,  aarhus University hospital, aarhus,  Denmark;  2astraZeneca nordic  Baltic, södertälje, sweden Correspondence: Elisabeth svensson   Department of Clinical Epidemiology,  aarhus University, Olof Palmes   allé 43-45, 8200 aarhus n, Denmark   Tel +45 8716 6351  Fax +45 8716 7215  Email e lisabeth.svensson@dce.au.d kPurpose:  To examine the annual rate and cumulative prevalence of statin use in Denmark   2004–10, including adherence of use and attainment of cholesterol targets.",Non-OADS,/arxiv_data1/oa_pdf/b3/f4/clep-7-213.PMC4345937.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica - tion of risk factors and screening procedures to develop optimal pre - ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/b3/f4/clep-7-213.PMC4345937.pdf
Available  from: http://nbv.cardio.dk/dyslipidaemi.,Non-OADS,/arxiv_data1/oa_pdf/b3/f4/clep-7-213.PMC4345937.pdf
Available from: http://www.irf.dk/dk/nyheder/kan_kolesterolpatienter_ behandles_bedre.htm .,Non-OADS,/arxiv_data1/oa_pdf/b3/f4/clep-7-213.PMC4345937.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6f/54/ccid-8-095.PMC4345938.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical, Cosmetic and Investigational Dermatology 2015:8 95–104Clinical, Cosmetic and Investigational Dermatology Dove press submit your manuscript | www.dovepress.co m Dove press  95OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CCID.S7544 1effects of plant sterols derived from Aloe vera    gel on human dermal fibroblasts in vitro and   on skin condition in Japanese women Miyuki Tanaka1 eriko Misawa1 Koji Yamauchi1 Fumiaki Abe1 Chiaki Ishizaki2 1Functional Food research  Department, Food science and  Technology Institute, Morinaga Milk  Industry Co, ltd, Zama, Kanagawa,   2Ebisu Skin Research Center,   Inforward, Inc., T okyo, Japan Correspondence: Miyuki Tanaka   Functional Food research Department,  Food science and Technology Institute,  Morinaga Milk Industry Co, ltd, 1-83,  higashihara 5-Chome, Zama, Kanagawa  252-8583, Japan   Tel +81 046 252 3070   Fax +81 046 252 3049   email m_tanaka@morinagamilk.co.j pBackground:   Aloe is known for its topical use for treating wounds and burns.",Non-OADS,/arxiv_data1/oa_pdf/6f/54/ccid-8-095.PMC4345938.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/6f/54/ccid-8-095.PMC4345938.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6f/54/ccid-8-095.PMC4345938.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a5/36/ijn-10-1505.PMC4345939.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 1505–1519International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1505OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7521 3exceedingly biocompatible and thin-layered  reduced graphene oxide nanosheets using an  eco-friendly mushroom extract strategy Kasturi Muthoosamy1 renu geetha Bai1 Ibrahim Babangida  abubakar2 surya Mudavasseril  sudheer1 hong Ngee lim3 hwei-san loh2,4 Nay Ming huang5 chin hua chia6 sivakumar Manickam1 1Manufacturing and Industrial  Processes research Division,   Faculty of engineering, 2school  of Biosciences, Faculty of science,   University of Nottingham Malaysia  campus, semenyih, selangor,   Malaysia; 3Department of chemistry,   Faculty of science, Universiti  Putra Malaysia, serdang, selangor,   Malaysia; 4Biotechnology research  centre, University of Nottingham  Malaysia campus, semenyih, selangor,   Malaysia; 5low Dimension Materials  research centre, Department  of Physics, Faculty of science,   University of Malaya, Kuala lumpur,   Malaysia; 6school of applied Physics,   Faculty of science and T echnology,   Universiti Kebangsaan Malaysia,   Bangi,  selangor,  MalaysiaPurpose:  A simple, one-pot strategy was used to synthesize reduced graphene oxide (RGO)  nanosheets by utilizing an easily available over-the-counter medicinal and edible mushroom,  Ganoderma lucidum .",Non-OADS,/arxiv_data1/oa_pdf/a5/36/ijn-10-1505.PMC4345939.pdf
edu.m y Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Muthoosamy et al Running head recto: Biocompatible and thin-layered reduced graphene oxide DOI: http://dx.doi.org/10.2147/IJN.S75213,Non-OADS,/arxiv_data1/oa_pdf/a5/36/ijn-10-1505.PMC4345939.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/a5/36/ijn-10-1505.PMC4345939.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a5/36/ijn-10-1505.PMC4345939.pdf
Competing Interests All authors have completed the Uniﬁed Competing Inter- est form at http://www.icmje.org/coi_disclosure.pdf (avail- able on request from the corresponding author) and declare: no support from any organization for the submit- ted work; no ﬁnancial relationships with any organizations that might have an interest in the submitted work in the previous 3 years; no other relationships or activities that could appear to have inﬂuenced the submitted work.,Non-OADS,/arxiv_data1/oa_pdf/63/ff/bcp0079-0446.PMC4345955.pdf
Available at http://www.who.int/mediacentre/factsheets/fs338/en/ (last accessed 28 June 2013).,Non-OADS,/arxiv_data1/oa_pdf/63/ff/bcp0079-0446.PMC4345955.pdf
Available at http://www.who.int/childmedicines/en/index.html (last accessed 28 June 2013).,Non-OADS,/arxiv_data1/oa_pdf/63/ff/bcp0079-0446.PMC4345955.pdf
Available at http://www.who.int/selection_medicines/list/WMFc_2010.pdf (last accessed 28 August 2013).,Non-OADS,/arxiv_data1/oa_pdf/63/ff/bcp0079-0446.PMC4345955.pdf
Available at http://antibiotic-action.com (last accessed 25 August 2013).,Non-OADS,/arxiv_data1/oa_pdf/63/ff/bcp0079-0446.PMC4345955.pdf
Available at http://webarchive.nationalarchives.gov.uk/ +/http://www .dﬁd.gov.uk/Pubs/ﬁles/atm-factsheet0106.pdf (last accessed 28 August 2013).,Non-OADS,/arxiv_data1/oa_pdf/63/ff/bcp0079-0446.PMC4345955.pdf
Available at http://apps.who.int/medicinedocs/en/d/Js6160e/9.html (last accessed 28 August 2013).,OADS,/arxiv_data1/oa_pdf/63/ff/bcp0079-0446.PMC4345955.pdf
"Available at http://healthexchangenews.com/ (last accessed 28 August 2013).26Holloway K, van Dijk L. The World Medicines Situation 2011, Rational Use of Medicines, 3rd edn.",Non-OADS,/arxiv_data1/oa_pdf/63/ff/bcp0079-0446.PMC4345955.pdf
Available at http://apps.who.int/iris/bitstream/10665/81170/ 1/9789241548373_eng.pdf (last accessed 28 August 2013).,OADS,/arxiv_data1/oa_pdf/63/ff/bcp0079-0446.PMC4345955.pdf
Available at http://bnfc.org/bnfc/ (last accessed 28 August 2013).,Non-OADS,/arxiv_data1/oa_pdf/63/ff/bcp0079-0446.PMC4345955.pdf
Available at http://www.who.int/hinari/en/ (last accessed 28 August 2013).,Non-OADS,/arxiv_data1/oa_pdf/63/ff/bcp0079-0446.PMC4345955.pdf
Available at http://www.eupﬁ.org/ Conference2012webpage/Conferenceproceedings/ abstractsforpublication.pdf (last accessed 28 August 2013).,Non-OADS,/arxiv_data1/oa_pdf/63/ff/bcp0079-0446.PMC4345955.pdf
"Competing Interests All authors have completed the Uniﬁed Competing Inter- est form at http://www.icmje.org/coi_disclosure.pdf (avail- able on request from the corresponding author) and declare the study received funding from Elevation Phar- maceuticals Inc., now incorporated with Sunovion Pharmaceuticals Inc. BRL has received research funding from AstraZeneca and Pﬁzer in the previous 3 years.",Non-OADS,/arxiv_data1/oa_pdf/0a/d6/bcp0079-0492.PMC4345959.pdf
Available at https://www.clinicaltrialsregister.eu/ctr-search/trial/2011 -003588-31/GB (last accessed 9 October 2014).,Non-OADS,/arxiv_data1/oa_pdf/0a/d6/bcp0079-0492.PMC4345959.pdf
Available at https://www.clinicaltrialsregister.eu/ctr-search/trial/ 2011-004759-37/GB (last accessed 9 October 2014).,Non-OADS,/arxiv_data1/oa_pdf/0a/d6/bcp0079-0492.PMC4345959.pdf
Available at http://www.fda.gov/ downloads/Drugs/Guidances/UCM072137.pdf (last accessed 22 July 2014).,Non-OADS,/arxiv_data1/oa_pdf/04/e0/bcp0079-0514.PMC4345961.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/53/47/ndt-11-453.PMC4345972.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 453–459Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  453OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S7649 4Influence of 5-HT1A  and 5-HTTLPR  genetic  variants on the schizophrenia symptoms and  occurrence of treatment-resistant schizophrenia T ea T erzić1 Matej Kastelic2 Vita Dolžan2 Blanka Kores Plesničar1 1ljubljana University Psychiatric  hospital, ljubljana, slovenia;   2Pharmacogenetics laboratory,   Institute of Biochemistry, Faculty  of Medicine, University of Ljubljana,   ljubljana, sloveniaAbstract:  This study aimed to explore the influence of two genetic polymorphisms of the  5-hydroxytryptamine 1A receptor ( 5-HT1A ) and solute carrier family 6, member 4 ( SLC6A4 )  genes on the clinical symptoms and treatment resistance in Slovenian patients with schizophre - nia.",Non-OADS,/arxiv_data1/oa_pdf/53/47/ndt-11-453.PMC4345972.pdf
"5-HT1A is a subtype  of the serotonergic receptor that has an important influence on dopamine release.5 Correspondence: Blanka Kores Plesničar ljubljana University Psychiatric hospital,  studenec 48, 1260 ljubljana, slovenia Tel +386 1 587 24 67 Fax +386 1 529 41 11  email blanka.kores@psih-klinika.s i Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Terzi ć et al Running head recto: Serotonergic genetic variants and schizophrenia DOI: http://dx.doi.org/10.2147/NDT.S76494",Non-OADS,/arxiv_data1/oa_pdf/53/47/ndt-11-453.PMC4345972.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/53/47/ndt-11-453.PMC4345972.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/53/47/ndt-11-453.PMC4345972.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ annrheumdis-2013-204845).,OADS,/arxiv_data1/oa_pdf/6e/ea/annrheumdis-2013-204845.PMC4345975.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Goldstone DC, Ennis-Adeniran V, Hedden JJ, et al.",Non-OADS,/arxiv_data1/oa_pdf/6e/ea/annrheumdis-2013-204845.PMC4345975.pdf
"ORIGINAL ARTICLE The SPORTSMART study: a pilot randomised controlled trial of sexually transmitted infectionscreening interventions targeting men in footballclub settings Sebastian S Fuller,1Catherine H Mercer,2Andrew J Copas,2John Saunders,3 Lorna J Sutcliffe,3Jackie A Cassell,4Graham Hart,5Anne M Johnson,6 Tracy E Roberts,7Louise J Jackson,7Pamela Muniina,2Claudia S Estcourt3 1Queen Mary University of London, UK (where theresearch took place) 2Centre for Sexual Health and HIV Research, University College London, London, UK 3Blizard Institute of Cell and Molecular Science, Queen Mary, University of London, London, UK 4Division of Primary Care and Public Health, Brighton and Sussex Medical School, Brighton, UK 5Faculty of Population Health Sciences, University College London, London, UK 6Department of Infection & Population Health, UniversityCollege London, London, UK 7Department of Health Economics Facility, University ofBirmingham, Birmingham, UK Correspondence to Dr Sebastian S Fuller, St George ’s, University of London, Infection and Immunityresearch institute, Cranmer Terrace, London, UK, SW17 0RE;sfuller@sgul.ac.uk Received 4 June 2014 Revised 14 September 2014 Accepted 24 November 2014 Published Online First15 December 2014 ▸http://dx.doi.org/10.1136/ sextrans-2014-051715 To cite: Fuller SS, Mercer CH, Copas AJ, et al.",Non-OADS,/arxiv_data1/oa_pdf/dc/86/sextrans-2014-051719.PMC4345976.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Public Health England.,Non-OADS,/arxiv_data1/oa_pdf/dc/86/sextrans-2014-051719.PMC4345976.pdf
"2013. http://www.amateurfootballcombination.com/ clubs/list/ 33 Hengel B, Jamil MS, Mein JK, et al.",Non-OADS,/arxiv_data1/oa_pdf/dc/86/sextrans-2014-051719.PMC4345976.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Kuper H, Marmot M, Hemingway H. Systematic review of prospective cohort studies of psychosocial factors in the etiology and prognosis of coronary heart disease.",Non-OADS,/arxiv_data1/oa_pdf/de/10/oemed-2014-102256.PMC4345978.pdf
See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES References linked to data-based articles (included in table 1) are identi ﬁed by level(s) of the EMHP tackled.,OADS,/arxiv_data1/oa_pdf/fd/7b/tobaccocontrol-2014-051906.PMC4345979.pdf
"https://uwspace.uwaterloo.ca/bitstream/handle/10012/7419/Mohammed_HebaTallah.pdf?sequence=1 163 Grekin ER, Ayna D. Argileh use among college students in the United States: an emerging trend.",Non-OADS,/arxiv_data1/oa_pdf/fd/7b/tobaccocontrol-2014-051906.PMC4345979.pdf
http://www.who.int/tobacco/mpower/en/ (accessed 25 Sep 2014).,Non-OADS,/arxiv_data1/oa_pdf/fd/7b/tobaccocontrol-2014-051906.PMC4345979.pdf
"http://www.youtube.com/watch?v=pTgxMSjbF7Q 173 Abouaziza E, Eissenberg T. Waterpipe tobacco smoking: what is the evidence that it supports nicotine/tobacco dependence?",Non-OADS,/arxiv_data1/oa_pdf/fd/7b/tobaccocontrol-2014-051906.PMC4345979.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ References EV ANS, J. M., LANE, D. R. & HENDY , P .",Non-OADS,/arxiv_data1/oa_pdf/b5/3b/vetrec-2014-102786.PMC4345980.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/annrheumdis-2013-203913).,Non-OADS,/arxiv_data1/oa_pdf/e8/7d/annrheumdis-2013-203913.PMC4345981.pdf
"Competing interests All authors have completed the ICMJE uniform disclosure form at http://www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organisation for the submitted work other than detailed above; JJE, MK and JB provide general medicalservices and bene ﬁtﬁnancially from the Quality and Outcomes Framework (which does not currently include osteoarthritis), KSD has been an invited speaker to the EULAR conference and a member of the NICE OA guideline development group — Keele University have received payments and reimbursements of travel and otherexpenses related to these activities.",Non-OADS,/arxiv_data1/oa_pdf/e8/7d/annrheumdis-2013-203913.PMC4345981.pdf
See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 RCGP Birmingham Research Unit.,Non-OADS,/arxiv_data1/oa_pdf/e8/7d/annrheumdis-2013-203913.PMC4345981.pdf
Weekly Returns Service Annual Prevalence Report 2007. http://www.rcgp.org.uk/clinical-and-research/~/media/Files/CIRC/CIRC%2076%20-%2080/BRU_Annual_prevalence_report_2007.ashx 2 National Collaborating Centre for Chronic Conditions.,Non-OADS,/arxiv_data1/oa_pdf/e8/7d/annrheumdis-2013-203913.PMC4345981.pdf
http://www.ahrq.gov23 University of Oxford: Centre for Evidence Based Medicine.,Non-OADS,/arxiv_data1/oa_pdf/e8/7d/annrheumdis-2013-203913.PMC4345981.pdf
"Levels of Evidence 2009. http://www.cebm.net/index.aspx?o=1025 24 Campbell SM, Cantrill JA.",OADS,/arxiv_data1/oa_pdf/e8/7d/annrheumdis-2013-203913.PMC4345981.pdf
"2012. http://www.eumusc.net/ workpackages_wp6.cfm 56 Higgins JPT, Green S. eds.",Non-OADS,/arxiv_data1/oa_pdf/e8/7d/annrheumdis-2013-203913.PMC4345981.pdf
2013. http://www.nhsemployers.,Non-OADS,/arxiv_data1/oa_pdf/e8/7d/annrheumdis-2013-203913.PMC4345981.pdf
"MATERIALS AND METHODS Gene expression microarray Publicly available Affymetrix GeneChip Human Genome U133 Plus 2.0 microarray data from 138clear cell RCC samples and 22 normal kidneytissue samples were downloaded from the GeneExpression Omnibus (http://www.ncbi.nlm.nih.gov/geo, accession ID: GSE17895) and processed usingthe R statistical software (http://www.r-project.org)and open-source BioConductor (http://www.bioconductor.org) packages.",OADS,/arxiv_data1/oa_pdf/69/f9/jclinpath-2014-202735.PMC4345982.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Snow RM, Schellhammer PF.",Non-OADS,/arxiv_data1/oa_pdf/69/f9/jclinpath-2014-202735.PMC4345982.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/tobaccocontrol-2014-051911).,Non-OADS,/arxiv_data1/oa_pdf/2a/cc/tobaccocontrol-2014-051911.PMC4345984.pdf
"METHODS T wo sources of data were used: (1) legislation compiled by thewebsite T obacco Control Laws (http://www.tobaccocontrollaws.org), and (2) news articles received by email from the internetcontent retrieving service ‘Google Alerts ’(http://www.google.",Non-OADS,/arxiv_data1/oa_pdf/2a/cc/tobaccocontrol-2014-051911.PMC4345984.pdf
Enactment and enforcement of WTS legislation Eligibility criteria W e used the automatic internet content retrieving service ‘Google Alerts ’(http://www.google.com/alerts) to receive news articles by email.,Non-OADS,/arxiv_data1/oa_pdf/2a/cc/tobaccocontrol-2014-051911.PMC4345984.pdf
"For example, in the case of W ashingtonDC, under the exemption, waterpipe lounges are permitted tooperate given that ‘a majority of the revenue generated from the business must come from smoking, not food, wine or beer ’(In the Capital, September 17, 2013; http://bit.ly/ZmiRte) Articles from the UK mainly addressed the growing number of waterpipe-serving premises nationwide and dif ﬁculties asso- ciated with enforcing the smoke free legislation.",Non-OADS,/arxiv_data1/oa_pdf/2a/cc/tobaccocontrol-2014-051911.PMC4345984.pdf
"”(Mancunian Matters, 14 April 2014; http://bit.ly/ZmgmqH) ﬁnes ranged from £500 to £5000 for smoke-free law breaches.",Non-OADS,/arxiv_data1/oa_pdf/2a/cc/tobaccocontrol-2014-051911.PMC4345984.pdf
"’ (The Times of India, 4 September 2013; http://bit.ly/1uOihOH).One article suggested that waterpipe-serving premises wereowned by relatives of af ﬂuent people or politicians ‘making them harder to control or impose a ban on ’(Prune Mirror, 27 May 2014; http://bit.ly/1tUsaJL).",Non-OADS,/arxiv_data1/oa_pdf/2a/cc/tobaccocontrol-2014-051911.PMC4345984.pdf
"(The Times ofIndia, 15 July 2013; http://bit.ly/1pgbFDY)Table 3 Nine waterpipe-specific laws from six countries Country Extract from legislation Smoke-free law Costa Rica “It is prohibited to smoke or to hold lit tobacco products and derivatives that discharge smoke, gases or vapors, in any of their forms or in devices, including the electronic cigarette and the waterpipe or hookah and similar devices used to concentrate or discharge smoke, gases or vapors of tobacco products and derivatives, in the following public and private spaces or places, ….”(TC Regs Decree 37185) Israel “Personally or by means of another on his behalf, approached a person smoking or holding a lit cigarette, cigarillo, hookah , cigar or pipe in a public place requesting that he desist from the prohibited act, or took all reasonable steps to ensure the prevention of offenses under subsections 1(A) and 1(B).”(Prevention of Smoking and Exposure in Public Places Act) Turkey “No use of tobacco products shall be allowed in any indoor areas of any public and private buildings, including any places providing entertainment such as cafes, cafeterias, beer houses, hookah places, popular spots and club houses of any organisations and foundations, as well as restaurants.",Non-OADS,/arxiv_data1/oa_pdf/2a/cc/tobaccocontrol-2014-051911.PMC4345984.pdf
"”(Arab New, 24 December 2014; http://bit.ly/1qPRNww) Articles from Pakistan highlighted that sales, promotion, and both indoor and outdoor public consumption of WTS are pro-hibited throughout the country.",Non-OADS,/arxiv_data1/oa_pdf/2a/cc/tobaccocontrol-2014-051911.PMC4345984.pdf
"’(Pakistan today, 8 July 2013; http://bit.ly/1m7xR8k) DISCUSSION This manuscript is the ﬁrst to provide a review of how WTS regulation is addressed in current tobacco control frameworksglobally as well as is the ﬁrst documentation of the challenges and experiences some countries face in regulating WTS.",Non-OADS,/arxiv_data1/oa_pdf/2a/cc/tobaccocontrol-2014-051911.PMC4345984.pdf
"With regards to limitations, the T obacco Control Laws website acknowledges several limitations of their project (http://www.tobaccocontrollaws.org/learn-more/about/) and brie ﬂy includes the dif ﬁculties in reviewing laws when in-country lawyers are not contactable (leading to uncertainty in legislativeinterpretations), lack of subnational analyses which may addressWTS differently and the lack of real time updates.",Non-OADS,/arxiv_data1/oa_pdf/2a/cc/tobaccocontrol-2014-051911.PMC4345984.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Fong G, Cummings K, Shopland D. Building the evidence base for effective tobacco control policies: the International Tobacco Control Policy Evaluation Project (the ITC Project).",Non-OADS,/arxiv_data1/oa_pdf/2a/cc/tobaccocontrol-2014-051911.PMC4345984.pdf
http://www.gpo.gov/fdsys/pkg/PLAW-111publ31/ pdf/PLAW-111publ31.pdf (accessed 1 Dec 2014).,Non-OADS,/arxiv_data1/oa_pdf/2a/cc/tobaccocontrol-2014-051911.PMC4345984.pdf
2014. http://tobacco.ucsf.edu/sites/tobacco.ucsf.edu/ ﬁles/u9/FDA-comment-%20Deeming%20Hookah% 20-%20Final%20-%206-27-2014%20%282%29.pdf (accessed 8 Sep 2014).,Non-OADS,/arxiv_data1/oa_pdf/2a/cc/tobaccocontrol-2014-051911.PMC4345984.pdf
20 February 2013. http://publichealthlawcenter.org/sites/default/ ﬁles/ pdf/tclc-fs-regulatory-options-hookahs-2013.pdf (accessed 11 Sep 2014).,Non-OADS,/arxiv_data1/oa_pdf/2a/cc/tobaccocontrol-2014-051911.PMC4345984.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 White A, Ernst E. A brief history of acupuncture.",Non-OADS,/arxiv_data1/oa_pdf/80/d2/acupmed-2014-010650.PMC4345985.pdf
"http://www.plosone.orgOriginal paper Kang Y-T, et al.Acupunct Med 2015; 33:36–41.",Non-OADS,/arxiv_data1/oa_pdf/80/d2/acupmed-2014-010650.PMC4345985.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/thoraxjnl-2014-205940).,Non-OADS,/arxiv_data1/oa_pdf/0b/ea/thoraxjnl-2014-205940.PMC4345987.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Figure 5 Relationship between peak glottic narrowing ratio (GNR) and dynamic hyperin ﬂation index (DHI) in controls ( ), patients with mild–moderate COPD ( □) and patients with severe COPD ( ▪).",Non-OADS,/arxiv_data1/oa_pdf/0b/ea/thoraxjnl-2014-205940.PMC4345987.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ annrheumdis-2013-203915).,OADS,/arxiv_data1/oa_pdf/23/9f/annrheumdis-2013-203915.PMC4345988.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Schellekens GA, Visser H, de Jong BA, et al.",Non-OADS,/arxiv_data1/oa_pdf/23/9f/annrheumdis-2013-203915.PMC4345988.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Dixon-W oods M, Leslie M, T arrant C, et al.",Non-OADS,/arxiv_data1/oa_pdf/1e/e5/bmjqs-2014-003627.PMC4345989.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/88/65/ndt-11-435.PMC4345990.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 435–452Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  435OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S7754 2safety and effectiveness of controlled-release  paroxetine in routine clinical practice: results  of a postmarketing surveillance study of patients  with depression Masaki Kato1 T oshifumi Kimura2 Takeshi Kimura3 T erufumi hara3 1Department of Neuropsychiatry,   Kansai Medical University, Moriguchi- shi, Osaka, Japan; 2Medical affairs,   3clinical safety and PM s, Development  and Medical affairs Division,   glaxo smithKline K.K., shibuya-ku,   T okyo, JapanObjective:  Selective serotonin reuptake inhibitors are commonly used in the pharmacotherapy  of depression.",Non-OADS,/arxiv_data1/oa_pdf/88/65/ndt-11-435.PMC4345990.pdf
"An analysis of the US Claims Database  revealed that the first choice of treatment was SSRIs in 69.6% and SNRIs in 9.6%  (in total, 79.2%) of depressive patients.1 According to the analysis of the prescription  patterns of antidepressants in East Asia, SSRIs and other newer antidepressants were  also frequently prescribed.2 Different guidelines that have been developed to treat  depressive disorder recommend SSRIs among the first drugs of choice.3–6correspondence: Masaki Kato Department of Neuropsychiatry, Kansai  Medical University, Fumizono-cho 10-15,  Moriguchi-shi, Osaka 570-8506, Japan Tel +81 6 6992 1001 Fax +81 6 6995 2669 email katom@takii.kmu.ac.j pJournal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Kato et al Running head recto: Safety and effectiveness of controlled-release paroxetine in depression DOI: http://dx.doi.org/10.2147/NDT.S77542",Non-OADS,/arxiv_data1/oa_pdf/88/65/ndt-11-435.PMC4345990.pdf
"Available from:  http://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/ guidelines/mdd.pd f. Accessed November 14, 2014.",Non-OADS,/arxiv_data1/oa_pdf/88/65/ndt-11-435.PMC4345990.pdf
"Available  from: http://www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafe - tyInformationforPatientsandProviders  /ucm161696.ht m. Accessed  November 14, 2014.22.",Non-OADS,/arxiv_data1/oa_pdf/88/65/ndt-11-435.PMC4345990.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/88/65/ndt-11-435.PMC4345990.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/88/65/ndt-11-435.PMC4345990.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d6/07/ijn-10-1547.PMC4345991.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 1547–1567International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1547OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7620 8Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Zane et al Running head recto: Bright fluorophore core-silica shell nanoparticles DOI: http://dx.doi.org/10.2147/IJN.S76208 Uptake of bright fluorophore core-silica shell  nanoparticles by biological systems Abstract:  Nanoparticles are used in a variety of consumer applications.,Non-OADS,/arxiv_data1/oa_pdf/d6/07/ijn-10-1547.PMC4345991.pdf
Available from: http://www.nanotechproject.org/cpi/.,Non-OADS,/arxiv_data1/oa_pdf/d6/07/ijn-10-1547.PMC4345991.pdf
Available from: http://www.fda.gov/Food/ GuidanceRegulation/GuidanceDocumentsRegulatoryInformation/ IngredientsAdditivesGRASPackaging/ucm300661.htm.,Non-OADS,/arxiv_data1/oa_pdf/d6/07/ijn-10-1547.PMC4345991.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/d6/07/ijn-10-1547.PMC4345991.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d6/07/ijn-10-1547.PMC4345991.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a6/2d/ijn-10-1463.PMC4345992.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 1463–1477International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1463OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7611 4silica nanoparticles induce oxidative stress,  inflammation, and endothelial dysfunction  in vitro via activation of the MAPK/Nrf2  pathway and nuclear factor- κB signaling caixia guo1,2 Yinye Xia1,2 Piye Niu1,2 Lizhen Jiang1,2 Junchao Duan1,2 Yang Yu1,2 Xianqing Zhou1,2 Yanbo li1,2 Zhiwei Sun1,2 1School of Public Health, 2Beijing  Key Laboratory of Environmental  T oxicology, Capital Medical University,   Beijing, People’s Republic of ChinaAbstract:  Despite the widespread application of silica nanoparticles (SiNPs) in industrial,  commercial, and biomedical fields, their response to human cells has not been fully eluci - dated.",Non-OADS,/arxiv_data1/oa_pdf/a6/2d/ijn-10-1463.PMC4345992.pdf
edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Guo et al Running head recto: Toxicological effects of SiNPs DOI: http://dx.doi.org/10.2147/IJN.S76114,OADS,/arxiv_data1/oa_pdf/a6/2d/ijn-10-1463.PMC4345992.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/a6/2d/ijn-10-1463.PMC4345992.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a6/2d/ijn-10-1463.PMC4345992.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/thoraxjnl-2014-205127).,Non-OADS,/arxiv_data1/oa_pdf/62/23/thoraxjnl-2014-205127.PMC4345993.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Criner GJ, Cordova F, Sternberg AL, et al.",OADS,/arxiv_data1/oa_pdf/62/23/thoraxjnl-2014-205127.PMC4345993.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b4/b8/cia-10-499.PMC4345994.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 499–504Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  499ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S6787 2Association between muscle mass  and adipo-metabolic profile: a cross-sectional  study in older subjects Simone Perna1,* Davide Guido2,* Mario Grassi2 Mariangela Rondanelli1 1Department of Public Health,   Experimental and Forensic Medicine,   School of Medicine, Endocrinology  and Nutrition Unit, University of  Pavia, Azienda di Servizi alla Persona  di Pavia, Pavia, Italy; 2Medical and  Genomic Statistics Unit, Department  of Brain and Behavioral Sciences,   University of Pavia, Pavia, Italy *These authors contributed equally  to this workBackground:  Sarcopenia, the decrease in muscle mass and function, may lead to various nega - tive health outcomes in elderly.",Non-OADS,/arxiv_data1/oa_pdf/b4/b8/cia-10-499.PMC4345994.pdf
"The increase of BMI has already been recognized as one of the well-known risk  factors for many diseases, including metabolic disorders.6 However, in elderly patients  with various diseases, data from a large number of studies show that comparing patients Correspondence: Mariangela Rondanelli Department of Public Health,  Experimental and Forensic Medicine,  School of Medicine, Endocrinology and  Nutrition Unit, University of Pavia,  Azienda di Servizi alla Persona di Pavia,  via Emilia n. 12, 27100 Pavia, Italy Tel +39 03 8238 1749 Fax +39 03 8238 1218 Email mariangela.rondanelli@unipv.i t Journal name: Clinical Interventions in Aging Article Designation: ORIGINAL RESEARCH Y ear: 2015 Volume: 10 Running head verso: Perna et al Running head recto: Association between muscle mass and adipo-metabolic profile DOI: http://dx.doi.org/10.2147/CIA.S67872",Non-OADS,/arxiv_data1/oa_pdf/b4/b8/cia-10-499.PMC4345994.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/b4/b8/cia-10-499.PMC4345994.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/b4/b8/cia-10-499.PMC4345994.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/08/ae/ndt-11-419.PMC4345995.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 419–434Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  419OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S7897 7aripiprazole for the management of schizophrenia  in the Japanese population: a systematic review  and meta-analysis of randomized controlled trials Taro Kishi Yuki Matsuda shinji Matsunaga Nakao iwata Department of Psychiatry, Fujita  health University school of Medicine,   T oyoake, aichi, JapanBackground:  We conducted a systematic review and meta-analysis of randomized  controlled trials comparing aripiprazole with pooled antipsychotics in Japanese patients with  schizophrenia.",Non-OADS,/arxiv_data1/oa_pdf/08/ae/ndt-11-419.PMC4345995.pdf
"Keywords:  Japan, antipsychotics, efficacy, safety, meta-analysis, systematic review Introduction “Aripiprazole”, a third-generation antipsychotic, is a potent, high-affinity, partial  dopamine D2 receptor and serotonin (5-HT)1A receptor agonist and a potent 5-HT2A  receptor antagonist, and has a lower risk of metabolic side effects compared with  second-generation antipsychotics (SGAs).1,2 A recent network meta-analysis showed  that aripiprazole caused more weight gain than placebo, with a small effect size  (standardized mean difference [SMD] =0.17).3 Another meta-analysis showed that  aripiprazole treatment was associated with a lower risk of both weight gain (vs olan - zapine, SMD =-0.42) and an increase in total cholesterol (vs olanzapine, SMD =-0.34;  correspondence: Taro Kishi Department of Psychiatry, Fujita  health University school of Medicine,  1-98 Dengakugakubo,Kutsukake-cho,  Toyoake, aichi 470-1192, Japan Tel +81 562 93 9250 Fax +81 562 93 1831 email tarok@fujita-hu.ac.j p Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Kishi et al Running head recto: Aripiprazole for schizophrenia in the Japanese population DOI: http://dx.doi.org/10.2147/NDT.S78977",Non-OADS,/arxiv_data1/oa_pdf/08/ae/ndt-11-419.PMC4345995.pdf
The minor allele frequencies  rs2283265 ( http://www.ncbi.nlm.nih.gov/projects/SNP/ snp_ref.cgi?rs =228326 5) and rs1076560 ( http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/08/ae/ndt-11-419.PMC4345995.pdf
"For example, the Asian population is reported  to exhibit a higher rate of clozapine-induced agranulocytosis  than other populations.12 Reports have also highlighted dif - ferences in the prevalence of metabolic syndrome and its  predisposition factors, such as diabetes, between races of  individuals without psychiatric disorders.13,14 A recent clinical  study reported that olanzapine caused greater weight gain  in black patients with schizophrenia than in white patients  with schizophrenia.15 The Asian population is reported to  exhibit a higher rate of clozapine-induced agranulocytosis  than other populations.12 Although there is a lower preva - lence of obesity in the Japanese population, there is a higher  rate of diabetes than in other races.16 Metabolic syndrome is  considered a complex disease in which the pathophysiology  of insulin resistance probably includes a gene–environment  interaction.17,18 A recent genome-wide association study  showed that rs489693, which is located approximately 190 kb   downstream from the melanocortin 4 receptor gene, was  associated with antipsychotic-induced weight gain.19 The  minor allele frequency rs489693 also differs between races  of individuals ( http://www.ncbi.nlm.nih.gov/projects/SNP/ snp_ref.cgi?rs =48969 3).",Non-OADS,/arxiv_data1/oa_pdf/08/ae/ndt-11-419.PMC4345995.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/08/ae/ndt-11-419.PMC4345995.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/08/ae/ndt-11-419.PMC4345995.pdf
Available from: http://www.info.pmda.go.jp/shinyaku/P200600001/18  007800_21800AMZ10011_G100_1.pdf#search=’03195003 ’.,Non-OADS,/arxiv_data1/oa_pdf/08/ae/ndt-11-419.PMC4345995.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4e/4d/ijn-10-1521.PMC4345996.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 1521–1545International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1521OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7618 7analyses of protein corona on bare and  silica-coated gold nanorods against four  mammalian cells Minakshi Das1 Dong Kee Yi2 seong soo a an1 1Department of Bionanotechnology,   gachon University, seongnam,   republic of Korea; 2Department of  chemistry, Myongji University, Y ongin,   republic of KoreaAbstract:  The purpose of this study was to investigate the mechanisms responsible for the toxic  effects of gold nanorods (AuNRs).",Non-OADS,/arxiv_data1/oa_pdf/4e/4d/ijn-10-1521.PMC4345996.pdf
"Several biochemical tests have been applied to determine the levels of nanomateri - als that were toxic to cell lines, using viability, reactive oxygen species (ROS), and correspondence: seong soo a an Department of Bionanotechnology,  gachon Medical research Institute,  gachon University, sungnam-si,  gyeonggi-do, 461 701, republic of Korea Tel +82 31 750 8755 Fax +82 31 750 8755 email seongaan@gachon.ac.k r Dong Kee Yi Department of chemistry, Myongji  University, Yongin, 449 728,   republic of Korea Tel +82 31 330 6178 email vitalis@mju.ac.k rJournal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Das et al Running head recto: Analyses of protein corona on bare and silica-coated AuNRs DOI: http://dx.doi.org/10.2147/IJN.S76187",Non-OADS,/arxiv_data1/oa_pdf/4e/4d/ijn-10-1521.PMC4345996.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/4e/4d/ijn-10-1521.PMC4345996.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4e/4d/ijn-10-1521.PMC4345996.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5c/cf/cia-10-505.PMC4345997.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 505–513Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  505OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S7475 5Kinematic analysis of motor strategies in frail aged  adults during the Timed Up and go: how to spot  the motor frailty?,Non-OADS,/arxiv_data1/oa_pdf/5c/cf/cia-10-505.PMC4345997.pdf
"Correspondence: Alexandre Kubicki InserM U1093, Cognition, Action,  et Plasticité sensori-Motrice, BP 27877,  Campus Universitaire, Université de  Bourgogne, Dijon, France Tel +33 3 80 39 67 67 Fax +33 3 80 39 67 02 email alexandre.kubicki@u-bourgogne.f r Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Hassani et al Running head recto: Spotting motor frailty in elderly using sit-to-stand and back-to-sit transfers DOI: http://dx.doi.org/10.2147/CIA.S74755",Non-OADS,/arxiv_data1/oa_pdf/5c/cf/cia-10-505.PMC4345997.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/5c/cf/cia-10-505.PMC4345997.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/5c/cf/cia-10-505.PMC4345997.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/03/c6/clep-7-201.PMC4345998.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Epidemiology 2015:7 201–212Clinical Epidemiology Dove press submit your manuscript | www.dovepress.co m Dove press  201Original rEsEarChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CLEP .S7767 6Prevalence and characteristics of patients with  low levels of low-density lipoprotein cholesterol  in northern Denmark: a descriptive study sigrun alba Johannesdottir  schmidt1 Uffe heide-Jørgensen1 angelika D Manthripragada2 Vera Ehrenstein1 1Department of Clinical Epidemiology,   aarhus University hospital, aarhus,   Denmark;  2Center for Observational  research, amgen inc., Thousand Oaks,   Ca, Usa Correspondence: sigrun alba  Johannesdottir schmidt   Department of Clinical Epidemiology,  aarhus University hospital, Olof Palmes  allé 43-45, 8200 aarhus n, Denmark   Tel +45 8716 8245  Fax +45 8716 7215  Email saj@clin.au.d kBackground:  With the emergence of new lipid-lowering therapies, more patients are expected  to achieve substantial lowering of low-density lipoprotein cholesterol (LDL-C).",Non-OADS,/arxiv_data1/oa_pdf/03/c6/clep-7-201.PMC4345998.pdf
"In the first quarter of  2011, the total adult population of northern Denmark was   1,463,997 persons (source: http://statistikbanken.dk /).",OADS,/arxiv_data1/oa_pdf/03/c6/clep-7-201.PMC4345998.pdf
"Types of tests are coded using the Inter - national Nomenclature, Properties and Units (NPU) code  (http://www.labterm.dk/Enterprise%20Portal/NPU_search.",OADS,/arxiv_data1/oa_pdf/03/c6/clep-7-201.PMC4345998.pdf
Available from: http://www.irf.dk/dk/publikationer/ rationel_ farmakoterapi/maanedsblad/2006/lipidsaenkende_behandling.htm .,Non-OADS,/arxiv_data1/oa_pdf/03/c6/clep-7-201.PMC4345998.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica - tion of risk factors and screening procedures to develop optimal pre - ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/03/c6/clep-7-201.PMC4345998.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4f/9e/ijn-10-1493.PMC4346002.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 1493–1503International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1493OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7631 7Oral lipid-based nanoformulation of tafenoquine  enhanced bioavailability and blood stage  antimalarial efficacy and led to a reduction  in human red blood cell loss in mice Paula Melariri1 lonji Kalombo2 Patric Nkuna2 admire Dube2,3 rose hayeshi2 Benhards Ogutu4,5 liezl gibhard6 carmen deKock6 Peter smith6 lubbe Wiesner6 hulda swai2 1Polymers and composites, Material  science and Manufacturing, council  for scientific and Industrial research,   Port elizabeth, south africa; 2Polymer  and composites, Material science and  Manufacturing, council for scientific  and Industrial research, Pretoria,   south africa; 3school of Pharmacy,   University of the Western cape,   Bellville, south africa; 4centre for  research in Therapeutic sciences,   strathmore University, Nairobi, Kenya;   5centre for clinical research, Kenya  Medical research Institute, Nairobi,   Kenya; 6Division of Pharmacology,   University of cape Town Medical  school, groote schuur hospital,   cape T own, south africaAbstract:  Tafenoquine (TQ), a new synthetic analog of primaquine, has relatively poor  bioavailability and associated toxicity in glucose-6-phosphate dehydrogenase (G6PD)-deficient  individuals.",Non-OADS,/arxiv_data1/oa_pdf/4f/9e/ijn-10-1493.PMC4346002.pdf
"Nanoparticle drug  delivery systems using microemulsions have the potential to improve drug therapeutic  properties and enhance bioavailability by improving solubility of the drugs.5 This will correspondence: Paula Melariri   Polymers and composites, Material  science and Manufacturing, council  for Scientific and Industrial Research,  4 gomery avenue, summerstrand, 6001,  Port elizabeth, south africa email pmelariri@csir.co.z a Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Melariri et al Running head recto: Bioavailability, antimalarial efficacy, and HuRBC loss with tafenoquine DOI: http://dx.doi.org/10.2147/IJN.S76317",Non-OADS,/arxiv_data1/oa_pdf/4f/9e/ijn-10-1493.PMC4346002.pdf
Available from: http://www.page-meeting.,Non-OADS,/arxiv_data1/oa_pdf/4f/9e/ijn-10-1493.PMC4346002.pdf
Available from: http://grants.nih.,Non-OADS,/arxiv_data1/oa_pdf/4f/9e/ijn-10-1493.PMC4346002.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/4f/9e/ijn-10-1493.PMC4346002.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4f/9e/ijn-10-1493.PMC4346002.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e5/1a/ott-8-461.PMC4346003.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 461–470OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  461Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S7835 8epigallocatechin-3-gallate suppresses cell  proliferation and promotes apoptosis and  autophagy in oral cancer ssc-4 cells alexandra iulia irimie1 cornelia Braicu2 Oana Zanoaga2 Valentina Pileczki2,3 claudia gherman2,4 ioana Berindan-n eagoe2,4–6 radu septimiu campian7 1Department of Prosthodontics and  Dental Materials, Faculty of Dental  Medicine, “ iuliu hatieganu” University  of Medicine and Pharmacy, cluj- napoca, romania; 2research center  for Functional genomics, Biomedicine  and Translational Medicine, “ iuliu  hatieganu” University of Medicine  and Pharmacy, cluj-n apoca,   romania; 3Department of analytical  chemistry, Faculty of Pharmacy, “ iuliu  hatieganu” University of Medicine  and Pharmacy, cluj-n apoca, romania;   4Department of Functional genomics  and experimental Pathology, The  Oncology institute “Prof Dr. ion  chiricuta”, cluj-n apoca, romania;   5Department of immunology, Faculty  of Medicine, University of Medicine  and Pharmacy, “ iuliu hatieganu”  University of Medicine and Pharmacy,   cluj-n apoca, romania; 6Department  of experimental Therapeutics MD  anderson cancer center houston,   TX, Usa; 7Department of Oral  rehabilitation, Faculty of Dental  Medicine, “ iuliu hatieganu” University  of Medicine and Pharmacy, cluj- napoca, romaniaAbstract:  Epigallocatechin-3-gallate (EGCG) is the major bioactive component of green tea.",Non-OADS,/arxiv_data1/oa_pdf/e5/1a/ott-8-461.PMC4346003.pdf
"In the last years, phytochemicals have received significant attention  and been proved to interfere in key cellular pathways.14 Epigallocatechin-3-gallate  (EGCG) is the most abundant and most active phenolic constituent of green tea  and has strong antioxidant properties, possessing chemotherapeutic and chemopre - ventive roles.15,16 correspondence: ioana Berindan-neagoe research center for Functional  genomics and Translational Medicine,  “iuliu hatieganu” University of Medicine  and Pharmacy, cluj-napoca, 23  Marinescu street, 40015, romania Tel +40 264 450 749  Fax +40 264 598 88 email ioana.neagoe@umfcluj.r oJournal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Irimie et al Running head recto: Epigallocatechin-3-gallate in oral cancer SSC-4 cells DOI: http://dx.doi.org/10.2147/OTT.S78358",Non-OADS,/arxiv_data1/oa_pdf/e5/1a/ott-8-461.PMC4346003.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/e5/1a/ott-8-461.PMC4346003.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e5/1a/ott-8-461.PMC4346003.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/60/e6/jpr-8-105.PMC4346004.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Pain Research 2015:8 105–118Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  105Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S7516 0New insights into the use of currently available  non-steroidal anti-inflammatory drugs Kay Brune1 Paola Patrignani2 1Department of experimental  and Clinical Pharmacology and  Toxicology, Friedrich-Alexander  University erlangen-Nuremberg,   erlangen, Germany;  2Department of  Neuroscience, imaging and Clinical  Sciences, Center of excellence on  Aging, G d’Annunzio University,   Chieti, italy Correspondence: Kay Brune   Department of experimental and  Clinical Pharmacology and Toxicology,  Friedrich-Alexander University erlangen- Nuremberg, Krankenhausstraße  9,  D-91054 erlangen, Germany   Tel +49 913 1852 2292  email brune@pharmakologie.uni- erlangen.d eAbstract:  Non-steroidal anti-inflammatory drugs (NSAIDs), which act via inhibition of the  cyclooxygenase (COX) isozymes, were discovered more than  100 years ago.",Non-OADS,/arxiv_data1/oa_pdf/60/e6/jpr-8-105.PMC4346004.pdf
Available from: http://www.nice.org.uk/guidance/cg8 8.,Non-OADS,/arxiv_data1/oa_pdf/60/e6/jpr-8-105.PMC4346004.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/60/e6/jpr-8-105.PMC4346004.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/60/e6/jpr-8-105.PMC4346004.pdf
Available from: http://www.cypalleles.ki.se /.,Non-OADS,/arxiv_data1/oa_pdf/60/e6/jpr-8-105.PMC4346004.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7a/3d/jpr-8-095.PMC4346005.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Pain Research 2015:8 95–104Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  95ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S7519 2grading the intensity of nondental orofacial pain:  identification of cutoff points for mild, moderate,  and severe pain Vlaho Brailo1 Joanna M Zakrzewska2 1Department of Oral Medicine, School  of Dental Medicine, University of  Zagreb, Zagreb, Croatia;  2Facial Pain  Unit, Division of Diagnostic, Surgical  and Medical Sciences, Eastman Dental  Hospital, UCLH NHS Foundation  Trust/University College London,   London, UK correspondence: Vlaho Brailo   Department of Oral Medicine, School of  Dental Medicine, University of Zagreb,   5 Gundulićeva Street, Zagreb  10000,  croatia   Tel +385 1 4802 174   Fax +385 1 4830 819   email brailo@sfzg.h rBackground:  When assessing pain in clinical practice, clinicians often label pain as mild,  moderate, and severe.",Non-OADS,/arxiv_data1/oa_pdf/7a/3d/jpr-8-095.PMC4346005.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/7a/3d/jpr-8-095.PMC4346005.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7a/3d/jpr-8-095.PMC4346005.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/43/b0/ijwh-7-259.PMC4346006.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2015:7 259–269International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  259OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S7866 4awareness and predictors of female genital  mutilation/cutting among young health advocates sherif M abolfotouh1,2 ahmed Z ebrahim1,3 Mostafa a abolfotouh4 On Behalf of IFM sa-egypt 1IFMsa-egypt, alexandria, egypt;   2Oulu University Hospital, Oulu,   Finland; 3alexandria Faculty of  Medicine, alexandria, egypt; 4King  abdullah International Medical  research center (K aIMrc), King  saud bin-abdulaziz University for  Health sciences, riyadh, saudi arabiaAbstract:  The act of female genital mutilation/cutting (FGM/C) is considered internationally  as a violent act against girls and women and a violation of their human rights.",Non-OADS,/arxiv_data1/oa_pdf/43/b0/ijwh-7-259.PMC4346006.pdf
"The age of the girls who undergo this procedure varies from weeks  after birth to puberty.2 Common early complications of FGM/C include uncontrolled  bleeding, fever, wound infection, sepsis, and death.3 FGM/C is also reported to cause  psychological consequences, such as anxiety, horror, posttraumatic stress disorders,  and depression.4–6 Long-term complications include dysmenorrhea, dyspareunia, recur - rent vaginal and urinary tract infections, infertility, cysts, abscesses, keloid formation,  difficulty with childbirth, and sexual dysfunction.3,7–11correspondence: Mostafa a abolfotouh section Head – Biobanking – King  abdullah International Medical research  center (Mail code 1515), King saud Bin- abdulaziz University for Health sciences  (KsaU-Hs), King abdulaziz Medical city,  national guard Health affairs, PO box  22490, riyadh 11426, saudi arabia email mabolfotouh@gmail.co mJournal name: International Journal of Women’s Health Article Designation: Original Research Y ear: 2015 Volume: 7 Running head verso: Abolfotouh et al Running head recto: Awareness of FGM/C among young health advocates DOI: http://dx.doi.org/10.2147/IJWH.S78664",Non-OADS,/arxiv_data1/oa_pdf/43/b0/ijwh-7-259.PMC4346006.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/43/b0/ijwh-7-259.PMC4346006.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/43/b0/ijwh-7-259.PMC4346006.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/33/0f/ppa-9-327.PMC4346007.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 327–336Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  327OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S7453 1extent and reasons for nonadherence to  antihypertensive, cholesterol, and diabetes  medications: the association with depressive  symptom burden in a sample of American veterans hollis J Weidenbacher1 christopher A Beadles1,2 Matthew l Maciejewski1,3 Bryce B reeve2 corrine i Voils1,3 1center for health services research  in Primary care, Durham Veterans  Affairs Medical center, Durham, nc,   UsA; 2Department of health Policy  and Management, gillings school  of global Public health, University  of north carolina at chapel hill, nc,   UsA; 3Division of general internal  Medicine, Department of Medicine,   Duke University Medical center,   Durham, nc, UsAObjective:  Persons with depressive symptoms generally have higher rates of medication  nonadherence than persons without depressive symptoms.",Non-OADS,/arxiv_data1/oa_pdf/33/0f/ppa-9-327.PMC4346007.pdf
"To our knowledge, no studies have specifically examined the asso - ciation between depressive symptoms and medication nonadherence in concordant correspondence: corrine i Voils center for health services research  in Primary care, Durham Veterans Affairs  Medical center, Durham, nc, UsA Tel +1 919 286 0411 ext 5196 email corrine.voils@duke.ed u Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Weidenbacher et al Running head recto: Extent and reasons for nonadherence DOI: http://dx.doi.org/10.2147/PPA.S74531",Non-OADS,/arxiv_data1/oa_pdf/33/0f/ppa-9-327.PMC4346007.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/33/0f/ppa-9-327.PMC4346007.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/30/d3/dddt-9-1217.PMC4346008.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 1217–1224Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1217Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7934 3advantageous effects of immunosuppression  with tacrolimus in comparison with cyclosporine  a regarding renal function in patients after  heart transplantation correspondence: andreas O Doesch Medizinische Klinik iii, Kardiologie,  angiologie, Pulmologie, im neuenheimer  Feld 410, 69120 heidelberg, germany Tel +49 6221 56 39936 Fax +49 6221 56 4105 email andreas.doesch@med.uni- heidelberg.d e Matthias helmschrott1 rasmus rivinius1 arjang ruhparwar2 Bastian schmack2 christian erbel1 christian a gleissner1 Mohammadreza  akhavanpoor1 lutz Frankenstein1 Philipp ehlermann1 T om Bruckner3 hugo a Katus1 andreas O Doesch1 1Department of cardiology, angiology,   Pneumology, 2Department of cardiac  surgery, 3institute for Medical  Biometry and informatics, University  of heidelberg, heidelberg, germanyBackground:  Nephrotoxicity is a serious adverse effect of calcineurin inhibitor therapy in  patients after heart transplantation (HTX).",Non-OADS,/arxiv_data1/oa_pdf/30/d3/dddt-9-1217.PMC4346008.pdf
"Keywords:  heart transplantation, renal function, extended-release tacrolimus Introduction Calcineurin inhibitor (CNI-)-based immunosuppressive therapy is mainly used to  prevent acute rejection episodes (AREs) in patients after heart transplantation (HTX).1,2  Referring to current International Society for Heart and Lung Transplantation registry  data, the use of cyclosporine A (CSA) decreased in recent years, and accordingly, tac - rolimus (TAC) has become the predominant CNI in patients after HTX, as TAC is more  effective in avoiding AREs.1,3–7 Given the improved patient mortality during the last  decades, possible toxic effects of immunosuppression, especially nephrotoxicity, have  to be considered more carefully.8 In addition, prevention of severe renal dysfunction Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Helmschrott et al Running head recto: Tacrolimus compared with cyclosporine A after heart transplantation DOI: http://dx.doi.org/10.2147/DDDT.S79343",Non-OADS,/arxiv_data1/oa_pdf/30/d3/dddt-9-1217.PMC4346008.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/30/d3/dddt-9-1217.PMC4346008.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/30/d3/dddt-9-1217.PMC4346008.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d3/6f/copd-10-399.PMC4346009.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 399–406International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  399OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S7621 2exhaled volatile organic compounds discriminate  patients with chronic obstructive pulmonary  disease from healthy subjects Vasiliki Besa1 helmut T eschler2 Isabella Kurth1 amir Maqbul Khan3 Paul Zarogoulidis4 Joerg Ingo Baumbach5 Urte sommerwerck2 lutz Freitag1 Kaid Darwiche1 1Department of Interventional  Pneumology, ruhrlandklinik, West  german lung Center, University  hospital, University Duisburg- essen, essen, germany; 2Department  of Pneumology, ruhrlandklinik,   University hospital essen, University  of essen-Duisburg, essen, germany;   3Division of Thoracic surgery, Toronto  general hospital, University health  network, University of T oronto,   T oronto, On , Canada; 4Oncology  Unit, Pulmonary Department,   “g Papanikolaou” general hospital,   aristotle University of Thessaloniki,   greece; 5Faculty of applied Chemistry,   reutlingen University, reutlingen,   germanyAbstract:  Chronic obstructive pulmonary disease (COPD) is a chronic airway inflammatory  disease characterized by incompletely reversible airway obstruction.",Non-OADS,/arxiv_data1/oa_pdf/d3/6f/copd-10-399.PMC4346009.pdf
"Papanikolaou” general hospital,  aristotle University of Thessaloniki,  exohi 57010, Thessaloniki, greece Tel +306977271974 Fax +302310992433 email pzarog@hotmail.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Besa et al Running head recto: Exhaled VOCs discriminate patients with COPD from healthy subjects DOI: http://dx.doi.org/10.2147/COPD.S76212",Non-OADS,/arxiv_data1/oa_pdf/d3/6f/copd-10-399.PMC4346009.pdf
Available from: http://www.goldcopd.org / 2.,Non-OADS,/arxiv_data1/oa_pdf/d3/6f/copd-10-399.PMC4346009.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/d3/6f/copd-10-399.PMC4346009.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d3/6f/copd-10-399.PMC4346009.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cd/9d/copd-10-407.PMC4346013.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 407–414International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  407OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S7604 7Detection of COPD in a high-risk population:  should the diagnostic work-up include  bronchodilator reversibility testing?,Non-OADS,/arxiv_data1/oa_pdf/cd/9d/copd-10-407.PMC4346013.pdf
"Correspondence: Charlotte suppli Ulrik Department of Pulmonary Medicine 253,  hvidovre hospital, DK-2650 hvidovre,  Denmark email csulrik@dadlnet.d k Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Kjeldgaard et al Running head recto: Bronchodilator reversibility testing in high-risk COPD DOI: http://dx.doi.org/10.2147/COPD.S76047",Non-OADS,/arxiv_data1/oa_pdf/cd/9d/copd-10-407.PMC4346013.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/cd/9d/copd-10-407.PMC4346013.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/cd/9d/copd-10-407.PMC4346013.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/44/68/copd-10-415.PMC4346014.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 415–422International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  415OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S7503 4Treatment patterns of chronic obstructive  pulmonary disease in employed adults  in the United states gregory B Diette1  anand a Dalal2  anna O D’souza3  Orsolya e lunacsek3  saurabh P nagar2 1Johns hopkins University, Baltimore,   MD, 2glaxosmithKline, research  Triangle Park, nC, 3Xcenda, Palm  harbor, Fl, UsaBackground:  This study evaluated patterns of pharmacotherapy in chronic obstructive  pulmonary disease (COPD) as they relate to recommended guidelines in a prevalent COPD  patient population with employer-sponsored health insurance in the US.",Non-OADS,/arxiv_data1/oa_pdf/44/68/copd-10-415.PMC4346014.pdf
"Keywords:  COPD, pharmacotherapy, maintenance treatment, exacerbations Introduction Chronic obstructive pulmonary disease (COPD) is a chronic respiratory disorder  with significant morbidity and mortality, and is the fourth leading cause of death  worldwide.1 In the US, it affects more than 12 million people and is the third leading  cause of death.2,3 COPD also imposes a significant economic burden accounting for an  estimated $49.9 billion of the US health care budget annually ($29.5 billion direct and   $20.4 billion indirect costs), and €38.6 billion annually in the European Union.1Correspondence: Orsolya e lunacsek Xcenda, llC, 4114 Woodlands Parkway,  suite 500, Palm harbor, Fl 34685, Usa   Tel +1 727 771 4100   Fax +1 727 771 4145   email orsolya.lunacsek@xcenda.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Diette et al Running head recto: Pharmacologic treatment in chronic obstructive pulmonary disease DOI: http://dx.doi.org/10.2147/COPD.S75034",Non-OADS,/arxiv_data1/oa_pdf/44/68/copd-10-415.PMC4346014.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/44/68/copd-10-415.PMC4346014.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/44/68/copd-10-415.PMC4346014.pdf
"Available from: http://www.nhlbi.nih.gov/health/ health-topics/topics/cop d. Accessed August 15, 2013.",Non-OADS,/arxiv_data1/oa_pdf/44/68/copd-10-415.PMC4346014.pdf
"Available from: http://effectivehealthcare.ahrq.gov/reports/final.cf m.  Accessed August 15, 2013.",OADS,/arxiv_data1/oa_pdf/44/68/copd-10-415.PMC4346014.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/09/4c/dddt-9-1193.PMC4346015.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 1193–1208Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1193Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7212 7Koenimbin, a natural dietary compound  of Murraya koenigii  (l) spreng: inhibition of McF7  breast cancer cells and targeting of derived McF7  breast cancer stem cells (cD44+/cD24-/low):  an in vitro  study Fatemeh ahmadipour1 Mohamed ibrahim noordin1 syam Mohan2 aditya arya1 Mohammadjavad Paydar3 chung Yeng looi3 Yeap swee Keong4 ebrahimi nigjeh siyamak4 somayeh Fani1 Maryam Firoozi5 chung lip Y ong1 Mohamed aspollah sukari6 Behnam Kamalidehghan1 1Department of Pharmacy, Faculty of  Medicine, University of Malaya, Kuala  lumpur, Malaysia; 2Medical research  center, Jazan University, Jazan,   Kingdom of saudi arabia; 3Department  of Pharmacology, Faculty of Medicine,   University of Malaya, Kuala lumpur,   Malaysia; 4UPM-M aKna   cancer research laboratory,   institute of Bioscience, Universiti  Putra Malaysia, serdang, Malaysia;  5Department of Medical genetics,   national institute for genetic  engineering and Biotechnology, T ehran,   iran; 6Department of chemistry,   Faculty of science, Universiti Putra  Malaysia, serdang, MalaysiaBackground:  Inhibition of breast cancer stem cells has been shown to be an effective therapeutic  strategy for cancer prevention.",Non-OADS,/arxiv_data1/oa_pdf/09/4c/dddt-9-1193.PMC4346015.pdf
"Keywords:  Murraya koenigii (L) Spreng, koenimbin, MCF7 breast cancer stem cells, nuclear  factor kappa B, Wnt/ β-catenin, glycogen synthase kinase 3 β Introduction Murraya koenigii (L) Spreng (known as Surabhinimba in Sanskrit), known locally as the  curry leaf, is a member of the Rutaceae family and is widely distributed in South Asia.1 correspondence: Behnam Kamalidehghan Department of Pharmacy, Faculty of  Medicine, University of Malaya, Jalan  Universiti, 50603 Kuala lumpur, Malaysia Tel +60 37967 7897 Fax +60 37967 4964 email behnam@um.edu.m yJournal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Ahmadipour et al Running head recto: Koenimbin and inhibition of breast cancer cells DOI: http://dx.doi.org/10.2147/DDDT.S72127",Non-OADS,/arxiv_data1/oa_pdf/09/4c/dddt-9-1193.PMC4346015.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/09/4c/dddt-9-1193.PMC4346015.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/09/4c/dddt-9-1193.PMC4346015.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4c/2f/dddt-9-1209.PMC4346016.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 1209–1216Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1209Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7871 3Pharmacokinetic interaction between udenafil  and dapoxetine: a randomized, open-labeled  crossover study in healthy male volunteers Y o han Kim1 hee Y oun choi1 shi hyang lee1 hae sun Jeon1 hyeong-seok lim1 Mi Y oung Bahng2 Kyun-seop Bae1 1Department of clinical Pharmacology  and Therapeutics, asan Medical center,  college of Medicine, University  of Ulsan, 2clinical Development  Department, Dong-a sT co, ltd,  seoul, republic of KoreaBackground:  “Udenafil” is a phosphodiesterase-5 inhibitor indicated for erectile dysfunction.",Non-OADS,/arxiv_data1/oa_pdf/4c/2f/dddt-9-1209.PMC4346016.pdf
"It is absorbed with time to reach peak concentration (tmax) at 0.8–1.3 hours, then correspondence: Kyun-seop Bae Department of clinical Pharmacology  and Therapeutics, asan Medical center,  college of Medicine, University of Ulsan,  88 Olympic-ro 43-gil, songpa-gu, seoul  138-736, republic of Korea Tel +82 2 3010 4623 Fax +82 2 3010 4622 email ksbae@amc.seoul.k r Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Kim et al Running head recto: Pharmacokinetic interaction between udenafil and dapoxetine DOI: http://dx.doi.org/10.2147/DDDT.S78713",Non-OADS,/arxiv_data1/oa_pdf/4c/2f/dddt-9-1209.PMC4346016.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/4c/2f/dddt-9-1209.PMC4346016.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4c/2f/dddt-9-1209.PMC4346016.pdf
URL http://dx.doi.org/10.1137/0609033 .,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/nihms661755.PMC4346100.pdf
URL http://dx.doi.org/10.1093/biomet/68.1.265 .,OADS,/arxiv_data1/oa_pdf/e3/9c/nihms661755.PMC4346100.pdf
URL http://dx.doi.org/10.1137/ S0895479896305696 .,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/nihms661755.PMC4346100.pdf
URL http://dx.doi.org/10.1137/S0895479898346995 .,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/nihms661755.PMC4346100.pdf
URL http://dx.doi.org/10.1137/06066518X .,OADS,/arxiv_data1/oa_pdf/e3/9c/nihms661755.PMC4346100.pdf
URL http://dx.doi.org/10.1214/aos/1176350615 .,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/nihms661755.PMC4346100.pdf
URL http://dx.doi.org/10.1016/j.jspi.2004.07.004 .,OADS,/arxiv_data1/oa_pdf/e3/9c/nihms661755.PMC4346100.pdf
URL  http://dx.doi.org/10.1214/aos/1176348244 .,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/nihms661755.PMC4346100.pdf
URL http://dx.doi.org/10.1214/11-BA606 .,OADS,/arxiv_data1/oa_pdf/e3/9c/nihms661755.PMC4346100.pdf
URL http://dx.doi.org/10.1137/07070111X .,OADS,/arxiv_data1/oa_pdf/e3/9c/nihms661755.PMC4346100.pdf
"URL http://dx.doi.org/10.1017/CBO9780511550683 Kroonenberg, PM.",Non-OADS,/arxiv_data1/oa_pdf/e3/9c/nihms661755.PMC4346100.pdf
"URL http://dx.doi.org/10.1002/9780470238004 Lin, SP.",Non-OADS,/arxiv_data1/oa_pdf/e3/9c/nihms661755.PMC4346100.pdf
URL http://dx.doi.org/10.1016/j.jmva.,OADS,/arxiv_data1/oa_pdf/e3/9c/nihms661755.PMC4346100.pdf
"URL http://dx.doi.org/ 10.1007/978-1-4612-4176-8 Shitan M, Brockwell PJ.",Non-OADS,/arxiv_data1/oa_pdf/e3/9c/nihms661755.PMC4346100.pdf
URL http://dx.doi.org/ 10.1080/03610929508831600 .,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/nihms661755.PMC4346100.pdf
URL http://dx.doi.org/10.1109/TSP.2012.2218241 .,OADS,/arxiv_data1/oa_pdf/e3/9c/nihms661755.PMC4346100.pdf
URL http://dx.doi.org/10.1214/aos/1176325625 .,Non-OADS,/arxiv_data1/oa_pdf/e3/9c/nihms661755.PMC4346100.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ Correspondence to: Matthew L Bechtold, MD, FACP, FASGE, FACG, Division of Gastroenterology and Hepatology, University of  Missouri, Five Hospital Drive, Columbia, MO 65212, United States.",Non-OADS,/arxiv_data1/oa_pdf/d8/b4/nihms662253.PMC4346140.pdf
14 http://repository.academyhealth.org/egems/vol2/iss1/14 DOI: 10.13063/2327-9214.1109,Non-OADS,/arxiv_data1/oa_pdf/02/74/egems1109.PMC4346157.pdf
14 http://repository.academyhealth.org/egems/vol2/iss1/14 DOI: 10.13063/2327-9214.1109,Non-OADS,/arxiv_data1/oa_pdf/02/74/egems1109.PMC4346157.pdf
"2014 [August 25, 2014]; Available from: http://www.qualitynet.org/dcs/ContentServer?c=Page&pagename=QnetPublic%2F-Page%2FQnetTier2&cid=1191255879384.",Non-OADS,/arxiv_data1/oa_pdf/02/74/egems1109.PMC4346157.pdf
"[August  25, 2014]; Available from: http://www.qualityforum.org/qps/.",Non-OADS,/arxiv_data1/oa_pdf/02/74/egems1109.PMC4346157.pdf
14 http://repository.academyhealth.org/egems/vol2/iss1/14 DOI: 10.13063/2327-9214.1109,Non-OADS,/arxiv_data1/oa_pdf/02/74/egems1109.PMC4346157.pdf
"To view a copy of this license, http://creativecommons.org/licenses/by-nc-sa/3.0/ .",Non-OADS,/arxiv_data1/oa_pdf/29/08/emss-62131.PMC4346196.pdf
"The Protein Data Bank (PDB)13 is the oldest  surviving electronic archive of biomolecular data, and it now stores over 100,000 atomic  models determined by a variety of techniques; the Biological Magnetic Resonance Data  Bank (BMRB; http://www.bmrb.wisc.edu/ ) archives data related to NMR experiments; and  the Electron Microscopy Data Bank (EMDB)14 archives 3D EM reconstructions, including  electron tomograms.",OADS,/arxiv_data1/oa_pdf/29/08/emss-62131.PMC4346196.pdf
"Since 2003, the PDB has been managed by the Worldwide PDB  consortium (wwPDB; http://wwpdb.org/ )15, which includes the Protein Data Bank in Europe  (PDBe; http://pdbe.org/ )16, the Research Collaboratory for Structural Bioinformatics (RCSB  PDB; http://rcsb.org/ ), the Protein Data Bank Japan (PDBj; http://pdbj.org/ ) and the BMRB.",OADS,/arxiv_data1/oa_pdf/29/08/emss-62131.PMC4346196.pdf
"These professionally and collaboratively managed  archives provide mutual integration (for example, describing which PDB entries have been  fitted to a particular EMDB map) and also link to other key biological resources such as  UniProt18, Gene Ontology (GO)19 and Pfam20 through the Structure Integration with  Function, Taxonomy and Sequences (SIFTS) resource ( http://pdbe.org/sifts/ )21.",OADS,/arxiv_data1/oa_pdf/29/08/emss-62131.PMC4346196.pdf
"The EMDB was established at the EMBL European Bioinformatics Institute (EMBL-EBI) in  2002 and has become the single global archive for EM-derived 3D reconstructions of  biomacromolecules and their complexes, with over 2,400 released maps ( http://pdbe.org/ emstats/ ; August 2014).",OADS,/arxiv_data1/oa_pdf/29/08/emss-62131.PMC4346196.pdf
"In part as a result of the  workshop and ensuing discussions, the PDBe is developing a pilot archive for raw 2D image  data underpinning EM and ET structures in the EMDB (Electron Microscopy Pilot Image  Archive (EMPIAR); http://pdbe.org/empiar/ ).",Non-OADS,/arxiv_data1/oa_pdf/29/08/emss-62131.PMC4346196.pdf
"OMERO is used at thousands of sites worldwide; it is the basis for several large  public repositories ( http://jcb-dataviewer.rupress.org/23; http:// www.cellimagelibrary.org/24), and its tomogram-slice viewer has been integrated into the  EMDB entry pages (e.g., http://pdbe.org/emd-1906/slice )25.",OADS,/arxiv_data1/oa_pdf/29/08/emss-62131.PMC4346196.pdf
"Bio-Image Semantic Query  User Environment (BISQUE; http://www.bioimage.ucsb.edu/bisque/ ) is an open-source  data-management system, developed at the University of California, Santa Barbara, that is  used by a major plant bioimaging project ( http://bovary.iplantcollaborative.org/ ) and several  image-processing groups in the United States.",OADS,/arxiv_data1/oa_pdf/29/08/emss-62131.PMC4346196.pdf
"The participants included experts on 3D imaging, on scales from  molecules to cells, by a range of techniques including X-ray crystallography,  macromolecular EM, ET, 3D-SEM, SXT and LM; experts on archiving 3D structural data,  including representatives from the EMDataBank, the wwPDB, The Cell: an Image Library  (http://www.cellimagelibrary.org/ ), the JCB DataViewer ( http://jcb-dataviewer.rupress.org/ ) Patwardhan et al.",OADS,/arxiv_data1/oa_pdf/29/08/emss-62131.PMC4346196.pdf
and the Cell Centered Database ( http://ccdb.ucsd.edu/ ); and experts on visualization and  segmentation of 3D imaging data.,OADS,/arxiv_data1/oa_pdf/29/08/emss-62131.PMC4346196.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8d/39/dmso-8-129.PMC4346284.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015:8 129–136Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  129Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DMSO.S5179 2Urinary tract infections in patients with type  2  diabetes mellitus: review of prevalence, diagnosis,  and management Orna Nitzan1–3 Mazen elias2,4 Bibiana Chazan1,2 walid Saliba2,4 1infectious Disease Unit, Ha’emek  Medical Center, Afula, israel;  2Bruce  Rappaport Faculty of Medicine,  Technion–israel institute of  Technology, Haifa, israel;  3infectious  Disease Unit, Padeh-Poriya Medical  Center,  4Department of internal  Medicine C, Ha’emek Medical Center,  Afula, israel Correspondence: walid Saliba   Department of internal Medicine C,  Ha’emek Medical Center,   Afula 18101, israel   Tel +972 4 649 5132  Fax +972 4 649 5134  email saliba_wa@clalit.org.i lAbstract:  Urinary tract infections are more common, more severe, and carry worse outcomes  in patients with type  2 diabetes mellitus.",Non-OADS,/arxiv_data1/oa_pdf/8d/39/dmso-8-129.PMC4346284.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/8d/39/dmso-8-129.PMC4346284.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8d/39/dmso-8-129.PMC4346284.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1c/db/dmso-8-121.PMC4346285.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015:8 121–127Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  121Original reSearchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DMSO.S7634 2Sotagliflozin improves glycemic control in  nonobese diabetes-prone mice with type 1  diabetes David r Powell Deon Doree Sabrina Jeter-Jones Zhi-Ming Ding Brian Zambrowicz arthur Sands lexicon Pharmaceuticals, The  Woodlands, TX, USa correspondence: David r Powell   lexicon Pharmaceuticals,   8800 Technology Forest Place,   The Woodlands, TX 77381-1160, USa   Tel +1 281 863 3060   Fax +1 281 863 8115   email dpowell@lexpharma.co mPurpose:  Oral agents are needed that improve glycemic control without increasing  hypoglycemic events in patients with type 1 diabetes (T1D).",Non-OADS,/arxiv_data1/oa_pdf/1c/db/dmso-8-121.PMC4346285.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/1c/db/dmso-8-121.PMC4346285.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1c/db/dmso-8-121.PMC4346285.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5f/4a/ijn-10-1597.PMC4346358.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 1597–1608International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1597OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7177 6Detection of hepatitis c virus core protein  in serum by atomic force microscopy combined  with mass spectrometry Yuri D Ivanov1 anna l Kaysheva1,2 Pavel a Frantsuzov1 Tatyana O Pleshakova1 Nikolay V Krohin1 alexander a Izotov1 Ivan D shumov1 Vasiliy F Uchaikin1 Vladimir a Konev1 Vadim s Ziborov1 alexander I archakov1 1Institute of Biomedical chemistry,   2PostgenT ech ltd, Moscow, russiaAbstract:  A method for detection and identification of core antigen of hepatitis C virus  (HCVcoreAg)-containing particles in the serum was proposed, with due account taken of the  interactions of proteotypic peptides with Na+, K+, and Cl- ions.",Non-OADS,/arxiv_data1/oa_pdf/5f/4a/ijn-10-1597.PMC4346358.pdf
"In some studies, radiolabeled nanoparticles were used to stain immune complexes  upon their detection by AFM in blood plasma.12 However, the nanoparticles are correspondence: Ivan D shumov Institute of Biomedical chemistry,  Pogodinskaya 10, Moscow 119121, russia Tel +7 499 246 3761 Fax +7 499 245 0857 email shum230988@mail.r u Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Ivanov et al Running head recto: Detection of HCV core protein in serum DOI: http://dx.doi.org/10.2147/IJN.S71776",Non-OADS,/arxiv_data1/oa_pdf/5f/4a/ijn-10-1597.PMC4346358.pdf
"At the same time, a number of scientific groups  are developing high-speed AFM devices with scanning  speeds up to 20 Hz ( http://www.bruker.com /) and even  1.25 kHz,24 which allow a reduced scanning time.",Non-OADS,/arxiv_data1/oa_pdf/5f/4a/ijn-10-1597.PMC4346358.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/5f/4a/ijn-10-1597.PMC4346358.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5f/4a/ijn-10-1597.PMC4346358.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/33/8f/ijgm-8-087.PMC4346359.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of General Medicine 2015:8 87–92International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  87Short reportopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/10.2147/IJGM.S7713 9Association between education and quality   of diabetes care in Switzerland Aline Flatz Alejandra Casillas Silvia Stringhini emilie Zuercher Bernard Burnand Isabelle peytremann- Bridevaux Institute of Social and preventive  Medicine, Lausanne University  hospital, Lausanne, Switzerland Correspondence: Aline Flatz   Institute of Social and preventive  Medicine, Lausanne University hospital,  route de la Corniche 10,   1010 Lausanne, Switzerland   tel +41 44 634 63 16   Fax +41 21 314 49 54   email aline.flatz@chuv.c hPurpose:  Low socioeconomic status is associated with higher prevalence of diabetes, worse  outcomes, and worse quality of care.",Non-OADS,/arxiv_data1/oa_pdf/33/8f/ijgm-8-087.PMC4346359.pdf
"Available from: http://www.iumsp.ch/ Publications/pdf/rds211_fr.pd f. Accessed October 1, 2014.",Non-OADS,/arxiv_data1/oa_pdf/33/8f/ijgm-8-087.PMC4346359.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/33/8f/ijgm-8-087.PMC4346359.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/33/8f/ijgm-8-087.PMC4346359.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f6/86/jmdh-8-117.PMC4346360.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Multidisciplinary Healthcare 2015:8 117–125Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  117Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JMDH.S7197 8Physiotherapy for human T -lymphotropic   virus 1-associated myelopathy: review of the  literature and future perspectives Katia N Sá1 Maíra C Macêdo1 Rosana P Andrade2 Selena D Mendes1 José v Martins3 Abrahão F Baptista1,4 1Neuromusculoskeletal Research  Group, Bahian School of Medicine  and Human Health, Salvador,   Brazil;  2edgard Santos University  Hospital, Federal University of Bahia,   Salvador,  3Deolindo Couto institute  of Neurology, Federal University  of Rio de Janeiro, Rio de Janeiro,   4Biomorphology Department, Health  Sciences institute, Federal University  of Bahia, Salvador, Brazil Correspondence: Abrahão F Baptista   Universidade Federal da Bahia, Rua   Dr Antônio Monteiro,  228/602, itaigara,  Salvador Bahia, Brazil, CeP  41815130   email afbaptista@ufba.b rAbstract:  Human T -lymphotropic virus  1 (HTL V -1) infection may be associated with damage  to the spinal cord – HTL V -associated myelopathy/tropical spastic paraparesis – and other  neurological symptoms that compromise everyday life activities.",Non-OADS,/arxiv_data1/oa_pdf/f6/86/jmdh-8-117.PMC4346360.pdf
Available from: http://www.who.int/ healthpromotion/conferences/previous/ottawa/en /.,Non-OADS,/arxiv_data1/oa_pdf/f6/86/jmdh-8-117.PMC4346360.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/f6/86/jmdh-8-117.PMC4346360.pdf
Visit http://www.dove - press.com/testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f6/86/jmdh-8-117.PMC4346360.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/70/0c/ijn-10-1569.PMC4346361.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 1569–1584International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1569OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7547 4layered nanoemulsions as mucoadhesive buccal  systems for controlled delivery of oral cancer  therapeutics amy gavin1 Jimmy Th Pham2 Dawei Wang2 Bill Brownlow3 Tamer a elbayoumi3 1college of Dental Medicine, 2arizona  college of Osteopathic Medicine,   3Department of Pharmaceutical  sciences, college of Pharmacy- glendale,  Midwestern University,   glendale, aZ, UsaAbstract:  Oral cavity and oropharyngeal cancers are considered the eighth most common cancer  worldwide, with relatively poor prognosis (62% of patients surviving 5 years, after diagnosis).",Non-OADS,/arxiv_data1/oa_pdf/70/0c/ijn-10-1569.PMC4346361.pdf
"Patients with head and neck cancers have been rec - ognized to have an increased risk of developing a second primary tumor of the upper  aerodigestive tract.1 Oral squamous cell carcinomas, regardless of various histological  features, predominantly carry a high risk of metastatic spread to other body organs.1 While early cancers (stage I and stage II) of the lip and oral cavity are highly  curable by surgery or radiation therapy,2 the presence of a positive margin or a tumor  depth 5 mm significantly increases the risk of local recurrence and often calls for  aggressive combined modality treatment.3 Advanced cancers (stage III and stage IV) of correspondence: Tamer elbayoumi Midwestern University, college  of Pharmacy-glendale, Department  of Pharmaceutical sciences, glendale hall  236-14, 19555 N 59th ave, glendale,  aZ 85308, Usa Tel +1 623 572 3592 Fax +1 623 572 3565 email telbayoumi@midwestern.ed u Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Gavin et al Running head recto: Mucoadhesive anticancer lozenges DOI: http://dx.doi.org/10.2147/IJN.S75474",Non-OADS,/arxiv_data1/oa_pdf/70/0c/ijn-10-1569.PMC4346361.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/70/0c/ijn-10-1569.PMC4346361.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/70/0c/ijn-10-1569.PMC4346361.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/99/40/ijn-10-1609.PMC4346362.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 1609–1623International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1609OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7816 7T emperature-dependent and time-dependent  effects of hyperthermia mediated by dextran- coated la0.7sr0.3MnO3: in vitro studies reihaneh haghniaz rinku D Umrani Kishore M Paknikar centre for Nanobioscience, agharkar  research Institute, Pune, Maharashtra,   IndiaBackground:  The purpose of this study was to investigate the therapeutic efficacy of  dextran-coated (Dex) La0.7Sr0.3MnO3 (LSMO) nanoparticles-mediated hyperthermia at different  temperatures (43 °C, 45 °C, and 47 °C) based on cell killing potential and induction of heat shock  proteins in a murine melanoma cell (B16F1) line.",Non-OADS,/arxiv_data1/oa_pdf/99/40/ijn-10-1609.PMC4346362.pdf
"However,  a major concern with this type of treatment is the lack of local and uniform heating in  the tumor region.6 This is especially true for deep-seated tumors, where noninvasive  external energy sources used for hyperthermia, such as warm water blankets, laser  ablation, microwaves, and radiowaves, inevitably damage adjacent normal tissues.6,7 correspondence: Kishore M Paknikar centre for Nanobioscience, agharkar  research Institute, gg agarkar road,  Pune 411 004, Maharashtra, India Tel +91 20 2565 4831 Fax +91 20 2565 1542 email kpaknikar@gmail.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Haghniaz et al Running head recto: Hyperthermia mediated by Dex-LSMO DOI: http://dx.doi.org/10.2147/IJN.S78167",Non-OADS,/arxiv_data1/oa_pdf/99/40/ijn-10-1609.PMC4346362.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/99/40/ijn-10-1609.PMC4346362.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/99/40/ijn-10-1609.PMC4346362.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f0/07/bctt-7-059.PMC4346363.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pBreast Cancer: Targets and Therapy 2015:7 59–79Breast Cancer: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  59Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BCTT .S4379 9Critical analysis of the potential for microRNA  biomarkers in breast cancer management Carrie R Graveel1 Heather M Calderone2 Jennifer J westerhuis2 Mary e winn3 Lorenzo F Sempere2 1Breast Cancer Signaling and Thera­ peutics Team, Program in Molecular  Oncology and Pre­clinical Therapeutics,  Center for Cancer and Cell Biology,  2Laboratory of microRNA Diagnostics  and Therapeutics, Program in Skeletal  Disease and T umor Microenvironment,  Center for Cancer and Cell Biology,  3Bioinformatics and Biostatistics Core,  Program for T echnologies and Cores,  van Andel Research institute, Grand  Rapids, M i, USA Correspondence: Lorenzo F Sempere   Laboratory of microRNA Diagnostics and  Therapeutics, Program in Skeletal Disease  and Tumor Microenvironment, Center  for Cancer and Cell Biology, van Andel  Research institute, 333 Bostwick Ave Ne,  Grand Rapids, Mi 49503, USA   Tel +1 616 234 5530   email l orenzo.",Non-OADS,/arxiv_data1/oa_pdf/f0/07/bctt-7-059.PMC4346363.pdf
Or use: http://dvpr.es/1CNPZt I,Non-OADS,/arxiv_data1/oa_pdf/f0/07/bctt-7-059.PMC4346363.pdf
Available from: http://seer.cancer.gov/csr/1975_2011 /.,Non-OADS,/arxiv_data1/oa_pdf/f0/07/bctt-7-059.PMC4346363.pdf
Available from: http://asuragen.com/ products-and-services/clinical-lab/mirinform-pancreas /.,Non-OADS,/arxiv_data1/oa_pdf/f0/07/bctt-7-059.PMC4346363.pdf
"Available from:  http://www.rosettagenomics.com/micrornas-in-diagnostic s. Accessed  October 31, 2014.",OADS,/arxiv_data1/oa_pdf/f0/07/bctt-7-059.PMC4346363.pdf
"Breast Cancer: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/breast­cancer ­­­targets­and­therapy­journa lBreast Cancer: Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven - tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/f0/07/bctt-7-059.PMC4346363.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5d/1e/ijn-10-1625.PMC4346364.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 1625–1636International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1625OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7595 4Mixed nanomicelles as potential carriers  for systemic delivery of Z-gP-Dox, an  FaPα-based doxorubicin prodrug: formulation  and pharmacokinetic evaluation Yuchen Zhang1,* Xingwang Zhang2,* hongming liu2 shaohui cai1 Baojian Wu2 1Department of Pharmacology,   2Division of Pharmaceutics, college  of Pharmacy, Jinan University,   guangzhou, People’s republic  of china *These authors contributed equally  to this workAbstract:  Z-GP-Dox, the FAP α (fibroblast activation protein- α)-based doxorubicin prodrug,  demonstrates excellent tumor targeting effects and a favorable toxicokinetic profile.",Non-OADS,/arxiv_data1/oa_pdf/5d/1e/ijn-10-1625.PMC4346364.pdf
"A variety of nanocarrier systems have shown great potential in drug solubilization,  including liposomes,3 microemulsions,4 nanoparticles,5 and micelles.6 Of these, correspondence: Baojian Wu; shaohui cai college of Pharmacy, Jinan University,  601 West huangpu avenue, guangzhou  510632, People’s republic of china Tel +86 20 8522 0482 Fax +86 20 8522 0482 email bj.wu@hotmail.co m;  csh5689 @sina.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Zhang et al Running head recto: Mixed nanomicelles as carriers for Z-GP-Dox DOI: http://dx.doi.org/10.2147/IJN.S75954",Non-OADS,/arxiv_data1/oa_pdf/5d/1e/ijn-10-1625.PMC4346364.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/5d/1e/ijn-10-1625.PMC4346364.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5d/1e/ijn-10-1625.PMC4346364.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/35/25/ijn-10-1585.PMC4346365.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 1585–1596International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1585OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7759 1In vitro and in vivo effects of graphene oxide  and reduced graphene oxide on glioblastoma Sławomir Jaworski1 ewa sawosz1 Marta Kutwin1 Mateusz Wierzbicki1 Mateusz hinzmann1 Marta Grodzik1 Anna Winnicka2 Ludwika Lipińska3 Karolina Włodyga1 andrè chwalibog4 1Warsaw University of Life Science,   Faculty of Animal Science, Division  of Biotechnology and Biochemistry of   Nutrition, 2Department of Pathology  and Veterinary Diagnostics, Faculty  of Veterinary Medicine, Warsaw  University of Life Sciences, 3Institute  of Electronic Materials T echnology,   Warsaw, Poland; 4University of  Copenhagen, Department of  Veterinary Clinical and Animal  Sciences, Copenhagen, DenmarkAbstract:  Graphene and its related counterparts are considered the future of advanced  nanomaterials owing to their exemplary properties.",Non-OADS,/arxiv_data1/oa_pdf/35/25/ijn-10-1585.PMC4346365.pdf
"Graphene  and its oxidized forms have drawn intense attention in recent years for biological and correspondence: andrè chwalibog University of Copenhagen, Department  of Veterinary Clinical and Animal  Sciences, Groennegaardsvej 3,  1870 Frederiksberg, Denmark Tel +45 3533 3044 Fax +45 3533 3020 email ach@sund.ku.d k Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Jaworski et al Running head recto: Effects of GO and rGO on glioblastoma DOI: http://dx.doi.org/10.2147/IJN.S77591",Non-OADS,/arxiv_data1/oa_pdf/35/25/ijn-10-1585.PMC4346365.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/35/25/ijn-10-1585.PMC4346365.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/35/25/ijn-10-1585.PMC4346365.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/34/60/jir-8-059.PMC4346366.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Inflammation Research 2015:8 59–69Journal of Inflammation Research Dove press submit your manuscript | www.dovepress.co m Dove press  59ORIg Inal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JIR.S7863 1effect of pulsed electromagnetic field treatment  on programmed resolution of inflammation  pathway markers in human cells in culture nicole J Kubat1 John Moffett2 linley M Fray2 1nicole Kubat consulting, Pasadena,  ca, Usa;  2life science Department,  Regenesis Biomedical, Inc., scottsdale,  aZ, Usa correspondence: John Moffett   Regenesis Biomedical, Inc.,   5301 north Pima Road, scottsdale,   aZ 85250-3773 Usa   Tel +1 480 970 4970  Fax +1 866 857 8792  email moffett@regenesisbio.co mAbstract:  Inflammation is a complex process involving distinct but overlapping biochemical  and molecular events that are highly regulated.",Non-OADS,/arxiv_data1/oa_pdf/34/60/jir-8-059.PMC4346366.pdf
"Journal of Inflammation Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-inflammation-research-journa lThe Journal of Inflammation Research is an international, peer-reviewed  open-access journal that welcomes laboratory and clinical findings on the  molecular basis, cell biology and pharmacology of inflammation including  original research, reviews, symposium reports, hypothesis formation and  commentaries on: acute/chronic inflammation; mediators of inflamma -tion; cellular processes; molecular mechanisms; pharmacology and novel  anti-inflammatory drugs; clinical conditions involving inflammation.",Non-OADS,/arxiv_data1/oa_pdf/34/60/jir-8-059.PMC4346366.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/34/60/jir-8-059.PMC4346366.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/In vivo MRS for metabolic diseases J-H Hwang and CS Choi 8 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/75/76/emm2014101a.PMC4346484.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/Subdominance of H60 in skin transplantation KI Yoo et al 12 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/73/9c/emm2014107a.PMC4346485.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Bucillamine prevents cisplatin ototoxicity S-J Kim et al 16 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/4f/65/emm2014112a.PMC4346486.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/Development of NK cell therapy SR Yoon et al 11 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/00/0c/emm2014114a.PMC4346487.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/Three candidate biomarkers in CHD HH a n et al 7 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/2b/c9/emm201481a.PMC4346489.pdf
An independent and external validation of the ACC NCDR bleeding risk score among a NationalMulti-Site Community Hospital Registry of Cardiac Interventions.Inter J Stat Med Res 2014;3:153-60. doi:http://dx.doi.org/10.6000/ 1929-6029.2014.03.02.9 20.,Non-OADS,/arxiv_data1/oa_pdf/93/c3/openhrt-2014-000088.PMC4346578.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/a3/25/openhrt-2014-000200.PMC4346579.pdf
http://www.massdac.org/wp-content/uploads/PCI-FY2011.pdf (accessed 6 Jul 2014).,Non-OADS,/arxiv_data1/oa_pdf/a3/25/openhrt-2014-000200.PMC4346579.pdf
https://www.health.ny.gov/statistics/diseases/cardiovascular/docs/pci_2007 –2009.pdf (accessed 6 Jul 2014).,Non-OADS,/arxiv_data1/oa_pdf/a3/25/openhrt-2014-000200.PMC4346579.pdf
http://www.ccn.on.ca/ccn_public/uploadfiles/files/Provincial_PCI_Report_FINAL.pdf (accessed 6 Jul 2014).,Non-OADS,/arxiv_data1/oa_pdf/a3/25/openhrt-2014-000200.PMC4346579.pdf
See: http:// creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1. http://guidance.nice.org.uk/TA95 2.,Non-OADS,/arxiv_data1/oa_pdf/5c/33/openhrt-2014-000198.PMC4346580.pdf
"Osong Public Health Res Perspect 2015 6(1), 9 e13 http://dx.doi.org/10.1016/j.phrp.2014.10.012pISSN 2210-9099 eISSN 2233-6052 Copyright ª2014 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/67/74/main.PMC4346588.pdf
"1These two authors contributed equally to this paper.Osong Public Health Res Perspect 2015 6(1), 52 e58 http://dx.doi.org/10.1016/j.phrp.2014.12.004pISSN 2210-9099 eISSN 2233-6052 Copyright ª2015 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/76/dd/main.PMC4346589.pdf
"Osong Public Health Res Perspect 2015 6(1), 64 e69 http://dx.doi.org/10.1016/j.phrp.2014.08.009pISSN 2210-9099 eISSN 2233-6052 Copyright ª2014 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/1d/6c/main.PMC4346590.pdf
"Article ID 315389, http://dx.doi.org/10.1155/2013/315389 .",Non-OADS,/arxiv_data1/oa_pdf/1d/6c/main.PMC4346590.pdf
"Osong Public Health Res Perspect 2015 6(1), 27 e33 http://dx.doi.org/10.1016/j.phrp.2015.01.002pISSN 2210-9099 eISSN 2233-6052 Copyright ª2015 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/2a/1f/main.PMC4346591.pdf
"Retrieved from, http://www.who.int/substance_abuse/ publications/global_alcohol_report/en/ [accessed 07.05.14].",OADS,/arxiv_data1/oa_pdf/2a/1f/main.PMC4346591.pdf
"Retrieved from,https://melbourneinstitute.com/downloads/hilda/Bibliography/Other_Publications/pre2010/Laslett_etal_Alcohol’s_Harm_to_ Others.pdf [accessed 07.10.13].",Non-OADS,/arxiv_data1/oa_pdf/2a/1f/main.PMC4346591.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License(http://creativecommons.org/licenses/by-nc/3.0 ) which per- mits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ef/55/main.PMC4346592.pdf
"Osong Public Health Res Perspect 2015 6(1), 1 e2 http://dx.doi.org/10.1016/j.phrp.2015.01.001pISSN 2210-9099 eISSN 2233-6052 Copyright ª2015 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/ef/55/main.PMC4346592.pdf
"Osong Public Health Res Perspect 2015 6(1), 14 e19 http://dx.doi.org/10.1016/j.phrp.2014.12.001pISSN 2210-9099 eISSN 2233-6052 Copyright ª2014 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/55/1a/main.PMC4346593.pdf
"Osong Public Health Res Perspect 2015 6(1), 3 e8 http://dx.doi.org/10.1016/j.phrp.2014.10.011pISSN 2210-9099 eISSN 2233-6052 Copyright ª2014 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/f1/62/main.PMC4346594.pdf
"Osong Public Health Res Perspect 2015 6(1), 59 e63 http://dx.doi.org/10.1016/j.phrp.2014.11.008pISSN 2210-9099 eISSN 2233-6052 Copyright ª2015 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/00/98/main.PMC4346595.pdf
Available from: https://knhanes.cdc.go.kr/knhanes/index.do [accessed 22.05.14].,OADS,/arxiv_data1/oa_pdf/00/98/main.PMC4346595.pdf
"Osong Public Health Res Perspect 2015 6(1), 20 e26 http://dx.doi.org/10.1016/j.phrp.2014.11.006pISSN 2210-9099 eISSN 2233-6052 Copyright ª2014 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/ea/24/main.PMC4346596.pdf
Available from: http://www.census.gov.ph/tags/2010-cph [accessed 26.02.14].,OADS,/arxiv_data1/oa_pdf/ea/24/main.PMC4346596.pdf
http://dx.doi.org/10.1093/heapro/ dal047 .,OADS,/arxiv_data1/oa_pdf/ea/24/main.PMC4346596.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/ea/24/main.PMC4346596.pdf
Availablefrom: http://www.healthleadersmedia.com/content/232588/topic/ WS_HLM2_QUA/Survey-Education-Levels-Related-to-Health- Status.html [accessed 03.03.14].,Non-OADS,/arxiv_data1/oa_pdf/ea/24/main.PMC4346596.pdf
BMC Public Health 2005;5:46. http://dx.doi.org/ 10.1186/1471-2458-5-46 .,Non-OADS,/arxiv_data1/oa_pdf/ea/24/main.PMC4346596.pdf
"Osong Public Health Res Perspect 2015 6(1), 34 e38 http://dx.doi.org/10.1016/j.phrp.2014.12.002pISSN 2210-9099 eISSN 2233-6052 Copyright ª2015 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/ba/8c/main.PMC4346597.pdf
Available from: http://www.who.int/tb/ publications/global_report/en .,Non-OADS,/arxiv_data1/oa_pdf/ba/8c/main.PMC4346597.pdf
"Osong Public Health Res Perspect 2015 6(1), 39 e46 http://dx.doi.org/10.1016/j.phrp.2014.12.003pISSN 2210-9099 eISSN 2233-6052 Copyright ª2015 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/75/d1/main.PMC4346598.pdf
"Osong Public Health Res Perspect 2015 6(1), 47 e51 http://dx.doi.org/10.1016/j.phrp.2014.11.007pISSN 2210-9099 eISSN 2233-6052 Copyright ª2015 Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/0f/67/main.PMC4346599.pdf
"8It is possible that the severity of renal dysfunction is underestimated by the measurement of serum creatininelevels, as it is most commonly measured using a modifiedcolorimetric Jaffe assay, which is prone to interference fromhttp://www.kidney-international.org mini review &2014 International Society of Nephrology Correspondence: Rajiv Jalan, Liver Failure Group, UCL Institute for Liver and Digestive Health, UCL Medical School, Royal Free Hospital, Rowland HillStreet, London NW3 2PF, UK.",Non-OADS,/arxiv_data1/oa_pdf/01/bb/ki2014338a.PMC4346614.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Kidney International (2015) 87, 509– 515 515D Adebayo et al.",Non-OADS,/arxiv_data1/oa_pdf/01/bb/ki2014338a.PMC4346614.pdf
"As the probe set designedfor the SAA2 gene cross-reacts with SAA1, it provides a mea- sure SAA 1, 2 mRNA (http://xavierlab2.mgh.harvard.edu/ EnrichmentProfiler/primary/Expression/214456_x_at.html).",Non-OADS,/arxiv_data1/oa_pdf/c3/b4/labinvest2014163a.PMC4346621.pdf
"Supplementary Information accompanies the paper on the Laboratory Investigation website (http://www.laboratoryinvestigation.org) ACKNOWLEDGMENTS We thank Dr Robert Short for assistance with statistical analysis and Dr MariaBertagnolli, Dr Carolyn Johnson, Dr Brad Dieter, and Mr Thomas Cooney for their editorial commentaries on this manuscript.",Non-OADS,/arxiv_data1/oa_pdf/c3/b4/labinvest2014163a.PMC4346621.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Diabetic kidney disease RJ Anderberg et al 262 Laboratory Investigation | Volume 95 March 2015 | www.laboratoryinvestigation.org",Non-OADS,/arxiv_data1/oa_pdf/c3/b4/labinvest2014163a.PMC4346621.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014-006184).,Non-OADS,/arxiv_data1/oa_pdf/f6/96/bmjopen-2014-006184.PMC4346673.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/f6/96/bmjopen-2014-006184.PMC4346673.pdf
http://www.ncbi.nlm.nih.gov/pubmed/10090377 (accessed17 Jan 2012).,Non-OADS,/arxiv_data1/oa_pdf/f6/96/bmjopen-2014-006184.PMC4346673.pdf
http://www.ncbi.nlm.nih.gov/pubmed/10812262 6.,Non-OADS,/arxiv_data1/oa_pdf/f6/96/bmjopen-2014-006184.PMC4346673.pdf
http://journals.lww.com/pec-online/Abstract/2007/05000/ Epidemiology_and_Outcome_Analysis_of_208_Children.3.aspx (accessed 25 Nov 2011).,Non-OADS,/arxiv_data1/oa_pdf/f6/96/bmjopen-2014-006184.PMC4346673.pdf
http://www.sciencedirect.com/science/ article/pii/S0305417913003197 (accessed 27 Dec 2013).,Non-OADS,/arxiv_data1/oa_pdf/f6/96/bmjopen-2014-006184.PMC4346673.pdf
2012. http://www.hesonline.,Non-OADS,/arxiv_data1/oa_pdf/f6/96/bmjopen-2014-006184.PMC4346673.pdf
http://www.ibidb.org/ (accessed 1 May 2014).,Non-OADS,/arxiv_data1/oa_pdf/f6/96/bmjopen-2014-006184.PMC4346673.pdf
2012. http://www.ons.gov.uk/ons/ index.html 20.,Non-OADS,/arxiv_data1/oa_pdf/f6/96/bmjopen-2014-006184.PMC4346673.pdf
"Geneva, 2008. http://www.who.int/healthinfo/global_burden_disease/estimates_regional/en/index.html (accessed 2 Nov 2011).",Non-OADS,/arxiv_data1/oa_pdf/f6/96/bmjopen-2014-006184.PMC4346673.pdf
"Geneva, 2004. http://www.who.int/healthinfo/global_burden_disease/estimates_regional/en/index.html (accessed 3 Nov 2011).",Non-OADS,/arxiv_data1/oa_pdf/f6/96/bmjopen-2014-006184.PMC4346673.pdf
Am Assoc Mot 2009. http://www.aamva.org/uploadedFiles/MainSite/Content/SolutionsBestPractices/BestPracticesModelLegislation(1)/DriverFitnessMedicalGuidelines_092009.pdf (accessed 4 Jun 2014).,OADS,/arxiv_data1/oa_pdf/8a/a7/bmjopen-2014-006379.PMC4346674.pdf
2013. http://www.austroads.com.au/ images/stories/AFTD_reduced_for_web.pdf#search= ‘assessing +fitness+to+drive+australia ’ 5.,Non-OADS,/arxiv_data1/oa_pdf/8a/a7/bmjopen-2014-006379.PMC4346674.pdf
http://www.ncbi.nlm.nih.gov/pubmed/8407219 10.,Non-OADS,/arxiv_data1/oa_pdf/8a/a7/bmjopen-2014-006379.PMC4346674.pdf
http://www.pubmedcentral.nih.gov/articlerender.,OADS,/arxiv_data1/oa_pdf/8a/a7/bmjopen-2014-006379.PMC4346674.pdf
"fcgi?artid=1722423&tool=pmcentrez&rendertype=abstract, http://dx.doi.org/10.1136/bjo.82.11.1236 31.",OADS,/arxiv_data1/oa_pdf/8a/a7/bmjopen-2014-006379.PMC4346674.pdf
"A  recent study including 27 patients with de novo  drug-naï ve PD hypothesized that global measurements  of brain volume and structure, such those possible with  SIENAX software (part of FSL 4.0  http://www.fmrib.ox.ac.uk/fsl/) and histogram analysis of  DTI could reveal subtle tissue changes in the early  clinical phase of PD[17].",Non-OADS,/arxiv_data1/oa_pdf/c2/f4/NRR-7-611.PMC4346987.pdf
References 1 http://globocan.iarc.fr.,Non-OADS,/arxiv_data1/oa_pdf/48/97/0392-100X-34-382.PMC4346995.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/   by-nc/3.0/) which permits unrestricted, non -commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/20/f8/TOBIOCJ-9-7.PMC4347023.pdf
"Generally, the ORIGINAL ARTICLE Su-Gwan Kim Department of Oral and Maxillofacial Surgery, School of Dentistry, Chosun  University, 309 Pilmun-daero, Dong-gu, Gwangju 501-759, Korea TEL: +82-62-220-3819   FAX: +82-62-228-7316 E-mail: sgckim@chosun.ac.kr    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Relationship between mandibular condyle and angle fractures and   the presence of mandibular third molars Deuk-Hyun Mah, Su-Gwan Kim, Seong-Yong Moon, Ji-Su Oh, Jae-Seek You Department of Oral and Maxillofacial Surgery, School of Dentistry, Chosun University, Gwangju, Korea Abstract  (J Korean Assoc Oral Maxillofac Surg 2015;41:3-10) Objectives:  We retrospectively evaluated the impact of mandibular third molars on the occurrence of angle and condyle fractures.",Non-OADS,/arxiv_data1/oa_pdf/17/9e/jkaoms-41-3.PMC4347027.pdf
http://dx.doi.org/10.5125/jkaoms.2015.41.1.3 pISSN 2234-7550 ·eISSN 2234-5930,OADS,/arxiv_data1/oa_pdf/17/9e/jkaoms-41-3.PMC4347027.pdf
"These complications are mostly transient and the incidence  rates are low, but these complications can inconvenience ORIGINAL ARTICLE Young-Soo Jung Department of Oral and Maxillofacial Surgery, Yonsei University College of  Dentistry, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Korea TEL: +82-2-2228-3139   FAX: +82-2-2227-8022 E-mail: ysjoms@yuhs.ac    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Complication rates in patients using absorbable collagen sponges   in third molar extraction sockets: a retrospective study Hoon Cho1, Hwi-Dong Jung1, Bok-Joo Kim2, Chul-Hoon Kim2, Young-Soo Jung1 1Department of Oral and Maxillofacial Surgery, Yonsei University College of Dentistry, Seoul,   2Department of Oral and Maxillofacial Surgery, Dong-A University School of Medicine, Busan, Korea Abstract  (J Korean Assoc Oral Maxillofac Surg 2015;41:26-29) Objectives:  The purpose of this study is to retrospectively evaluate the postoperative complication rates for absorbable type-I collagen sponge (Atelo- plug; Bioland) use in third molar extraction.",Non-OADS,/arxiv_data1/oa_pdf/40/54/jkaoms-41-26.PMC4347028.pdf
http://dx.doi.org/10.5125/jkaoms.2015.41.1.26 pISSN 2234-7550 ·eISSN 2234-5930,OADS,/arxiv_data1/oa_pdf/40/54/jkaoms-41-26.PMC4347028.pdf
"In the case of mammals, oxygen and nutrient ORIGINAL ARTICLE Kyung-Wook Kim Department of Oral and Maxillofacial Surgery, College of Dentistry, Dankook  University, 119 Dandae-ro, Dongnam-gu, Cheonan 330-714, Korea TEL: +82-41-550-1994   FAX: +82-41-551-8988 E-mail: kkwoms@dku.edu    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Expression of vascular endothelial growth factor   in oral squamous cell carcinoma Seok-Kon Kim2, Seung-Goo Park1, Kyung-Wook Kim1 1Department of Oral and Maxillofacial Surgery, College of Dentistry, Dankook University,   2Department of Anesthesiology and Pain Medicine, Dankook University College of Medicine, Cheonan, Korea Abstract  (J Korean Assoc Oral Maxillofac Surg 2015;41:11-18) Objectives:  The goal of this study was to determine the correlation of clinicopathological factors and the up-regulation of vascular endothelial growth  factor (VEGF) expression in oral squamous cell carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/27/e4/jkaoms-41-11.PMC4347029.pdf
http://dx.doi.org/10.5125/jkaoms.2015.41.1.11 pISSN 2234-7550 ·eISSN 2234-5930,OADS,/arxiv_data1/oa_pdf/27/e4/jkaoms-41-11.PMC4347029.pdf
"Low-grade lesions are rare and include well-CASE REPORT Hyung Jun Kim Department of Oral and Maxillofacial Surgery, Yonsei University College of  Dentistry, 50 Yonsei-ro, Seodaemoon-gu, Seoul 120-752, Korea TEL: +82-2-2228-3132   FAX: +82-2-2227-8256 E-mail: kimoms@yuhs.ac    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Copyright ⃆ 2015 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/92/a0/jkaoms-41-48.PMC4347030.pdf
http://dx.doi.org/10.5125/jkaoms.2015.41.1.48 pISSN 2234-7550 ·eISSN 2234-5930,OADS,/arxiv_data1/oa_pdf/92/a0/jkaoms-41-48.PMC4347030.pdf
Many researchers have shown that MSCs exert immune  suppression and anti-inflammatory activity by dominantly EDITORIALhttp://dx.doi.org/10.5125/jkaoms.2015.41.1.1 pISSN 2234-7550 ·eISSN 2234-5930,Non-OADS,/arxiv_data1/oa_pdf/d7/9b/jkaoms-41-1.PMC4347031.pdf
"Similar to temporoman- dibular disorder (TMD), the initial symptoms are trismus CASE REPORT Kwan-Soo Park Department of Oral and Maxillofacial Surgery, Inje University Sanggye Paik  Hospital, 1342 Dongil-ro, Nowon-gu, Seoul 139-707, Korea TEL: +82-2-950-1161   FAX: +82-2-950-1167 E-mail: OMS_kspark@paik.ac.kr    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC An unusual abscess formation in the masticator space after   acupressure massage: a case report In-Chan Ko, Kyu-Ho Yoon, Kwan-Soo Park, Jeong-Kwon Cheong, Jung-Ho Bae, Kwon-Woo Lee, Young-Jai Chin Department of Oral and Maxillofacial Surgery, Inje University Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea Abstract  (J Korean Assoc Oral Maxillofac Surg 2015;41:52-56) Clinical features of masticator-space abscess (MSA) are very similar to those of parotitis or temporomandibular disorder (TMD), making early differ - ential diagnosis difficult.",Non-OADS,/arxiv_data1/oa_pdf/ce/12/jkaoms-41-52.PMC4347032.pdf
http://dx.doi.org/10.5125/jkaoms.2015.41.1.52 pISSN 2234-7550 ·eISSN 2234-5930,OADS,/arxiv_data1/oa_pdf/ce/12/jkaoms-41-52.PMC4347032.pdf
"On physical examination, mouth open- ing was limited to approximately 10 mm, with mild pain on CASE REPORT Jae Young Ryu Department of Oral and Maxillofacial Surgery, Gachon University Gil Medical  Center, 21 Namdong-daero 774beon-gil, Namdong-gu, Incheon 405-760, Korea TEL: +82-32-460-3373   FAX: +82-32-460-3101 E-mail: face@gilhospital.com    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Cavernous sinus thrombosis progression from trismus Jin Yong Cho, Hyeon Min Kim, Jae Young Ryu Department of Oral and Maxillofacial Surgery, Gachon University Gil Medical Center, Incheon, Korea Abstract  (J Korean Assoc Oral Maxillofac Surg 2015;41:43-47) In the Department of Oral and Maxillofacial Surgery, patients with trismus can be easily identified.",Non-OADS,/arxiv_data1/oa_pdf/9d/26/jkaoms-41-43.PMC4347033.pdf
http://dx.doi.org/10.5125/jkaoms.2015.41.1.43 pISSN 2234-7550 ·eISSN 2234-5930,OADS,/arxiv_data1/oa_pdf/9d/26/jkaoms-41-43.PMC4347033.pdf
"To the authors’ knowledge, there is no  study investigating postoperative QoL of surgically treated ORIGINAL ARTICLE Kelvin Uchenna Omeje Department of Oral and Maxillofacial Surgery, Aminu Kano Teaching Hospital,  Zaria Road, P.M.B 3452, Kano 700001, Nigeria TEL: +234-8033956135   FAX: +234-64663354 E-mail: uchennakevin@yahoo.com    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Quality of life following surgical treatment of oral cancers Akinwale Adeyemi Efunkoya1,2, Raphael Adetokunbo Adebola1,2, Kelvin Uchenna Omeje1,2,   Ibiyinka Olushola Amole1,2, Benjamin Idemudia Akhiwu1,2, Daniel Otasowie Osunde3 Departments of Oral and Maxillofacial Surgery, 1Bayero University, 2Aminu Kano Teaching Hospital, Kano,   3Department of Dental and Maxillofacial Surgery, University of Calabar, Calabar, Nigeria Abstract  (J Korean Assoc Oral Maxillofac Surg 2015;41:19-25) Objectives:  Quality of life (QoL) studies provide information about the impact of disease, the treatment of symptoms, and outcomes following treat- ment.",Non-OADS,/arxiv_data1/oa_pdf/3f/30/jkaoms-41-19.PMC4347034.pdf
http://dx.doi.org/10.5125/jkaoms.2015.41.1.19 pISSN 2234-7550 ·eISSN 2234-5930,OADS,/arxiv_data1/oa_pdf/3f/30/jkaoms-41-19.PMC4347034.pdf
Quality of life following surgical treatment of oral cancers 23from: http://seer.cancer.gov/archive/csr/1975_2005.,Non-OADS,/arxiv_data1/oa_pdf/3f/30/jkaoms-41-19.PMC4347034.pdf
Available from:  http://www.oralcancerfoundation.org.,Non-OADS,/arxiv_data1/oa_pdf/3f/30/jkaoms-41-19.PMC4347034.pdf
Available from: https://ispub.com/IJDS/1/2/10778.,Non-OADS,/arxiv_data1/oa_pdf/3f/30/jkaoms-41-19.PMC4347034.pdf
Available from: https://ispub.com/IJDS/1/2/5720.,Non-OADS,/arxiv_data1/oa_pdf/3f/30/jkaoms-41-19.PMC4347034.pdf
"Preprosthetic surgeries, like maxillary  sinus floor augmentation through a lateral antrostomy, gained  popularity in restoring functional dentition in the posterior ORIGINAL ARTICLE Kusum Rajendra Gandhi Department of Anatomy, Rural Medical College, Pravara Institute of Medical  Sciences, Loni, Maharashtra 413736, India TEL: +91-9689484225   FAX: +91-2422273442 E-mail: gandhikusum.r@gmail.com    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC The incidence and morphology of maxillary sinus septa in dentate and  edentulous maxillae: a cadaveric study with a brief review of the literature Kusum Rajendra Gandhi1, Rajendra Namdeo Wabale1,   Abu Ubaida Siddiqui2, Mujjebuddeen Samsudeen Farooqui1 1Department of Anatomy, Rural Medical College, Pravara Institute of Medical Sciences, Loni, Maharashtra,   2All India Institute of Medical Sciences, Tatibandh, Raipur, Chattisgarh, India Abstract  (J Korean Assoc Oral Maxillofac Surg 2015;41:30-36) Objectives:  The aim of this study is to determine the incidence, location, and orientation of maxillary sinus septa in formalin embalmed cadavers.",Non-OADS,/arxiv_data1/oa_pdf/45/c4/jkaoms-41-30.PMC4347035.pdf
http://dx.doi.org/10.5125/jkaoms.2015.41.1.30 pISSN 2234-7550 ·eISSN 2234-5930,OADS,/arxiv_data1/oa_pdf/45/c4/jkaoms-41-30.PMC4347035.pdf
"Previously, there has been general consensus advising the  complete eradication of these lesions using an aggressive sur-CASE REPORT Vijay Kumar Department of Oral and Maxillofacial Surgery, R. D. Dental Hospital &  Research Center, K-584, Hanuman Nagar, Kankarbagh, Patna 800020, Bihar,  India TEL: +91-9431253479   FAX: +91-612-2348746 E-mail: vijaypraveenmds@gmail.com    This is an open-access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.CC Copyright ⃆ 2015 The Korean Association of Oral and Maxillofacial Surgeons.",Non-OADS,/arxiv_data1/oa_pdf/81/c9/jkaoms-41-37.PMC4347036.pdf
http://dx.doi.org/10.5125/jkaoms.2015.41.1.37 pISSN 2234-7550 ·eISSN 2234-5930,OADS,/arxiv_data1/oa_pdf/81/c9/jkaoms-41-37.PMC4347036.pdf
"160pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.88.3.160 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Clinical outcome of early relaparotomy after elective  open repair of abdominal aortic aneurysms Youngjin Han, Tae-Won Kwon, Gi-Young Ko1, Hojong Park2, Ji Yoon Choi, Yong-Pil Cho Departments of Surgery and 1Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul,   2Department of Surgery, Ulsan University Hospital, Ulsan, Korea INTRODUCTION Abdominal aortic aneurysm (AAA) is a degenerative disease  that becomes more prevalent with age.",Non-OADS,/arxiv_data1/oa_pdf/47/05/astr-88-160.PMC4347037.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/47/05/astr-88-160.PMC4347037.pdf
" Annals of Surgical Treatment and Research 179pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.88.3.179 Annals of Surgical Treatment and ResearchERRATUM ERRATUM: Correction of affiliation Posterior triangle approach for lateral in-plane technique  during hemodialysis catheter insertion via the internal jugular vein Dan Song, Sangchul Yun, Sungwoo Cho Department of Surgery, Soonchunhyang University College of Medicine, Seoul, Korea The affiliation was misprinted.",Non-OADS,/arxiv_data1/oa_pdf/20/e8/astr-88-179.PMC4347038.pdf
"The affiliation should be corrected as follows: Corrected affiliation  Department of Surgery, Soonchunhyang University Seoul Hospital , Soonchunhyang University College of Medicine, Seoul, Korea Reviewed  JanuaryFebruaryMarchApril May June July  August September October November December http://dx.doi.org/10.4174/astr.2015.88.2.114 Ann Surg Treat Res 2015;88(2):114-117",Non-OADS,/arxiv_data1/oa_pdf/20/e8/astr-88-179.PMC4347038.pdf
" Annals of Surgical Treatment and Research 145pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.88.3.145 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Clinical outcome for laparoscopic cholecystectomy in  extremely elderly patients Sang-Ill Lee, Byung-Gon Na, Young-Sun Yoo, Seong-Pyo Mun, Nam-Kyu Choi Division of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, Chosun University Hospital, Gwangju, Korea INTRODUCTION Gallstone disease is the most common global indication  for abdominal surgery.",Non-OADS,/arxiv_data1/oa_pdf/13/ed/astr-88-145.PMC4347039.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/13/ed/astr-88-145.PMC4347039.pdf
"178pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.88.3.178 Annals of Surgical Treatment and ResearchERRATUM ERRATUM: Correction of the 1st and 2nd authors' affiliation  Transfusion free radical antegrade modular  pancreaticosplenectomy of metastatic neuroendocrine tumor of the pancreas in Jehovah’s Witness patient Young Bae Jeon*, Sangchul Yun*, Dongho Choi1 Department of Surgery, Soonchunhyang University College of Medicine, Cheonan, 1Department of Surgery, Hanyang University  College of Medicine, Seoul, Korea The 1st and 2nd authors’ affiliation was misprinted.",Non-OADS,/arxiv_data1/oa_pdf/23/41/astr-88-178.PMC4347040.pdf
"The affiliation should be corrected as follows: Corrected the 1st and 2nd authors’ affiliation  Department of Surgery, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul , Korea Reviewed  JanuaryFebruaryMarchApril May June July  August September October November December http://dx.doi.org/10.4174/astr.2015.88.2.106 Ann Surg Treat Res 2015;88(2):106-110",Non-OADS,/arxiv_data1/oa_pdf/23/41/astr-88-178.PMC4347040.pdf
"152pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.88.3.152 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Effect of imatinib mesylate and rapamycin on the  preformed intimal hyperplasia in rat carotid injury model Yang Jin Park*, Seung-Kee Min1,*, Sang-Il Min1, Sang Joon Kim1, Jongwon Ha1 Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 1Department of Surgery,  Seoul National University College of Medicine, Seoul, Korea INTRODUCTION The long-term success of vein graft bypass or endovascular  therapy (angioplasty or stenting) is limited by the development  of stenosis or restenosis in the target lesion and intimal hyperplasia (IH) is considered as the major etiology of this phenomenon [1].",Non-OADS,/arxiv_data1/oa_pdf/1b/00/astr-88-152.PMC4347041.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1b/00/astr-88-152.PMC4347041.pdf
" Annals of Surgical Treatment and Research 119pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.88.3.119 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE A preliminary study for the development of indices and  the current state of surgical site infections (SSIs) in Korea: the Korean Surgical Site Infection Surveillance (KOSSIS) program Sun Jin Park, Kil Yeon Lee, Ji Won Park1, Jae Gil Lee2, Hee Jung Choi3, Hee Kyung Chun4, Jung Gu Kang5 Department of Surgery, Kyung Hee University School of Medicine, Seoul, 1Department of Surgery, Seoul National University  College of Medicine, Seoul, 2Department of Surgery, Yonsei University College of Medicine, Seoul, 3Department of Internal  Medicine, Ewha Womans University School of Medicine, Seoul, 4Department of Infection Control, Kyung Hee University Medical  Center, Seoul, 5Department of Surgery, National Health Insurance Service Ilsan Hospital, Goyang, Korea INTRODUCTION Surgical site infections (SSIs) are the leading cause of  nosocomial infection.",Non-OADS,/arxiv_data1/oa_pdf/d1/42/astr-88-119.PMC4347042.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d1/42/astr-88-119.PMC4347042.pdf
"140pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.88.3.140 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Role of charcoal tattooing in localization of recurred  papillary thyroid carcinoma: initial experiences Hyungju Kwon1,*, Soon Young Tae2,*, Su-Jin Kim1, Kyeong Cheon Jung3, Ji-Hoon Kim4, Kyu Eun Lee1,   Yeo-Kyu Youn1,5 1Department of Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, 2Department of  Surgery, Ulsan University Hospital, Ulsan University College of Medicine, Ulsan, Departments of 3Pathology and 4Radiology, Seoul  National University Hospital, Seoul National College of Medicine, Seoul, 5Department of Surgery, National Medical Center, Seoul, Korea INTRODUCTION Thyroid cancer is the most prevalent cancer in Korea, and  its incidence has increased strikingly [1].",Non-OADS,/arxiv_data1/oa_pdf/5d/5a/astr-88-140.PMC4347043.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5d/5a/astr-88-140.PMC4347043.pdf
"174pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.88.3.174 Annals of Surgical Treatment and ResearchTECHNICAL ADVANCE Dual-incision laparoscopic spleen-preserving distal  pancreatectomy Eun Young Kim, Young Kyoung You, Dong Goo Kim, Soo Ho Lee, Jae Hyun Han, Sung Kyun Park, Gun Hyung  Na, Tae Ho Hong Department of Surgery, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, Korea INTRODUCTION Laparoscopic distal pancreatectomy (LDP) is a commonly  performed surgery for benign and borderline malignancies  in the body or tail of the pancreas [1].",Non-OADS,/arxiv_data1/oa_pdf/ea/62/astr-88-174.PMC4347044.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ea/62/astr-88-174.PMC4347044.pdf
"126pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.88.3.126 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Early outcome of the Korean Diagnosis-Related Groups  payment system for appendectomy Hyeyoung Kim, In Mok Jung, Keong Won Yun, Seung Chul Heo, Young Joon Ahn, Ki-Tae Hwang, Hae Won Lee,  Do Hoon Koo, Eunyoung Ko, Hye Seong Ahn, Rumi Shin, Jung Kee Chung Department of Surgery, Seoul Metropolitan Government - Seoul National University Boramae Medical Center, Seoul, Korea INTRODUCTION The diagnosis-related groups (DRG) based payment system  was introduced in stages after the beginning of demonstration  project at National Health Insurance Service Ilsan Hospital in 2009 and finally, entire hospitals in Korea were required to implement a DRG based payment system for seven groups of specific operations/diseases including appendectomy from July 2013 onwards.",Non-OADS,/arxiv_data1/oa_pdf/ab/c0/astr-88-126.PMC4347045.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ab/c0/astr-88-126.PMC4347045.pdf
"166pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.88.3.166 Annals of Surgical Treatment and ResearchCASE REPORT An idiopathic gigantomastia Min Jeng Cho, Jung-Hyun Yang, Hyeon-Gon Choi1, Wan Seop Kim2, Yeong-Beom Yu, Kyoung Sik Park Departments of Surgery, 1Plastic Surgery, and 2Pathology, Konkuk University Medical Center, Konkuk University School of  Medicine, Seoul, Korea INTRODUCTION Gigantomastia is a rare but disabling condition characterized  by excessive breast growth.",Non-OADS,/arxiv_data1/oa_pdf/84/04/astr-88-166.PMC4347046.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/84/04/astr-88-166.PMC4347046.pdf
" Annals of Surgical Treatment and Research 133pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.88.3.133 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE The reality in the follow-up of breast cancer survivors:  survey of Korean Breast Cancer Society  Ku Sang Kim*, Zisun Kim1,*, Eun-Jung Shim2, Nam Hyoung Kim3, So-Youn Jung4, Jisun Kim5, Guiyun Sohn5,  Jong Won Lee5, Jihyoung Cho6, Jung Eun Lee7, Juhyung Lee8, Hyun Jo Youn9, Jihyoun Lee10, Min Hyuk Lee10;  Korean Breast Cancer Society Department of Surgery, Breast-Thyroid Center, Ulsan City Hospital, Ulsan, 1Department of Surgery, Soonchunhyang University  Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, 2Department of Psychology, Pusan National  University, Pusan, 3Department of Advertising and Branding, Kaywon University of Art and Design, Uiwang, 4Breast Cancer  Center, National Cancer Center, Goyang, 5Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine,  Seoul, 6Department of Surgery, Dongsan Medical Center, Keimyung University School of Medicine, Daegu, 7Department of Food  and Nutrition, Sookmyung Women’s University, Seoul, Departments of 8Preventive Medicine and 9Surgery, Chonbuk National  University Medical School, Jeonju, 10Department of Surgery, Soonchunhyang University Seoul Hospital, Soonchunhyang  University College of Medicine, Seoul, Korea INTRODUCTION According to the data from National Statistical Office publi­shed in 2013, the number of Korean cancer survivors (those  who have received cancer treatment or are in treatment) is 1.1 million people, and breast cancer survivors among them Purpose:  Follow-up after primary treatment for breast cancer is an important component of survivor care and various  international guidelines exist for the surveillance.",Non-OADS,/arxiv_data1/oa_pdf/4f/3e/astr-88-133.PMC4347047.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Received September 22, 2014, Reviewed September 24, 2014,   Accepted September 25, 2014 Corresponding Author: Hyun Jo Youn Division of Breast • Thyroid Surgery, Department of Surgery, Chonbuk National University Medical School, 567 Baekje-daero, Deokjin-gu, Jeonju 561-756, KoreaTel: +82-63-250-2389, Fax: +82-63-271-6197E-mail: yhj0903@jbnu.ac.kr",Non-OADS,/arxiv_data1/oa_pdf/4f/3e/astr-88-133.PMC4347047.pdf
"The survey was completed on November 30, 2013 and the results of the survey were collected by specialized software development company (Yeoulsoft, http://www.yeoulsoft.com).",OADS,/arxiv_data1/oa_pdf/4f/3e/astr-88-133.PMC4347047.pdf
Available from: http://kosis.kr.,Non-OADS,/arxiv_data1/oa_pdf/4f/3e/astr-88-133.PMC4347047.pdf
"Questionnnaire  ÂÂ$CUKEKPHQTOCVKQP  :KDWLV\RXU IGPFGT"" 0DOH)HPDOH  :KDWLV\RXU CIG"" 8QGHU\HDUVa\HDUVa\HDUV0RUH WKDQ\HDUV   9JGTGGR\RXZRUNLQ"" 6HRXO*\HRQJJL*DQJZRQ&KXQJFKHRQJ-HROOD *\HRQJVDQJ -HMX   :KDWV[RGRIKRVSLWDOGR\RXZRUNDW""   3 U L Y D W H K R V S L W D O   6 H P L  J H Q H U D O K R V S L W D O   * H Q H U D O K R V SLWDO    8QLYHUVLW\ KRVSLWDO   :KDWLV\RXU VKVNG"" 'LUHFWRU+HDGRIWKHGHSDUWPHQWRI6XUJHU\)HOORZ &OLQLFDO3URIHVVRU 3URIHVVRU   :KDWLV\RXU FKUEKRNKPG "" 6XUJHRQ0HGLFDORQFRORJLVW2WKHU   +RZNQPIRI\RXUFOLQLFDOSUDFWLFHLVGHYRWHGWRWUHDWPHQWRIEUHDVWFD QFHU"" /HVVWKDQWZR\HDUV\HDUV\HDUV \HDUV 0RUHWKDQ\HDUV  Â%QPUKFGTCDNGHCEVQTKPHQNNQYWR  /LVWWKHIDFWRUVIRUEUHDVWFDQFHUSDWLHQWĜVIR OORZXSLQRUGHUWRLWĜV RTKQTKV[  6WDJH  6\PSWRPDQGVLJQ  ,+&VXEW\SH  $JH  2SHUDWLYHPHWKRG   ' R \ R X W D N H W K H V D P H I R O O R Z  X S W R S D W L H Q W V Z K R K D Y H X Q G H U J R Q H  PQPKPXCUKXG CPF KPXCUKXGDTGCUVECPEGT ""Ku Sang Kim, et al: The reality in the follow-up of breast cancer survivors Ann Surg Treat Res 2015;88(3):133-139 http://dx.doi.org/10.4174/astr.2015.88.3.133",Non-OADS,/arxiv_data1/oa_pdf/4f/3e/astr-88-133.PMC4347047.pdf
" Annals of Surgical Treatment and Research<HV1R  'R\RXWDNHWKHVDPHIROORZXSIRU LQYDVLYHEUHDVWFDQFHUSDWLHQWV KPTGICTFNGUUQHVJGKT  UVCIG"" <HV1R   'R\RX WDNHWKHVDPH IROORZXS WRSDWLHQWV ZKRKDYHXQGHUJRQH DTGCUVEQPUGTXKPI UWTIGT[CPFOCUVGEVQO[ "" <HV1R  'R\RXWDNHWKHVDPHIROORZXSIRU EUHDVWFDQFHUSDWLHQWV KPTGICTFNGUUQH+*%UWDV[RG  OXPLQDO$OXPLQDO%+(5DQG71%&"" <HV1R  ' R \ R X W D N H W K H V D P H I R O O R Z  X S I R U EUHDVW FDQFHU SDWLHQWV KP TGICTFNGUU QH $4%# OWVCVKQP "" <HV1R  ,VWKHUHDQ\FKDQJHRQWKHIROORZXSVFKHGXOHDIWHU Ğ%CPEGT2CVKGPV4GIKUVT[ğU[UVGO ""   <HV1R  1$EHJLQQLQJWUHDWPHQWDIWHU ě&DQFHU3DWLHQW5HJLVWU\ĜHQIRUFH PHQW   ÂÂ(TGSWGPE[QHHQNNQYWROQFG 4XHVWLRQVDERXWWKHSRVWRSHUDWLYHIROORZXSPRGDOLWLHVIRU KPXCUKXGDTGCUVECPEGT RCVKGPVU    +RZRIWHQGR\RXWDNH JKUVQT[VCMKPICPFRJ[UKECNGZCOKPCVKQP "" RQUVQRGTCVKXG   \HDU ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\  \HDUV ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\  \HDUV ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\  \HDUVODWHU ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\    +RZRIWHQGR\RXWDNH OCOOQITCRJ[ "" RQUVQRGTCVKXG   \HDU ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\Ku Sang Kim, et al: The reality in the follow-up of breast cancer survivors Ann Surg Treat Res 2015;88(3):133-139 http://dx.doi.org/10.4174/astr.2015.88.3.133",Non-OADS,/arxiv_data1/oa_pdf/4f/3e/astr-88-133.PMC4347047.pdf
"(6 "" RQUVQRGTCVKXG   \HDU ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\  \HDUV ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\  \HDUV ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\  \HDUVODWHU ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\  +RZRIWHQGR\RXWDNH %JGUV:TC[ "" RQUVQRGTCVKXG   \HDU ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\  \HDUV ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\  \HDUV ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\  \HDUVODWHU ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\   +RZRIWHQGR\RXWDNH %JGUV%6 "" RQUVQRGTCVKXG   \HDU ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\  \HDUV ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\  \HDUV ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\  \HDUVODWHU ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\   +RZRIWHQGR\RXWDNH DQPGUECP "" RQUVQRGTCVKXG Ku Sang Kim, et al: The reality in the follow-up of breast cancer survivors Ann Surg Treat Res 2015;88(3):133-139 http://dx.doi.org/10.4174/astr.2015.88.3.133",Non-OADS,/arxiv_data1/oa_pdf/4f/3e/astr-88-133.PMC4347047.pdf
" Annals of Surgical Treatment and Research \HDU ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\  \HDUV ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\  \HDUV ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\  \HDUVODWHU ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\   +RZRIWHQGR\RXWDNH CDFQOKPCN75 RU%6"" RQUVQRGTCVKXG   \HDU ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\  \HDUV ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\  \HDUV ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\  \HDUVODWHU ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\   +RZRIWHQGR\RXWDNH DTCKP%6 "" RQUVQRGTCVKXG   \HDU ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\  \HDUV ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\  \HDUV ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\  \HDUVODWHU ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\   +RZRIWHQGR\RXWDNH DTGCUV/4+ "" RQUVQRGTCVKXG   \HDU ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\  \HDUV ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\  \HDUV ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\  \HDUVODWHU ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\   +RZRIWHQGR\RXWDNH 2'6%6"" RQUVQRGTCVKXG   \HDU ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\  \HDUV ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\  \HDUV ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\  \HDUVODWHU ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\   ' R \ R X W D N H U R X W L Q H H [ D P V  8 6  & 7  E R Q H V F D Q  D Q G 3 ( 7  & 7  D[ VWTPU W R F K H F N I R U  PHWDVWDVLV"" <HV1R  ÂÂ%WTTGPVRTCEVKEGQHHQNNQYWRKu Sang Kim, et al: The reality in the follow-up of breast cancer survivors Ann Surg Treat Res 2015;88(3):133-139 http://dx.doi.org/10.4174/astr.2015.88.3.133",Non-OADS,/arxiv_data1/oa_pdf/4f/3e/astr-88-133.PMC4347047.pdf
" Annals of Surgical Treatment and Research'R\RXWDNHUHJXODUFKHFNXSIRU VWOQTOCTMGT ""  &($ ǹ<HVǹ1R  &$ ǹ<HVǹ1R  &$ ǹ<HVǹ1R  +(5 ǹ<HVǹ1R   'R\RXWDNHUHJXODU I[PGEQNQIKECNGZCOKPCVKQP H[FHSWWDPR[LIHQWDNLQJSDWLHQWV"" <HV1R   'R\RXWDNHUHJXODU DQPGOKPGTCNFGPUKV[ $/&VGUV H[FHSWDURPDWDVHLQKLELWRUWDNLQJ SDWLHQWV"" <HV1R  'R\RXWDNHUHJXODUWHVWVVXFKDVHQGRVFRS\QHFN86WRGHWHFW WRWKHOCNKIPCPE[QH QVJGTQTICPU UGEQPFCT[ECPEGT "" <HV1R +HĞ;GUğ IRUZKLFKRUJDQVGR\RXFKHFN"" $ 7K\URLG ǹ<HV ǹ1R % 6WRPDFK ǹ<HV ǹ1R & &RORQ ǹ<HV ǹ1R ' (WFBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB   'R\RXWDNHFRQWLQXRXVIROORZXS D[[QWTUGNH IRUWKHSDWLHQWVZLWKRXWVSHFLILFVLJQVRI UHFXUUHQFHRUPHWDVWDVLVIRUPRUHWKDQ\HDUV"" <HV1R  +HĞ0Qğ WRZKRPGR\RXFRQVXOWIRUWKHIROORZXS""  -XQLRUVWDIIFOLQLFDOSURIHVVRUIHOORZ HWF  'HSDUWPHQWRI+HPDWRORJ\DQG2QFRORJ\  'HSDUWPHQWRI)DPLO\PHGLFLQH  8QLYHUVLW\KRVSLWDODURXQGUHVLGHQFHDUHD  *HQHUDOKRVSLWDODURXQGUHVLGHQFHDUHD  3ULYDWHKRVSLWDODURXQGUHVLGHQFHDUHD  (WF    %\YJKEJYC[ EUHDVWFDQFHUVXUYLYRUV EQPVCEVOGFKECNVGCO LQWKHFDVHRIQHZV\PSWRPV RUTXHVWLRQVDSSHDU""3LFNWKHPRVWIUHTXHQWRQH $ 'LUHFWFDOOWRGRFWRUKu Sang Kim, et al: The reality in the follow-up of breast cancer survivors Ann Surg Treat Res 2015;88(3):133-139 http://dx.doi.org/10.4174/astr.2015.88.3.133",Non-OADS,/arxiv_data1/oa_pdf/4f/3e/astr-88-133.PMC4347047.pdf
" Annals of Surgical Treatment and Research% (PDLOLQJGRFWRU & &DOOWRFRRUGLQDWRU ' (PDLOLQJFRRUGLQDWRU ( &DOOWRRXWSDWLHQWFOLQLF ) 9LVLWWRRXWSDWLHQWFOLQLF * (WFBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB   :KDWIWKFGNKPG GR\RXXVHPDLQO\IRUIROORZXS""3LFNWKHPRVWIUHTXHQWRQH  $ 1&&1JXLGHOLQH % (602JXLGHOLQH & 6W*DOOHQFRQIHUHQFHJXLGHOLQH ' .RUHDQ%UHDVW&DQFHU6RFLHW\JXLGHOLQH ( (WFBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB  7KDQN\RXYHU\PXFK  Ku Sang Kim, et al: The reality in the follow-up of breast cancer survivors Ann Surg Treat Res 2015;88(3):133-139 http://dx.doi.org/10.4174/astr.2015.88.3.133",Non-OADS,/arxiv_data1/oa_pdf/4f/3e/astr-88-133.PMC4347047.pdf
"Questionnnaire  ÂÂ$CUKEKPHQTOCVKQP  :KDWLV\RXU IGPFGT"" 0DOH)HPDOH  :KDWLV\RXU CIG"" 8QGHU\HDUVa\HDUVa\HDUV0RUH WKDQ\HDUV   9JGTGGR\RXZRUNLQ"" 6HRXO*\HRQJJL*DQJZRQ&KXQJFKHRQJ-HROOD *\HRQJVDQJ -HMX   :KDWV[RGRIKRVSLWDOGR\RXZRUNDW""   3 U L Y D W H K R V S L W D O   6 H P L  J H Q H U D O K R V S L W D O   * H Q H U D O K R V SLWDO    8QLYHUVLW\ KRVSLWDO   :KDWLV\RXU VKVNG"" 'LUHFWRU+HDGRIWKHGHSDUWPHQWRI6XUJHU\)HOORZ &OLQLFDO3URIHVVRU 3URIHVVRU   :KDWLV\RXU FKUEKRNKPG "" 6XUJHRQ0HGLFDORQFRORJLVW2WKHU   +RZNQPIRI\RXUFOLQLFDOSUDFWLFHLVGHYRWHGWRWUHDWPHQWRIEUHDVWFD QFHU"" /HVVWKDQWZR\HDUV\HDUV\HDUV \HDUV 0RUHWKDQ\HDUV  Â%QPUKFGTCDNGHCEVQTKPHQNNQYWR  /LVWWKHIDFWRUVIRUEUHDVWFDQFHUSDWLHQWĜVIR OORZXSLQRUGHUWRLWĜV RTKQTKV[  6WDJH  6\PSWRPDQGVLJQ  ,+&VXEW\SH  $JH  2SHUDWLYHPHWKRG   ' R \ R X W D N H W K H V D P H I R O O R Z  X S W R S D W L H Q W V Z K R K D Y H X Q G H U J R Q H  PQPKPXCUKXG CPF KPXCUKXGDTGCUVECPEGT ""Ku Sang Kim, et al: The reality in the follow-up of breast cancer survivors Ann Surg Treat Res 2015;88(3):133-139 http://dx.doi.org/10.4174/astr.2015.88.3.133",Non-OADS,/arxiv_data1/oa_pdf/4f/3e/astr-88-133.PMC4347047.pdf
" Annals of Surgical Treatment and Research<HV1R  'R\RXWDNHWKHVDPHIROORZXSIRU LQYDVLYHEUHDVWFDQFHUSDWLHQWV KPTGICTFNGUUQHVJGKT  UVCIG"" <HV1R   'R\RX WDNHWKHVDPH IROORZXS WRSDWLHQWV ZKRKDYHXQGHUJRQH DTGCUVEQPUGTXKPI UWTIGT[CPFOCUVGEVQO[ "" <HV1R  'R\RXWDNHWKHVDPHIROORZXSIRU EUHDVWFDQFHUSDWLHQWV KPTGICTFNGUUQH+*%UWDV[RG  OXPLQDO$OXPLQDO%+(5DQG71%&"" <HV1R  ' R \ R X W D N H W K H V D P H I R O O R Z  X S I R U EUHDVW FDQFHU SDWLHQWV KP TGICTFNGUU QH $4%# OWVCVKQP "" <HV1R  ,VWKHUHDQ\FKDQJHRQWKHIROORZXSVFKHGXOHDIWHU Ğ%CPEGT2CVKGPV4GIKUVT[ğU[UVGO ""   <HV1R  1$EHJLQQLQJWUHDWPHQWDIWHU ě&DQFHU3DWLHQW5HJLVWU\ĜHQIRUFH PHQW   ÂÂ(TGSWGPE[QHHQNNQYWROQFG 4XHVWLRQVDERXWWKHSRVWRSHUDWLYHIROORZXSPRGDOLWLHVIRU KPXCUKXGDTGCUVECPEGT RCVKGPVU    +RZRIWHQGR\RXWDNH JKUVQT[VCMKPICPFRJ[UKECNGZCOKPCVKQP "" RQUVQRGTCVKXG   \HDU ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\  \HDUV ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\  \HDUV ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\  \HDUVODWHU ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\    +RZRIWHQGR\RXWDNH OCOOQITCRJ[ "" RQUVQRGTCVKXG   \HDU ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\Ku Sang Kim, et al: The reality in the follow-up of breast cancer survivors Ann Surg Treat Res 2015;88(3):133-139 http://dx.doi.org/10.4174/astr.2015.88.3.133",Non-OADS,/arxiv_data1/oa_pdf/4f/3e/astr-88-133.PMC4347047.pdf
"(6 "" RQUVQRGTCVKXG   \HDU ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\  \HDUV ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\  \HDUV ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\  \HDUVODWHU ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\  +RZRIWHQGR\RXWDNH %JGUV:TC[ "" RQUVQRGTCVKXG   \HDU ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\  \HDUV ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\  \HDUV ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\  \HDUVODWHU ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\   +RZRIWHQGR\RXWDNH %JGUV%6 "" RQUVQRGTCVKXG   \HDU ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\  \HDUV ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\  \HDUV ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\  \HDUVODWHU ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\   +RZRIWHQGR\RXWDNH DQPGUECP "" RQUVQRGTCVKXG Ku Sang Kim, et al: The reality in the follow-up of breast cancer survivors Ann Surg Treat Res 2015;88(3):133-139 http://dx.doi.org/10.4174/astr.2015.88.3.133",Non-OADS,/arxiv_data1/oa_pdf/4f/3e/astr-88-133.PMC4347047.pdf
" Annals of Surgical Treatment and Research \HDU ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\  \HDUV ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\  \HDUV ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\  \HDUVODWHU ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\   +RZRIWHQGR\RXWDNH CDFQOKPCN75 RU%6"" RQUVQRGTCVKXG   \HDU ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\  \HDUV ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\  \HDUV ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\  \HDUVODWHU ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\   +RZRIWHQGR\RXWDNH DTCKP%6 "" RQUVQRGTCVKXG   \HDU ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\  \HDUV ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\  \HDUV ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\  \HDUVODWHU ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\   +RZRIWHQGR\RXWDNH DTGCUV/4+ "" RQUVQRGTCVKXG   \HDU ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\  \HDUV ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\  \HDUV ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\  \HDUVODWHU ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\   +RZRIWHQGR\RXWDNH 2'6%6"" RQUVQRGTCVKXG   \HDU ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\  \HDUV ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\  \HDUV ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\  \HDUVODWHU ɂPRQWKV ɂPRQWKV ɂPRQWKV ɂ,QFDVHRIQHFHVVLW\   ' R \ R X W D N H U R X W L Q H H [ D P V  8 6  & 7  E R Q H V F D Q  D Q G 3 ( 7  & 7  D[ VWTPU W R F K H F N I R U  PHWDVWDVLV"" <HV1R  ÂÂ%WTTGPVRTCEVKEGQHHQNNQYWRKu Sang Kim, et al: The reality in the follow-up of breast cancer survivors Ann Surg Treat Res 2015;88(3):133-139 http://dx.doi.org/10.4174/astr.2015.88.3.133",Non-OADS,/arxiv_data1/oa_pdf/4f/3e/astr-88-133.PMC4347047.pdf
" Annals of Surgical Treatment and Research'R\RXWDNHUHJXODUFKHFNXSIRU VWOQTOCTMGT ""  &($ ǹ<HVǹ1R  &$ ǹ<HVǹ1R  &$ ǹ<HVǹ1R  +(5 ǹ<HVǹ1R   'R\RXWDNHUHJXODU I[PGEQNQIKECNGZCOKPCVKQP H[FHSWWDPR[LIHQWDNLQJSDWLHQWV"" <HV1R   'R\RXWDNHUHJXODU DQPGOKPGTCNFGPUKV[ $/&VGUV H[FHSWDURPDWDVHLQKLELWRUWDNLQJ SDWLHQWV"" <HV1R  'R\RXWDNHUHJXODUWHVWVVXFKDVHQGRVFRS\QHFN86WRGHWHFW WRWKHOCNKIPCPE[QH QVJGTQTICPU UGEQPFCT[ECPEGT "" <HV1R +HĞ;GUğ IRUZKLFKRUJDQVGR\RXFKHFN"" $ 7K\URLG ǹ<HV ǹ1R % 6WRPDFK ǹ<HV ǹ1R & &RORQ ǹ<HV ǹ1R ' (WFBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB   'R\RXWDNHFRQWLQXRXVIROORZXS D[[QWTUGNH IRUWKHSDWLHQWVZLWKRXWVSHFLILFVLJQVRI UHFXUUHQFHRUPHWDVWDVLVIRUPRUHWKDQ\HDUV"" <HV1R  +HĞ0Qğ WRZKRPGR\RXFRQVXOWIRUWKHIROORZXS""  -XQLRUVWDIIFOLQLFDOSURIHVVRUIHOORZ HWF  'HSDUWPHQWRI+HPDWRORJ\DQG2QFRORJ\  'HSDUWPHQWRI)DPLO\PHGLFLQH  8QLYHUVLW\KRVSLWDODURXQGUHVLGHQFHDUHD  *HQHUDOKRVSLWDODURXQGUHVLGHQFHDUHD  3ULYDWHKRVSLWDODURXQGUHVLGHQFHDUHD  (WF    %\YJKEJYC[ EUHDVWFDQFHUVXUYLYRUV EQPVCEVOGFKECNVGCO LQWKHFDVHRIQHZV\PSWRPV RUTXHVWLRQVDSSHDU""3LFNWKHPRVWIUHTXHQWRQH $ 'LUHFWFDOOWRGRFWRUKu Sang Kim, et al: The reality in the follow-up of breast cancer survivors Ann Surg Treat Res 2015;88(3):133-139 http://dx.doi.org/10.4174/astr.2015.88.3.133",Non-OADS,/arxiv_data1/oa_pdf/4f/3e/astr-88-133.PMC4347047.pdf
" Annals of Surgical Treatment and Research% (PDLOLQJGRFWRU & &DOOWRFRRUGLQDWRU ' (PDLOLQJFRRUGLQDWRU ( &DOOWRRXWSDWLHQWFOLQLF ) 9LVLWWRRXWSDWLHQWFOLQLF * (WFBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB   :KDWIWKFGNKPG GR\RXXVHPDLQO\IRUIROORZXS""3LFNWKHPRVWIUHTXHQWRQH  $ 1&&1JXLGHOLQH % (602JXLGHOLQH & 6W*DOOHQFRQIHUHQFHJXLGHOLQH ' .RUHDQ%UHDVW&DQFHU6RFLHW\JXLGHOLQH ( (WFBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB  7KDQN\RXYHU\PXFK  Ku Sang Kim, et al: The reality in the follow-up of breast cancer survivors Ann Surg Treat Res 2015;88(3):133-139 http://dx.doi.org/10.4174/astr.2015.88.3.133",Non-OADS,/arxiv_data1/oa_pdf/4f/3e/astr-88-133.PMC4347047.pdf
"170pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.88.3.170 Annals of Surgical Treatment and ResearchCASE REPORT Complicated benign cystic mesothelioma of  mesoappendix misdiagnosed as an appendiceal  abscess in a postpartum period woman  Sunchul Yeom, Taeil Son, Young Ok Hong1 Departments of Surgery and 1Pathology, Eulji General Hospital, Eulji University School of Medicine, Seoul, Korea INTRODUCTION Benign cystic mesothelioma (BCM) is a rare tumor arising  from endothelial cells of the visceral or parietal peritoneum  [1].",Non-OADS,/arxiv_data1/oa_pdf/bf/a7/astr-88-170.PMC4347048.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bf/a7/astr-88-170.PMC4347048.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/86/0c/TORMJ-9-1.PMC4347051.pdf
"[16] Cystic Fibrosis Trust, Standards of Care and Good Clinical Practice for the Physiotherapy Management of Cystic Fibrosis, June 2011, Date Cited [2012 Aug 10], Available from URL: http://www.cftru st.org.uk/aboutcf/publications/consensusdoc/ [17] Dwyer TJ, Alison JA, McKeough ZJ, Daviskas E, Bye PT.",Non-OADS,/arxiv_data1/oa_pdf/ba/93/TORMJ-9-15.PMC4347052.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ba/93/TORMJ-9-15.PMC4347052.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f7/de/TOOPHTJ-9-20.PMC4347199.pdf
Websites with General   Inform ation Websites with pre - and Post -test Decision  Support Laboratories Offering DCM Genetic Testing with Genetic  Counse lors on Staff   www.genetests.org  http://www.dnadirect.com/   http://informeddna.com/  http://www.genedx.com/   http://genetics.emory.edu/egl/   http://pcpgm.partners.org/lmm/tests/cardiomyopathy   http://ambrygen.com/hereditary -cardiovascular -testing,Non-OADS,/arxiv_data1/oa_pdf/14/a9/CCR-11-10.PMC4347203.pdf
Available from: http://www.fda.gov/ dow n- loads/ Drugs/Dru gSafety/UCM089801.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d5/c7/CCR-11-73.PMC4347212.pdf
Med i- cation Guide - Letaris.Available from: http://www.fda.gov/ dow n- loads/Drugs/DrugSafety/ucm088617.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d5/c7/CCR-11-73.PMC4347212.pdf
"Considering these risks, a well-designed, evidence- based post-treatment surveillance protocol is needed to  manage patients with breast cancer after their primary http://dx.doi.org/10.3348/kjr.2015.16.2.219 pISSN 1229-6929  · eISSN 2005-8330Review Article | Breast Imaging Received March 8, 2014; accepted after revision November 24,  2014.",Non-OADS,/arxiv_data1/oa_pdf/d8/99/kjr-16-219.PMC4347260.pdf
"• Tel: (822) 2228-7400  • Fax: (822) 393-3035 • E-mail: mines@yuhs.ac This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d8/99/kjr-16-219.PMC4347260.pdf
"• Tel: (822) 2072-2518  • Fax: (822) 743-6385 • E-mail: imchangjm@gmail.com This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5a/86/kjr-16-229.PMC4347261.pdf
DBT allows reconstruction of  planes from breast tissue volume viewed in sequential  sections through the breast and potentially overcomes this  inherent limitation of DM caused by overlapping normal  and pathological tissue during standard two-dimensional http://dx.doi.org/10.3348/kjr.2015.16.2.229 pISSN 1229-6929  · eISSN 2005-8330Original Article  | Breast Imaging,Non-OADS,/arxiv_data1/oa_pdf/5a/86/kjr-16-229.PMC4347261.pdf
"• Tel: (822) 3010-4388  • Fax: (822) 476-0090 • E-mail: hwgoo@amc.seoul.kr This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/68/81/kjr-16-239.PMC4347262.pdf
"Korean J Radiol 2015;16(2):239-250http://dx.doi.org/10.3348/kjr.2015.16.2.239 pISSN 1229-6929  · eISSN 2005-8330Review Article  | Cardiovascular Imaging INTRODUCTION Coronary artery imaging in children is frequently  challenging due to small size, high heart rates, and motion  artifacts from cardiac pulsation, respiration, and the  patients themselves, which results in technical or procedural  difficulties (1).",Non-OADS,/arxiv_data1/oa_pdf/68/81/kjr-16-239.PMC4347262.pdf
"We intend to provide guidelines for http://dx.doi.org/10.3348/kjr.2015.16.2.251 pISSN 1229-6929  · eISSN 2005-8330Review Article | Cardiovascular Imaging Received December 7, 2014; accepted after revision January 3, 2015.",Non-OADS,/arxiv_data1/oa_pdf/0b/76/kjr-16-251.PMC4347263.pdf
"Acknowledgments Technical Panels Official Korean Society of Cardiology Representative: Jun  Kwan (Inha University), Ju-Young Yang (National Health  Insurance Corporation Ilsan Hospital), Jin Bae Lee (Catholic  University of Daegu), Hyuk-Jae Chang (Yonsei University),  Dong Ju Choi (Seoul National University), Seung Hyuk  Choi (Sungkyunkwan University), Young Jin Choi (Hallym  University), Tae Young Choi (Kwandong University), Bumkee  Hong (Yonsei University), Young Joon Hong (Chonnam  National University) Official Korean Society of Radiology Representative:  Doo Kyung Kang (Ajou University), Joon-Won Kang (Ulsan  University), Sung Min Ko (Konkuk University), Seung Min  Yoo (CHA Medical University), Heon Lee (Soonchunhyang  University), Whal Lee (Seoul National University), Jung Im  Jung (Catholic University), Kwang Nam Jin (Seoul National  University), Sang Il Choi (Seoul National University), Ki  Seuk Choo (Pusan National University) External Reviewers Official Korean Academy of Medical Science  Representative: Ein Soon Shin (Ajou University), You- Kyoung Lee (Soonchunhyang University) Official Korean Society of Cardiology Representative:  Dae-Hee Shin (Ulsan University), Yeonyee E. Yoon  (Seoul National University), Jin-Ho Choi (Sungkyunkwan  University) Official Korean Society of Radiology Representative:  Jae-Seung Seo (Chung-Ang University), Jong Min Lee  (Kyungpook National University), Byoung Wook Choi (Yonsei  University)Advisory Boards Methodology: Ein-Soon Shin (Ajou University), Yoo Kyung  Lee (Soonchunhyang University) Document Retrieval: Euisoo Shin (Asan Medical Center) Supplementary Materials The online-only Data Supplement is available with this  article at http://dx.doi.org/10.3348/kjr.2015.16.2.251.",Non-OADS,/arxiv_data1/oa_pdf/0b/76/kjr-16-251.PMC4347263.pdf
"• Tel: (822) 3010-5636  • Fax: (822) 477-2898 • E-mail: hello.hello.hj@gmail.com This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/37/e6/kjr-16-286.PMC4347264.pdf
"Nevertheless, intergroup comparability  remains an important consideration in radiology research,  particularly in interventional radiology that is a discipline  of therapeutic medicine, research commonly involves http://dx.doi.org/10.3348/kjr.2015.16.2.286 pISSN 1229-6929  · eISSN 2005-8330Review Article  | Experimental and Others",Non-OADS,/arxiv_data1/oa_pdf/37/e6/kjr-16-286.PMC4347264.pdf
Supplementary Materials The online-only Data Supplement is available with this  article at http://dx.doi.org/10.3348/kjr.2015.16.2.286.,Non-OADS,/arxiv_data1/oa_pdf/37/e6/kjr-16-286.PMC4347264.pdf
"• Tel: (822) 3010-3953  • Fax: (822) 476-0090 • E-mail: sjkimjb@amc.seoul.kr This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/58/28/kjr-16-297.PMC4347265.pdf
"However, measurement  of diffusion indices can depend on various factors (2-4) http://dx.doi.org/10.3348/kjr.2015.16.2.297 pISSN 1229-6929  · eISSN 2005-8330Original Article  | Experimental and Others",Non-OADS,/arxiv_data1/oa_pdf/58/28/kjr-16-297.PMC4347265.pdf
Supplementary Materials The online-only Data Supplement is available with this  article at http://dx.doi.org/10.3348/kjr.2015.16.2.297.,Non-OADS,/arxiv_data1/oa_pdf/58/28/kjr-16-297.PMC4347265.pdf
"• Tel: (822) 3010-4377  • Fax: (822) 476-4719 • E-mail: medimash@gmail.com This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fb/76/kjr-16-304.PMC4347266.pdf
"Korean J Radiol 2015;16(2):304-313http://dx.doi.org/10.3348/kjr.2015.16.2.304 pISSN 1229-6929  · eISSN 2005-8330Original Article  | Gastrointestinal Imaging INTRODUCTION The era of molecular targeted therapeutics (MTTs) began  with the development of imatinib mesylate, first approved  MTT for treatment of chronic myeloid leukemia in 2001  and for treatment of gastrointestinal stromal tumor (GIST)  in 2003 (1).",Non-OADS,/arxiv_data1/oa_pdf/fb/76/kjr-16-304.PMC4347266.pdf
"• Tel: (8233) 741-1223  • Fax: (8233) 741-1228 • E-mail: baiksk@yonsei.ac.kr This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b4/5c/kjr-16-314.PMC4347267.pdf
"For patients with compensated cirrhosis, the diagnosis  and grading of clinically significant portal hypertension  (CSPH) enable the prediction of prognoses such as the  possibility of progression to decompensated cirrhosis and  mortality (3).http://dx.doi.org/10.3348/kjr.2015.16.2.314 pISSN 1229-6929  · eISSN 2005-8330Original Article  | Gastrointestinal Imaging",Non-OADS,/arxiv_data1/oa_pdf/b4/5c/kjr-16-314.PMC4347267.pdf
Supplementary Materials The online-only Data Supplement is available with this  article at http://dx.doi.org/10.3348/kjr.2015.16.2.314.,Non-OADS,/arxiv_data1/oa_pdf/b4/5c/kjr-16-314.PMC4347267.pdf
"• Tel: (822) 709-9396  • Fax: (822) 709-3928 • E-mail: hongses@schmc.ac.kr This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/37/02/kjr-16-325.PMC4347268.pdf
"Then, additional  surgical clips are applied in a staple line to prevent post-http://dx.doi.org/10.3348/kjr.2015.16.2.325 pISSN 1229-6929  · eISSN 2005-8330Pictorial Essay  | Gastrointestinal Imaging",Non-OADS,/arxiv_data1/oa_pdf/37/02/kjr-16-325.PMC4347268.pdf
"• Tel: (8621) 64041990-2472  • Fax: (8621) 64220319 • E-mail: huang.beijian@zs-hospital.sh.cn This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fe/07/kjr-16-334.PMC4347269.pdf
Contrast-enhanced ultrasonography  (CEUS) is applied in the diagnosis of renal minimal fat  AMLs and some imaging features are reportedly helpful in http://dx.doi.org/10.3348/kjr.2015.16.2.334 pISSN 1229-6929  · eISSN 2005-8330Original Article  | Genitourinary Imaging,Non-OADS,/arxiv_data1/oa_pdf/fe/07/kjr-16-334.PMC4347269.pdf
"• Tel: (8158) 230-6439  • Fax: (8158) 230-6440 • E-mail: masa_gif@yahoo.co.jp This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/16/9f/kjr-16-342.PMC4347270.pdf
(9) reported non-contrast  enhanced MR imaging features of BCG-induced GP in 10 http://dx.doi.org/10.3348/kjr.2015.16.2.342 pISSN 1229-6929  · eISSN 2005-8330Brief Communication  | Genitourinary Imaging,Non-OADS,/arxiv_data1/oa_pdf/16/9f/kjr-16-342.PMC4347270.pdf
"• Tel: (822) 870-2535  • Fax: (822) 870-3863 • E-mail: sorock71@snu.ac.kr This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0f/cd/kjr-16-349.PMC4347271.pdf
"In addition, AVF can be dysfunctional due to various http://dx.doi.org/10.3348/kjr.2015.16.2.349 pISSN 1229-6929  · eISSN 2005-8330Original Article  | Intervention",Non-OADS,/arxiv_data1/oa_pdf/0f/cd/kjr-16-349.PMC4347271.pdf
"• Tel: (822) 3010-4352  • Fax: (822) 476-4719 • E-mail: mhlee625@gmail.com This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e8/68/kjr-16-357.PMC4347272.pdf
Korean J Radiol 2015;16(2):357-362http://dx.doi.org/10.3348/kjr.2015.16.2.357 pISSN 1229-6929  · eISSN 2005-8330Original Article  | Musculoskeletal Imaging INTRODUCTION Epidural steroid injections (ESI) are widely used for managing low back pain and radiating symptoms.,Non-OADS,/arxiv_data1/oa_pdf/e8/68/kjr-16-357.PMC4347272.pdf
"• Tel: (822) 958-8623  • Fax: (822) 968-0787 • E-mail: francesca@daum.net This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4d/5d/kjr-16-363.PMC4347273.pdf
It is important to define  normal postoperative radiological appearance of a repaired  tendon and recognize differences in diagnostic criteria for  tendon integrity between untreated and surgically repaired http://dx.doi.org/10.3348/kjr.2015.16.2.363 pISSN 1229-6929  · eISSN 2005-8330Original Article  | Musculoskeletal Imaging,Non-OADS,/arxiv_data1/oa_pdf/4d/5d/kjr-16-363.PMC4347273.pdf
"• Tel: (8232) 460-3060  • Fax: (8232) 460-3065 • E-mail: neuroradkim@gmail.com This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/95/6d/kjr-16-372.PMC4347274.pdf
Korean J Radiol 2015;16(2):372-390http://dx.doi.org/10.3348/kjr.2015.16.2.372 pISSN 1229-6929  · eISSN 2005-8330Review Article  | Neuroimaging and Head & Neck INTRODUCTION Intravenous and endovascular reperfusion therapy are the  only proven effective treatment options for acute ischemic  stroke patients.,Non-OADS,/arxiv_data1/oa_pdf/95/6d/kjr-16-372.PMC4347274.pdf
BioMed Central 2013. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/95/6d/kjr-16-372.PMC4347274.pdf
"In addition, performing repeated http://dx.doi.org/10.3348/kjr.2015.16.2.391 pISSN 1229-6929  · eISSN 2005-8330Review Article  | Neuroimaging and Head & Neck Received September 16, 2014; accepted after revision December  15, 2014.",Non-OADS,/arxiv_data1/oa_pdf/2e/67/kjr-16-391.PMC4347275.pdf
"• Tel: (8231) 412-5228  • Fax: (8231) 412-5224 • E-mail: younghen@korea.ac.kr This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2e/67/kjr-16-391.PMC4347275.pdf
"• Tel: (822) 2258-1455  • Fax: (822) 599-6771 • E-mail: sljung1@catholic.ac.kr This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/62/8e/kjr-16-402.PMC4347276.pdf
Preoperative detection of TPL or accessory thyroid is of  great clinical importance in patients who undergo total  thyroidectomy because these structures can be undesirable  thyroid remnants and can be a cause of disease recurrence  not only with malignant thyroid tumors but also with http://dx.doi.org/10.3348/kjr.2015.16.2.402 pISSN 1229-6929  · eISSN 2005-8330Original Article  | Neuroimaging and Head & Neck,Non-OADS,/arxiv_data1/oa_pdf/62/8e/kjr-16-402.PMC4347276.pdf
A variety of tract  characteristics have been qualitatively and quantitatively http://dx.doi.org/10.3348/kjr.2015.16.2.410 pISSN 1229-6929  · eISSN 2005-8330Original Article  | Neuroimaging and Head & Neck,Non-OADS,/arxiv_data1/oa_pdf/a9/58/kjr-16-410.PMC4347277.pdf
"• Tel: (8232) 621-5851  • Fax: (8232) 621-5874 • E-mail: hshong@schmc.ac.kr This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/eb/71/kjr-16-419.PMC4347278.pdf
The proximal http://dx.doi.org/10.3348/kjr.2015.16.2.419 pISSN 1229-6929  · eISSN 2005-8330Pictorial Essay  | Pediatric Imaging,Non-OADS,/arxiv_data1/oa_pdf/eb/71/kjr-16-419.PMC4347278.pdf
http://www.ncc.re.kr/.,Non-OADS,/arxiv_data1/oa_pdf/eb/71/kjr-16-419.PMC4347278.pdf
"http://dx.doi.org/10.3348/kjr.2015.16.2.430 pISSN 1229-6929  · eISSN 2005-8330Original Article  | Thoracic Imaging Received August 26, 2014; accepted after revision November 30,  2014.",Non-OADS,/arxiv_data1/oa_pdf/36/4b/kjr-16-430.PMC4347279.pdf
"• Tel: (822) 2072-2624  • Fax: (822) 743-7418 • E-mail: jmgoo@plaza.snu.ac.kr This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/36/4b/kjr-16-430.PMC4347279.pdf
"• Tel: (822) 958-8625  • Fax: (822) 2043-5051 • E-mail: sweetperi@naver.com This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/51/f2/kjr-16-440.PMC4347280.pdf
http://dx.doi.org/10.3348/kjr.2015.16.2.440 pISSN 1229-6929  · eISSN 2005-8330Case Report  | Thoracic Imaging,Non-OADS,/arxiv_data1/oa_pdf/51/f2/kjr-16-440.PMC4347280.pdf
"• Tel: (396) 33775989 • Fax: (396) 33775322 • E-mail: aresedo1992@yahoo.it This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e2/dd/kjr-16-444.PMC4347281.pdf
"The former is justified by the fact that the vast majority  of ingested foreign bodies is commonly expelled without  causing any inconvenience, but requires a scrupulous and  prolonged examination of the stool, as well as a repeat  radiography of the abdomen, whereas the latter is preferred  in patients already diagnosed with diverticulosis or inguinal  Korean J Radiol 2015;16(2):444-445http://dx.doi.org/10.3348/kjr.2015.16.2.444 pISSN 1229-6929  · eISSN 2005-8330",Non-OADS,/arxiv_data1/oa_pdf/e2/dd/kjr-16-444.PMC4347281.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e2/dd/kjr-16-444.PMC4347281.pdf
"• Tel: (65) 66022689 • Fax: (65) 66023796 • E-mail: sivasu2@gmail.com This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/68/bb/kjr-16-446.PMC4347282.pdf
The patient later underwent laparotomy  Korean J Radiol 2015;16(2):446-447http://dx.doi.org/10.3348/kjr.2015.16.2.446 pISSN 1229-6929  · eISSN 2005-8330 Fig.,Non-OADS,/arxiv_data1/oa_pdf/68/bb/kjr-16-446.PMC4347282.pdf
"43 BALKAN JOURNAL OF MEDICAL GENETICS Ficek K, Stepien-Slodkowska M, Kaczmarczyk M, Maciejewska-Karlowska A, Sawczuk M,  Cholewinski J, Leonska-Duniec A, Zarebska A, Cieszczyk P, Zmijewski Pwww.statsoft.com)	 was	used	for	computing	 statis- tics,	except	Hardy-Weinberg	 equilibrium	 which	was	 tested	with	the	programming	 language	 and	environ- ment	R	(http://www.r-project.org)	 and	the	test	for	 linear	trend,	which	was	performed	 using	the	STAT- CALC	module	in	Epi	Info	(http://wwwn.cdc.gov/ epiinfo).",OADS,/arxiv_data1/oa_pdf/cb/2f/bjmg-17-01-41.PMC4347476.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
"http://dx.doi.org/10.1093/nar/gkq113 9 Burkovics, P., M. Sebesta, D. Balogh, L. Haracska, and L. Krejci.",OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
"http://dx.doi.org/10.1093/nar/gkt104 0 Ciccia, A., A.V .",OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
"http://dx.doi.org/10.1016/   j.molcel.2012.05.02 4 Deans, A.J., and S.C. West.",OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
"http://dx.doi.org/10.1038/nrc308 8 Farmer, H., N. McCabe, C.J.",OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
"http://dx.doi.org/10.1038/nature0344 5 Gari, K., C. Décaillet, A.Z.",Non-OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
"191:1285– 1297. http://dx.doi.org/10.1083/jcb.20100707 4 Hashimoto, Y., A. Ray Chaudhuri, M. Lopes, and V. Costanzo.",OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
"http://dx.doi.org/10.1016/   0022-2836(76)90156- X Hoeijmakers, J.H.",OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
"http://dx.doi.org/10.1056/NEJMra080461 5 Jackson, D.A., and A. Pombo.",OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
"http://dx.doi.org/10.1083/jcb.140.6.128 5 Kanagaraj, R., N. Saydam, P.L.",Non-OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
"http://dx.doi.org/10.1093/nar/gkl67 7 Kerrigan, D., Y. Pommier, and K.W.",OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
"http://dx.doi.org/10.1016/j.cell.2014.05.04 6 León-Ortiz, A.M., J. Svendsen, and S.J.",OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
"http://dx.doi.org/10.1016/j.dnarep.2014.03.01 6 Lonskaya, I., V.N.",OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
"http://dx.doi.org/10.1074/jbc.M41348320 0 Lopes, M., C. Cotta-Ramusino, A. Pellicioli, G. Liberi, P. Plevani, M. Muzi- Falconi, C.S.",Non-OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
"http://dx.doi.org/10.1038/3508761 3 Lopes, M., M. Foiani, and J.M.",Non-OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
"http://dx.doi.org/10.1016/j.molcel.2005.11.01 5 Lossaint, G., M. Larroque, C. Ribeyre, N. Bec, C. Larroque, C. Décaillet, K. Gari,  and A. Constantinou.",Non-OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
"http://dx.doi.org/10.1016/j.molcel.2013.07.02 3 Machwe, A., L. Xiao, J. Groden, and D.K.",OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
"http://dx.doi.org/10.1021/bi061548 7 Madaan, K., D. Kaushik, and T. Verma.",Non-OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
"12:467– 473. http://dx.doi.org/10.1097/00001813-200106000-0000 8monoclonal (1:1,000; 20E3; Cell Signaling Technology), and H3 rabbit  polyclonal (1:1,000; ab1791; Abcam).",OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
Online supplemental material is available at  http://www.jcb.org/cgi/content/full/jcb.201406099/DC1.,Non-OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
"http://dx.doi.org/10.1038/nature1256 5 Alabert, C., J.C. Bukowski-Wills, S.B.",Non-OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
"http://dx.doi.org/10.1038/ncb291 8 Arlt, M.F., T.E.",OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
"http://dx.doi.org/10.1091/mbc.E04-11-100 6 Bermejo, R., T. Capra, R. Jossen, A. Colosio, C. Frattini, W. Carotenuto,   A. Cocito, Y. Doksani, H. Klein, B. Gómez-González, et al.",Non-OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
"http://dx.doi.org/10.1016/   j.cell.2011.06.03 3 Berti, M., A. Ray Chaudhuri, S. Thangavel, S. Gomathinayagam, S. Kenig,   M. Vujanovic, F. Odreman, T. Glatter, S. Graziano, R. Mendoza-Maldonado,  et al.",OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
"http://dx.doi.org/10.1038/nsmb.250 1 Bétous, R., A.C. Mason, R.P.",Non-OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
"http://dx.doi.org/10   .1101/gad.178459.11 1 Bétous, R., F.B.",Non-OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
"http://dx.doi.org/10.1016/j.celrep   .2013.05.00 2 Blastyák, A., I. Hajdú, I. Unk, and L. Haracska.",OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
"http://dx.doi.org/10.1128/MCB.00863-0 9 Bouwman, P., and J. Jonkers.",OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
http://dx.doi.org/10.1038/nrc334 2,Non-OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
"http://dx.doi.org/10.1016/j.semcdb.2011.07.01 9 Symington, L.S., and J. Gautier.",OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
"http://dx.doi.org/10   .1146/annurev-genet-110410-13243 5 Thangavel, S., M. Berti, M. Levikova, C. Pinto, S. Gomathinayagam,   M. Vujanovic, R. Zellweger, H. Moore, E.H. Lee, E.A.",Non-OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
"http://dx.doi   .org/10.1038/nature1329 5 Yeo, J.E., E.H. Lee, E.A.",OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
"http://dx.doi.org/10.1093/hmg/ddu07 8 Zeman, M.K., and K.A.",OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
"http://dx.doi.org/10.1038/ncb289 7 Zou, L., and S.J.",OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
"http://dx.doi   .org/10.1126/science.108343 0 Zwelling, L.A., S. Michaels, L.C.",OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
"http://dx.doi.org/10.1021/bi00526a00 6Murina, O., C. von Aesch, U. Karakus, L.P. Ferretti, H.A.",Non-OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
"http://dx.doi.org/10.1016/   j.celrep.2014.03.06 9 Nam, E.A., and D. Cortez.",OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
"http://dx.doi.org/10.1042/BJ2010216 2 Neelsen, K.J., and M. Lopes.",OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
"http://dx.doi.org/10.1083/jcb.20121205 8 Neelsen, K.J., I.M.",OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
"http://dx.doi.org/10.1101/   gad.226373.11 3 Neelsen, K.J., A.R.",OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
"http://dx.doi.org/10.1007/978-1-62703-706-8_1 5 Oakley, G.G., and S.M.",Non-OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
"http://dx.doi.org/10.2741/365 2 Petermann, E., and T. Helleday.",OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
"http://dx.doi.org/10.1038/   nrm297 4 Petermann, E., M.L.",OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
"http://dx.doi.org/10.1016/j.molcel.2010.01.02 1 Pines, A., L.H.",OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
"http://dx.doi   .org/10.1016/j.tibs.2013.03.00 2 Pommier, Y.",OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
"http://dx.doi.org/10.1021/cb300648 v Ralf, C., I.D.",OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
"http://dx.doi.org/10.1074/jbc.M60426820 0 Ray Chaudhuri, A., Y. Hashimoto, R. Herrador, K.J.",Non-OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
"http://dx.doi.org/10.1038/nsmb.225 8 Recolin, B., S. Van der Laan, and D. Maiorano.",Non-OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
"http://dx.doi.org/10.1093/   nar/gkr124 1 Rouleau, M., A. Patel, M.J. Hendzel, S.H.",OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
"http://dx.doi.org/10.1038/nrc281 2 Schlacher, K., N. Christ, N. Siaud, A. Egashira, H. Wu, and M. Jasin.",Non-OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
"http://dx.doi.org/10.1016/j.ccr.2012.05.01 5 Shiotani, B., H.D.",OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
"http://dx.doi.org/10.1016/   j.celrep.2013.04.01 8 Sirbu, B.M., F.B.",OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
"http://dx.doi.org/10.1101/   gad.205321 1 Sirbu, B.M., F.B.",Non-OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
"http://dx.doi.org/10.1038/nprot.2012.01 0 Sogo, J.M., M. Lopes, and M. Foiani.",OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
"http://dx.doi.org/10.1126/science.107402 3 Sugimura, K., S. Takebayashi, H. Taguchi, S. Takeda, and K. Okumura.",OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
http://dx.doi.org/10.1083/jcb.20080606 8,Non-OADS,/arxiv_data1/oa_pdf/fc/0f/JCB_201406099.PMC4347635.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"http://dx.doi.org/10.1016/0022-2836(73)90284- 2 Daneholt, B., K. Anderson, and M. Fagerlind.",OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"http://dx.doi.org/10.1083/jcb.73.1.14 9 Dowling, R.J.O., I. Topisirovic, B.D.",OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"http://dx.doi.org/10.1016/j.bbapap.2009.12.00 1 Fabian, M.R., N. Sonenberg, and W. Filipowicz.",OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"79:351– 379. http://dx.doi.org/10.1146/annurev-biochem-060308-10310 3 Frank, J., M. Radermacher, P. Penczek, J. Zhu, Y. Li, M. Ladjadj, and A. Leith.",OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"http://dx.doi.org/10.1006/jsbi.1996.003 0 Friedberg, I., M. Herzberg, S. Zarivatch, and E.Z.",OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"http://dx.doi   .org/10.1016/0014-5793(75)80121- 9 Gretton, A., K.M.",OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"http://dx.doi.org/10.1038/emboj.2010.4 5 Hansma, H.G., and D.E.",OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"70:1933– 1939. http://dx.doi.org/10.1016/S0006-3495(96)79757- 6 Hansma, H.G., K. Kasuya, and E. Oroudjev.",Non-OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"http://dx.doi.org/10.1016/j.sbi.2004.05.00 5 Harms, J., F. Schluenzen, R. Zarivach, A. Bashan, S. Gat, I. Agmon, H. Bartels,  F. Franceschi, and A. Yonath.",Non-OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"http://dx.doi.org/10.1016/S0092-8674(01)00546- 3 Hell, S.W., and J. Wichmann.",OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"http://dx.doi.org/10.1364/OL.19.00078 0 Ingolia, N.T., S. Ghaemmaghami, J.R.S.",Non-OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"http://dx.doi.org/   10.1126/science.116897 8 Jenner, L., S. Melnikov, N. Garreau de Loubresse, A. Ben-Shem, M. Iskakova, A.  Urzhumtsev, A. Meskauskas, J. Dinman, G. Yusupova, and M. Yusupov.",Non-OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"http://dx.doi.org/10.1016/j.sbi.2012.07.01 3 Kang, S.A., M.E.",OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"341:1236566. http://dx.doi.org/10.1126/science.123656 6 Kastner, B., N. Fischer, M.M.",OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"http://dx.doi.org/10.1038/nmeth113 9 Kim, S.G., G.R.",OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"http://dx.doi.org/10   .1007/s10059-013-0138- 2 Kondrashov, N., A. Pusic, C.R.",OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"http://dx.doi.org/10.1016/j.cell.2011.03.02 8 Kong, J., and P. Lasko.",OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"http://dx.doi.org/10   .1038/nrg318 4 Kopeina, G.S., Z.A.",OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"http://dx.doi.org/10.1093/nar/gkm117 7 Kremer, J.R., D.N.",OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"http://dx.doi.org/10.1006/jsbi.1996.001 3 Ludtke, S.J., P.R.",OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
http://dx.doi.org/10.1006/jsbi.1999.417 4Click-iT AHA Alexa Fluor 488 Protein Synthesis HCS Assay (Life Technolo - gies) according to the manufacturer’s protocol.,OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"http://dx.doi.org/10   .1134/S000629791305002 7 Afonina, Z.A., A.G. Myasnikov, V.A.",Non-OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"http://dx.doi.org/10.1093/nar/gku59 9 Anger, A.M., J.-P. Armache, O. Berninghausen, M. Habeck, M. Subklewe,  D.N.",Non-OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"http://dx.doi.org/10.1038/   nature1210 4 Brandt, F., S.A. Etchells, J.O.",OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"136:261– 271. http://dx.doi.org/10.1016/j.cell.2008.11.01 6 Brandt, F., L.-A.",OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"http://dx.doi.org/10.1016/j.molcel.2010.08.00 3 Buchan, J.R., and I. Stansfield.",OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"http://dx.doi.org/10.1042/BC2007003 7 Chu, D., E. Kazana, N. Bellanger, T. Singh, M.F.",Non-OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"http://dx.doi.org/10.1002/embj.20138565 1 Condon, A.",OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"http://dx.doi.org/   10.1038/nrg189 2 Craig, A.W., A. Haghighat, A.T. Yu, and N. Sonenberg.",Non-OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
http://dx.doi.org/10.1038/3319 8,Non-OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"461:1234– 1242. http://dx.doi.org/10.1038/nature0840 3 Schwanhäusser, B., D. Busse, N. Li, G. Dittmar, J. Schuchhardt, J. Wolf, W.  Chen, and M. Selbach.",Non-OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"http://dx.doi.org/10.1038/   nature1009 8 Shah, P., Y. Ding, M. Niemczyk, G. Kudla, and J.B. Plotkin.",Non-OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"http://dx.doi   .org/10.1016/j.cell.2013.05.04 9 Silvera, D., S.C. Formenti, and R.J. Schneider.",OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"http://dx.doi.org/10.1038/nrc282 4 Slayter, H.S., J.R. Warner, A.",OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"http://dx.doi.org/10.1016/   S0022-2836(63)80112- 6 Sonenberg, N., and A.G. Hinnebusch.",OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"http://dx.doi.org/10.1016/j.cell.2009.01.04 2 Steitz, J.A.",OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"224:957– 964. http://dx.doi.org/10.1038/224957a 0 Steward, O., and W.B.",Non-OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"http://dx.doi.org/10.1021/la060356 + Tebaldi, T., A.",OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"13:220. http://dx.doi.org/10.1186/1471-2164-13-22 0 Topisirovic, I., and N. Sonenberg.",OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"http://dx.doi.org/10.1016/j.cell.2011   .04.00 6 Tuller, T., A. Carmi, K. Vestsigian, S. Navon, Y. Dorfan, J. Zaborske, T. Pan,  O. Dahan, I. Furman, and Y. Pilpel.",OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"http://dx.doi.org/10.1016/j.cell.2010.03.03 1 Vicidomini, G., I.C.",OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"6:400. http://dx.doi   .org/10.1038/msb.2010.5 9 Warner, J.R., A.",OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"197:430– 435. http://dx.doi.org/10.1038/197430a 0 Wolin, S.L., and P. Walter.",Non-OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"http://dx.doi.org/10.1038/nrm335 9 Yazaki, K., T. Yoshida, M. Wakiyama, and K. Miura.",OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"http://dx.doi   .org/10.1038/nrm267 2 Madin, K., T. Sawasaki, N. Kamura, K. Takai, T. Ogasawara, K. Yazaki, T.  Takei, K. Miura, and Y. Endo.",OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"http://dx.doi.org/10.1016/S0014-5793(04)00221- 2 Mastronarde, D.N.",OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"http://dx.doi.org/10.1016/j.jsb.2005.07.00 7 Mauro, V.P., and G.M.",OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"http://dx.doi.org/10.1038/nsmb.231 3 Memczak, S., M. Jens, A. Elefsinioti, F. Torti, J. Krueger, A. Rybak, L. Maier,  S.D.",OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"http://dx.doi.org/10.1038/nature1192 8 Mikamo, E., C. Tanaka, T. Kanno, H. Akiyama, G. Jung, H. Tanaka, and T.  Kawai.",OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"151:106– 110. http://dx.doi.org/10.1016/j.jsb.2005.05.00 2 Mikamo-Satoh, E., A. Takagi, H. Tanaka, T. Matsumoto, T. Nishihara, and T.  Kawai.",OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"394:275– 280. http://dx.doi.org/10.1016/j.ab.2009.07.03 3 Myasnikov, A.G., Z.A.",OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"5:5294.  http://dx.doi.org/10.1038/ncomms629 4 Novoa, E.M., and L. Ribas de Pouplana.",OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"http://dx.doi   .org/10.1016/j.tig.2012.07.00 6 Ortiz, J.O., F. Brandt, V.R.F.",OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"http://dx.doi.org/10.1083/jcb.20100500 7 Ostroff, L.E., J.C. Fiala, B. Allwardt, and K.M.",OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"http://dx.doi.org/10.1083/jcb.1.1.5 9 Pascual-Montano, A., L.E.",Non-OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"133:233– 245. http://dx.doi.org/10.1006/jsbi.2001.436 9 Pastré, D., O. Piétrement, S. Fusil, F. Landousy, J. Jeusset, M.-O.",Non-OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"http://dx.doi.org/10.1016/S0006-3495(03)74673- 6 Pettersen, E.F., T.D.",OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"http://dx.doi.org/10.1002/jcc.2008 4 Pfeffer, S., F. Brandt, T. Hrabe, S. Lang, M. Eibauer, R. Zimmermann, and   F. Förster.",Non-OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"http://dx.doi   .org/10.1016/j.str.2012.06.01 0 Ramakrishnan, V. 2002.",OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"http://dx.doi.org/10.1016/S0092-8674(02)00619- 0 Rich, A., S. Penman, Y. Becker, J. Darnell, and C. Hall.",OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"http://dx.doi.org/10.1126/science.142.3600.165 8 Sandberg, K., D.N.",OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"http://dx.doi.org/10.1016/j.jsb.2003.09.01 3 Scheres, S.H.W., R. Núñez-Ramírez, C.O.S.",OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
"http://dx.doi.org/10.1038/   nprot.2008.6 2 Schluenzen, F., A. Tocilj, R. Zarivach, J. Harms, M. Gluehmann, D. Janell,  A. Bashan, H. Bartels, I. Agmon, F. Franceschi, and A. Yonath.",Non-OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
http://dx.doi.org/10.1016/S0092-   8674(00)00084- 2,OADS,/arxiv_data1/oa_pdf/46/70/JCB_201406040.PMC4347638.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/a0/51/JCB_201412011.PMC4347640.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/a0/51/JCB_201412011.PMC4347640.pdf
"http://dx.doi.org/10.1038/nature1037 9 Heeger, S., O. Leismann, R. Schittenhelm, O. Schraidt, S. Heidmann, and C.F.",OADS,/arxiv_data1/oa_pdf/a0/51/JCB_201412011.PMC4347640.pdf
"http://dx.doi.org/10.1101/gad.34780 5 Hinshaw, S.M., and S.C. Harrison.",OADS,/arxiv_data1/oa_pdf/a0/51/JCB_201412011.PMC4347640.pdf
"http://dx.doi.org/10.1016/j.celrep.2013.08.03 6 Hori, T., W.-H. Shang, K. Takeuchi, and T. Fukagawa.",OADS,/arxiv_data1/oa_pdf/a0/51/JCB_201412011.PMC4347640.pdf
"http://dx.doi.org/10   .1083/jcb.20121010 6 Hu, H., Y .",OADS,/arxiv_data1/oa_pdf/a0/51/JCB_201412011.PMC4347640.pdf
"http://dx.doi   .org/10.1101/gad.204511 1 Janicki, S.M., T. Tsukamoto, S.E.",OADS,/arxiv_data1/oa_pdf/a0/51/JCB_201412011.PMC4347640.pdf
"http://dx.doi.org/10.1016/   S0092-8674(04)00171- 0 Kan, Z.-Y ., L. Mayne, P.S.",OADS,/arxiv_data1/oa_pdf/a0/51/JCB_201412011.PMC4347640.pdf
"http://dx.doi.org/10.1007/s13361-011-0236- 3 Kato, H., J. Jiang, B.-R. Zhou, M. Rozendaal, H. Feng, R. Ghirlando, T.S.",Non-OADS,/arxiv_data1/oa_pdf/a0/51/JCB_201412011.PMC4347640.pdf
"http://dx.doi.org/10.1126/science.123553 2 Maddox, P.S., F. Hyndman, J. Monen, K. Oegema, and A. Desai.",Non-OADS,/arxiv_data1/oa_pdf/a0/51/JCB_201412011.PMC4347640.pdf
"http://dx.doi.org/10.1083/jcb.20070106 5 Masumoto, H., H. Masukata, Y. Muro, N. Nozaki, and T. Okazaki.",OADS,/arxiv_data1/oa_pdf/a0/51/JCB_201412011.PMC4347640.pdf
"http://dx.doi.org/10.1083/jcb.109.5.196 3 Mendiburo, M.J., J. Padeken, S. Fülöp, A. Schepers, and P. Heun.",Non-OADS,/arxiv_data1/oa_pdf/a0/51/JCB_201412011.PMC4347640.pdf
"http://dx.doi.org/10.1126/science.120688 0 Moree, B., C.B.",Non-OADS,/arxiv_data1/oa_pdf/a0/51/JCB_201412011.PMC4347640.pdf
"http://dx.doi.org/10.1083/jcb.20110607 9 Nishino, T., K. Takeuchi, K.E.",OADS,/arxiv_data1/oa_pdf/a0/51/JCB_201412011.PMC4347640.pdf
"http://dx.doi.org/10.1016/j.cell.2011.11.06 1 Sekulic, N., E.A.",OADS,/arxiv_data1/oa_pdf/a0/51/JCB_201412011.PMC4347640.pdf
"http://dx.doi.org/10.1038/nature0932 3 Straight, A.F., A.S. Belmont, C.C.",Non-OADS,/arxiv_data1/oa_pdf/a0/51/JCB_201412011.PMC4347640.pdf
"http://dx.doi.org/10.1016/S0960-9822(02)70783- 5 Westhorpe, F.G., and A.F.",OADS,/arxiv_data1/oa_pdf/a0/51/JCB_201412011.PMC4347640.pdf
"http://dx.doi.org/10.1016/j.devcel.2014.11.03 0 Zasadzińska, E., M.C.",OADS,/arxiv_data1/oa_pdf/a0/51/JCB_201412011.PMC4347640.pdf
http://dx.doi   .org/10.1038/emboj.2013.14 2centromeric chromatin.,OADS,/arxiv_data1/oa_pdf/a0/51/JCB_201412011.PMC4347640.pdf
"http://dx.doi.org/10.1083/jcb.20101201 7 Basilico, F., S. Maffini, J.R. Weir, D. Prumbaum, A.M. Rojas, T. Zimniak, A.",Non-OADS,/arxiv_data1/oa_pdf/a0/51/JCB_201412011.PMC4347640.pdf
"http://dx.doi.org/10.7554/eLife.0297 8 Bassett, E.A., S. Wood, K.J.",Non-OADS,/arxiv_data1/oa_pdf/a0/51/JCB_201412011.PMC4347640.pdf
"http://dx.doi.org/10.1083/jcb.20100103 5 Bassett, E.A., J. DeNizio, M.C.",Non-OADS,/arxiv_data1/oa_pdf/a0/51/JCB_201412011.PMC4347640.pdf
"http://dx.doi.org/10   .1016/j.devcel.2012.02.00 1 Black, B.E., and D.W. Cleveland.",OADS,/arxiv_data1/oa_pdf/a0/51/JCB_201412011.PMC4347640.pdf
"http://dx.doi   .org/10.1016/j.cell.2011.02.00 2 Black, B.E., D.R.",OADS,/arxiv_data1/oa_pdf/a0/51/JCB_201412011.PMC4347640.pdf
"http://dx.doi.org/10.1038/nature0276 6 Black, B.E., L.E.T.",OADS,/arxiv_data1/oa_pdf/a0/51/JCB_201412011.PMC4347640.pdf
"http://dx.doi.org/10.1016/j.molcel.2006.12.01 8 Bodor, D.L., M.G.",OADS,/arxiv_data1/oa_pdf/a0/51/JCB_201412011.PMC4347640.pdf
"http://dx.doi   .org/10.1038/ncb189 9 Carroll, C.W., K.J.",Non-OADS,/arxiv_data1/oa_pdf/a0/51/JCB_201412011.PMC4347640.pdf
"189:1143– 1155. http://dx.doi.org/10.1083/jcb.20100101 3 Cheeseman, I.M.",Non-OADS,/arxiv_data1/oa_pdf/a0/51/JCB_201412011.PMC4347640.pdf
"http://dx.doi.org/10.1101/cshperspect.a01582 6 Drinnenberg, I.A., D. deYoung, S. Henikoff, and H.S.",Non-OADS,/arxiv_data1/oa_pdf/a0/51/JCB_201412011.PMC4347640.pdf
"3. http://dx.doi.org/10.7554/eLife.0367 6 Dunleavy, E.M., D. Roche, H. Tagami, N. Lacoste, D. Ray-Gallet, Y .",OADS,/arxiv_data1/oa_pdf/a0/51/JCB_201412011.PMC4347640.pdf
"http://dx.doi.org/10.1016/j.cell.2009.02.04 0 Fachinetti, D., H.D.",OADS,/arxiv_data1/oa_pdf/a0/51/JCB_201412011.PMC4347640.pdf
"http://dx.doi.org/   10.1038/ncb280 5 Folco, H.D., C.S.",Non-OADS,/arxiv_data1/oa_pdf/a0/51/JCB_201412011.PMC4347640.pdf
"http://dx.doi.org/10.1016/   j.cub.2014.11.06 0 Foltz, D.R., L.E.T.",OADS,/arxiv_data1/oa_pdf/a0/51/JCB_201412011.PMC4347640.pdf
http://dx.doi   .org/10.1016/j.cell.2011.03.03 1,OADS,/arxiv_data1/oa_pdf/a0/51/JCB_201412011.PMC4347640.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/1b/34/JCB_201408106.PMC4347641.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/1b/34/JCB_201408106.PMC4347641.pdf
"For colocalization  assessment, intensity correlation analysis was performed to highlight pixels  positively covarying between two input channels using a plugin for ImageJ  (http://imagej.nih.gov/ij/plugins/mbf/).",OADS,/arxiv_data1/oa_pdf/1b/34/JCB_201408106.PMC4347641.pdf
Online supplemental material is available at http://www.jcb.org/   cgi/content/full/jcb.201408106/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/1b/34/JCB_201408106.PMC4347641.pdf
"http://dx.doi.org/10   .1016/j.cell.2012.08.02 3 Chimenti, F., B. Bizzarri, E. Maccioni, D. Secci, A. Bolasco, P. Chimenti,   R. Fioravanti, A. Granese, S. Carradori, F. Tosi, et al.",OADS,/arxiv_data1/oa_pdf/1b/34/JCB_201408106.PMC4347641.pdf
"http://dx.doi.org/10.1021/jm800885 d Frei, E., R. Schuh, S. Baumgartner, M. Burri, M. Noll, G. Jürgens, E. Seifert,   U. Nauber, and H. Jäckle.",Non-OADS,/arxiv_data1/oa_pdf/1b/34/JCB_201408106.PMC4347641.pdf
"http://dx.doi.org/10   .1073/pnas.130616011 0 Ho, L., R. Jothi, J.L.",OADS,/arxiv_data1/oa_pdf/1b/34/JCB_201408106.PMC4347641.pdf
http://dx.doi.org/10.1002/stem.1 4essential component of the core pluripotency transcriptional network.,OADS,/arxiv_data1/oa_pdf/1b/34/JCB_201408106.PMC4347641.pdf
"http://dx.doi.org/10.1073/   pnas.081288810 6 Ho, L., J.L.",OADS,/arxiv_data1/oa_pdf/1b/34/JCB_201408106.PMC4347641.pdf
"http://dx.doi.org/   10.1016/j.stem.2008.08.01 4 Hong, Y., R.B.",OADS,/arxiv_data1/oa_pdf/1b/34/JCB_201408106.PMC4347641.pdf
"http://dx.doi.org/10.1016/j.mrfmmm.2006.06.00 6 Jürgens, G. 1988.",OADS,/arxiv_data1/oa_pdf/1b/34/JCB_201408106.PMC4347641.pdf
"http://dx.doi.org/10.1038/ncb181 7 Kohlhase, J., M. Heinrich, M. Liebers, L. Fröhlich Archangelo, W. Reardon, and  A. Kispert.",Non-OADS,/arxiv_data1/oa_pdf/1b/34/JCB_201408106.PMC4347641.pdf
"http://dx.doi.org/10.1159/00007104 8 Koshiba-Takeuchi, K., J.K. Takeuchi, E.P.",OADS,/arxiv_data1/oa_pdf/1b/34/JCB_201408106.PMC4347641.pdf
"http://dx.doi.org/10.1038/ng170 7 Lans, H., J.A.",OADS,/arxiv_data1/oa_pdf/1b/34/JCB_201408106.PMC4347641.pdf
"5:4.  http://dx.doi.org/10.1186/1756-8935-5- 4 Lee, P.J.A.",Non-OADS,/arxiv_data1/oa_pdf/1b/34/JCB_201408106.PMC4347641.pdf
"http://dx.doi.org/10.1038/sj.onc.121087 2 Lee, H.S., J.H.",OADS,/arxiv_data1/oa_pdf/1b/34/JCB_201408106.PMC4347641.pdf
"http://dx.doi.org/   10.1038/emboj.2010.2 7 Meshorer, E., and T. Misteli.",OADS,/arxiv_data1/oa_pdf/1b/34/JCB_201408106.PMC4347641.pdf
"http://dx.doi.org/10.1016/j.bbagen.2012.09.00 1 Pellegrini, M., A. Celeste, S. Difilippantonio, R. Guo, W. Wang, L. Feigenbaum,  and A. Nussenzweig.",OADS,/arxiv_data1/oa_pdf/1b/34/JCB_201408106.PMC4347641.pdf
"http://dx.doi.org/10.1242/dev.0245 7 Shiloh, Y.",Non-OADS,/arxiv_data1/oa_pdf/1b/34/JCB_201408106.PMC4347641.pdf
"http://dx.doi.org/10.1038/nrc101 1 Song, H., M. Hollstein, and Y. Xu.",OADS,/arxiv_data1/oa_pdf/1b/34/JCB_201408106.PMC4347641.pdf
"9:573– 580. http://dx.doi.org/10.1038/ncb157 1 Stracker, T.H., and J.H.",OADS,/arxiv_data1/oa_pdf/1b/34/JCB_201408106.PMC4347641.pdf
"http://dx.doi.org/10.1038/   nrm304 7 Sweetman, D., and A. Münsterberg.",OADS,/arxiv_data1/oa_pdf/1b/34/JCB_201408106.PMC4347641.pdf
"http://dx.doi.org/10.1016/j   .ydbio.2006.02.00 9 Tichy, E.D., and P.J.",OADS,/arxiv_data1/oa_pdf/1b/34/JCB_201408106.PMC4347641.pdf
"http://dx.doi.org/10.1097/MOH.0b013e328353c68 4 Yuri, S., S. Fujimura, K. Nimura, N. Takeda, Y. Toyooka, Y. Fujimura, H.  Aburatani, K. Ura, H. Koseki, H. Niwa, and R. Nishinakamura.",OADS,/arxiv_data1/oa_pdf/1b/34/JCB_201408106.PMC4347641.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/fd/cd/JCB_201407105.PMC4347642.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/fd/cd/JCB_201407105.PMC4347642.pdf
Prediction of low-complexity sequence protein IUPred is web-based software (http://iupred.enzim.hu/) that was used to  predict if A. gossypii  Whi3 or Puf2 are intrinsically unstructured proteins.,OADS,/arxiv_data1/oa_pdf/fd/cd/JCB_201407105.PMC4347642.pdf
3 G. Online supplemental material is available  at http://www.jcb.org/cgi/content/full/jcb.201407105/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/fd/cd/JCB_201407105.PMC4347642.pdf
"http://dx.doi.org/10.1002/embr.20133803 7 Brangwynne, C.P., C.R.",Non-OADS,/arxiv_data1/oa_pdf/fd/cd/JCB_201407105.PMC4347642.pdf
http://dx.doi.org/10.1126/science.117204 6or genotype.,OADS,/arxiv_data1/oa_pdf/fd/cd/JCB_201407105.PMC4347642.pdf
"http://dx.doi.org/10.1016/j.cell.2012.05.02 2 Wendland, J., Y. Ayad-Durieux, P. Knechtle, C. Rebischung, and P. Philippsen.",OADS,/arxiv_data1/oa_pdf/fd/cd/JCB_201407105.PMC4347642.pdf
"http://dx.doi.org/10.1016/S0378-1119(99)00509- 0Buxbaum, A.R., B. Wu, and R.H. Singer.",OADS,/arxiv_data1/oa_pdf/fd/cd/JCB_201407105.PMC4347642.pdf
"http://dx.doi.org/10.1126/science.124293 9 Doyle, M., and M.A.",OADS,/arxiv_data1/oa_pdf/fd/cd/JCB_201407105.PMC4347642.pdf
"http://dx.doi   .org/10.1038/emboj.2011.27 8 Freisinger, T., B. Klünder, J. Johnson, N. Müller, G. Pichler, G. Beck, M.  Costanzo, C. Boone, R.A. Cerione, E. Frey, and R. Wedlich-Söldner.",Non-OADS,/arxiv_data1/oa_pdf/fd/cd/JCB_201407105.PMC4347642.pdf
"4:1807. http://dx.doi   .org/10.1038/ncomms279 5 Gladfelter, A.S., A.K.",OADS,/arxiv_data1/oa_pdf/fd/cd/JCB_201407105.PMC4347642.pdf
"172:347– 362. http://dx.doi.org/10.1083/jcb.20050700 3 Han, T.W., M. Kato, S. Xie, L.C.",OADS,/arxiv_data1/oa_pdf/fd/cd/JCB_201407105.PMC4347642.pdf
"http://dx.doi.org/10.1016/j.cell.2012.04.01 6 Irazoqui, J.E., A.S. Gladfelter, and D.J.",OADS,/arxiv_data1/oa_pdf/fd/cd/JCB_201407105.PMC4347642.pdf
"http://dx.doi.org/   10.1038/ncb106 8 Jansen, R.P., and D. Niessing.",OADS,/arxiv_data1/oa_pdf/fd/cd/JCB_201407105.PMC4347642.pdf
"http://dx.doi.org/10.2174/13892031280161949 3 Johnson, J.M., M. Jin, and D.J.",OADS,/arxiv_data1/oa_pdf/fd/cd/JCB_201407105.PMC4347642.pdf
"http://dx.doi.org/10.1016/j.gde.2011.09.00 7 Kato, M., T.W.",OADS,/arxiv_data1/oa_pdf/fd/cd/JCB_201407105.PMC4347642.pdf
"http://dx.doi.org/10.1016/j.cell.2012.04.01 7 Klünder, B., T. Freisinger, R. Wedlich-Söldner, and E. Frey.",OADS,/arxiv_data1/oa_pdf/fd/cd/JCB_201407105.PMC4347642.pdf
"http://dx.doi.org/   10.1371/journal.pcbi.100339 6 Kuo, C.C., N.S.",Non-OADS,/arxiv_data1/oa_pdf/fd/cd/JCB_201407105.PMC4347642.pdf
"http://dx.doi.org/10.1016/j.cub   .2014.02.02 4 Lee, C., H. Zhang, A.E.",OADS,/arxiv_data1/oa_pdf/fd/cd/JCB_201407105.PMC4347642.pdf
"http://dx.doi.org/10   .1016/j.devcel.2013.05.00 7 Lee, C.F., C.P.",OADS,/arxiv_data1/oa_pdf/fd/cd/JCB_201407105.PMC4347642.pdf
"111:088101. http://dx.doi.org/   10.1103/PhysRevLett.111.08810 1 Lehmann, R., and C. Nüsslein-Volhard.",OADS,/arxiv_data1/oa_pdf/fd/cd/JCB_201407105.PMC4347642.pdf
"http://dx.doi   .org/10.1016/0092-8674(86)90375- 2 Lew, R.R.",OADS,/arxiv_data1/oa_pdf/fd/cd/JCB_201407105.PMC4347642.pdf
"http://dx.doi.org/10   .1038/nrmicro259 1 Li, R., and B. Bowerman.",OADS,/arxiv_data1/oa_pdf/fd/cd/JCB_201407105.PMC4347642.pdf
"http://dx.doi.org/10.1101/cshperspect.a00347 5 Li, P., S. Banjade, H.C. Cheng, S. Kim, B. Chen, L. Guo, M. Llaguno, J.V.",Non-OADS,/arxiv_data1/oa_pdf/fd/cd/JCB_201407105.PMC4347642.pdf
"http://dx.doi.org/10.1038/nature1087 9 Park, H.Y., H. Lim, Y.J.",Non-OADS,/arxiv_data1/oa_pdf/fd/cd/JCB_201407105.PMC4347642.pdf
"http://dx.doi   .org/10.1126/science.123920 0 Ripley, B.D.",Non-OADS,/arxiv_data1/oa_pdf/fd/cd/JCB_201407105.PMC4347642.pdf
"http://dx.doi.org/10.1101/cshperspect.a00338 4 Smith, S.E., B. Rubinstein, I. Mendes Pinto, B.D.",Non-OADS,/arxiv_data1/oa_pdf/fd/cd/JCB_201407105.PMC4347642.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/94/3f/JCB_201406100.PMC4347643.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/94/3f/JCB_201406100.PMC4347643.pdf
"http://dx.doi.org/10.1074/ jbc.M20980120 0 Bae, S.H., K.H.",OADS,/arxiv_data1/oa_pdf/94/3f/JCB_201406100.PMC4347643.pdf
"http://dx.doi.org/10.1038/3508660 9 Berti, M., A. Ray Chaudhuri, S. Thangavel, S. Gomathinayagam, S. Kenig, M.  Vujanovic, F. Odreman, T. Glatter, S. Graziano, R. Mendoza-Maldonado,  et al.",Non-OADS,/arxiv_data1/oa_pdf/94/3f/JCB_201406100.PMC4347643.pdf
http://dx.doi.org/10.1038/nsmb.250 1PVDF membrane (GE Healthcare).,OADS,/arxiv_data1/oa_pdf/94/3f/JCB_201406100.PMC4347643.pdf
"278:23410– 23417. http://dx.doi.org/10.1074/jbc.M30299520 0 Karanja, K.K., S.W.",OADS,/arxiv_data1/oa_pdf/94/3f/JCB_201406100.PMC4347643.pdf
"http://dx.doi.org/10.4161/cc.2221 5 Karanja, K.K., E.H. Lee, E.A.",Non-OADS,/arxiv_data1/oa_pdf/94/3f/JCB_201406100.PMC4347643.pdf
"http://dx.doi   .org/10.4161/cc.2847 6 Kumar, S., and P.M. Burgers.",Non-OADS,/arxiv_data1/oa_pdf/94/3f/JCB_201406100.PMC4347643.pdf
"http://dx.doi.org/10.1101/gad.204750.11 2 Kuo, C., H. Nuang, and J.L.",OADS,/arxiv_data1/oa_pdf/94/3f/JCB_201406100.PMC4347643.pdf
"http://dx.doi.org/   10.1073/pnas.130039011 0 Liao, S., T. Toczylowski, and H. Yan.",OADS,/arxiv_data1/oa_pdf/94/3f/JCB_201406100.PMC4347643.pdf
"http://dx.doi.org/   10.1093/nar/gkn61 6 Machwe, A., R. Karale, X. Xu, Y. Liu, and D.K.",OADS,/arxiv_data1/oa_pdf/94/3f/JCB_201406100.PMC4347643.pdf
"http://dx.doi.org/10.1021/bi200105 4 Masuda-Sasa, T., O. Imamura, and J.L.",OADS,/arxiv_data1/oa_pdf/94/3f/JCB_201406100.PMC4347643.pdf
"http://dx.doi.org/   10.1093/nar/gkl07 0 Mendoza-Maldonado, R., V. Faoro, S. Bajpai, M. Berti, F. Odreman, M.  Vindigni, T. Ius, A. Ghasemian, S. Bonin, M. Skrap, et al.",Non-OADS,/arxiv_data1/oa_pdf/94/3f/JCB_201406100.PMC4347643.pdf
"http://dx.doi.org/10.1093/carcin/bgs20 6 Neelsen, K.J., A.R.",OADS,/arxiv_data1/oa_pdf/94/3f/JCB_201406100.PMC4347643.pdf
"http://dx.doi.org/10.1007/978-1-62703-706-8_1 5 Nicolette, M.L., K. Lee, Z. Guo, M. Rani, J.M.",Non-OADS,/arxiv_data1/oa_pdf/94/3f/JCB_201406100.PMC4347643.pdf
"http://dx.doi   .org/10.1038/nsmb.195 7 Nimonkar, A.V., J. Genschel, E. Kinoshita, P. Polaczek, J.L.",Non-OADS,/arxiv_data1/oa_pdf/94/3f/JCB_201406100.PMC4347643.pdf
"http://dx.doi.org/10.1101/gad.200381 1 Niu, H., W.H.",OADS,/arxiv_data1/oa_pdf/94/3f/JCB_201406100.PMC4347643.pdf
"467:108– 111. http://dx.doi.org/10.1038/nature0931 8 Peng, G., H. Dai, W. Zhang, H.J.",Non-OADS,/arxiv_data1/oa_pdf/94/3f/JCB_201406100.PMC4347643.pdf
"http://dx.doi.org/10.1158/0008-5472   .CAN-11-315 2 Pirzio, L.M., P. Pichierri, M. Bignami, and A. Franchitto.",Non-OADS,/arxiv_data1/oa_pdf/94/3f/JCB_201406100.PMC4347643.pdf
"http://dx.doi.org/10.1083/jcb.20070512 6 Ray Chaudhuri, A., Y. Hashimoto, R. Herrador, K.J.",Non-OADS,/arxiv_data1/oa_pdf/94/3f/JCB_201406100.PMC4347643.pdf
"http://dx.doi.org/10.1038/nsmb.225 8 Schlacher, K., N. Christ, N. Siaud, A. Egashira, H. Wu, and M. Jasin.",Non-OADS,/arxiv_data1/oa_pdf/94/3f/JCB_201406100.PMC4347643.pdf
"http://dx.doi   .org/10.1016/j.cell.2011.03.04 1Bétous, R., A.C. Mason, R.P.",OADS,/arxiv_data1/oa_pdf/94/3f/JCB_201406100.PMC4347643.pdf
"http://dx.doi.org/10   .1101/gad.178459.11 1 Bétous, R., F.B.",Non-OADS,/arxiv_data1/oa_pdf/94/3f/JCB_201406100.PMC4347643.pdf
"http://dx.doi.org/   10.1016/j.celrep.2013.05.00 2 Budd, M.E., and J.L.",OADS,/arxiv_data1/oa_pdf/94/3f/JCB_201406100.PMC4347643.pdf
http://dx.doi.org/10.1074/jbc.,Non-OADS,/arxiv_data1/oa_pdf/94/3f/JCB_201406100.PMC4347643.pdf
"http://dx.doi.org/10.1016/j.jmb.2013.04.02 3 Cejka, P., and S.C. Kowalczykowski.",OADS,/arxiv_data1/oa_pdf/94/3f/JCB_201406100.PMC4347643.pdf
"http://dx.doi   .org/10.1074/jbc.M109.08319 6 Cejka, P., E. Cannavo, P. Polaczek, T. Masuda-Sasa, S. Pokharel, J.L.",Non-OADS,/arxiv_data1/oa_pdf/94/3f/JCB_201406100.PMC4347643.pdf
"http://dx.doi.org/10.1038/nature0935 5 Cotta-Ramusino, C., D. Fachinetti, C. Lucca, Y. Doksani, M. Lopes, J. Sogo, and  M. Foiani.",Non-OADS,/arxiv_data1/oa_pdf/94/3f/JCB_201406100.PMC4347643.pdf
"http://dx.doi.org/10.1101/gad.214080.11 3 Courcelle, J., J.R. Donaldson, K.H.",Non-OADS,/arxiv_data1/oa_pdf/94/3f/JCB_201406100.PMC4347643.pdf
"http://dx.doi.org/10.1126/science.108132 8 Crabbe, L., R.E.",OADS,/arxiv_data1/oa_pdf/94/3f/JCB_201406100.PMC4347643.pdf
"http://dx.doi.org/10.1126/science.110361 9 Duxin, J.P., H.R.",OADS,/arxiv_data1/oa_pdf/94/3f/JCB_201406100.PMC4347643.pdf
"http://dx.doi.org/   10.1074/jbc.M112.35901 8 Franchitto, A., L.M.",Non-OADS,/arxiv_data1/oa_pdf/94/3f/JCB_201406100.PMC4347643.pdf
"http://dx.doi.org/10.1083/jcb.20080317 3 Franken, N.A., H.M. Rodermond, J. Stap, J. Haveman, and C. van Bree.",OADS,/arxiv_data1/oa_pdf/94/3f/JCB_201406100.PMC4347643.pdf
"http://dx.doi.org/10.1073/   pnas.080477710 5 Gravel, S., J.R. Chapman, C. Magill, and S.P.",OADS,/arxiv_data1/oa_pdf/94/3f/JCB_201406100.PMC4347643.pdf
"http://dx.doi.org/10.1101/gad.50310 8 Hanada, K., M. Budzowska, S.L.",OADS,/arxiv_data1/oa_pdf/94/3f/JCB_201406100.PMC4347643.pdf
"http://dx.doi.org/10.1038/nsmb.217 7 Henricksen, L.A., C.B.",Non-OADS,/arxiv_data1/oa_pdf/94/3f/JCB_201406100.PMC4347643.pdf
"http://dx.doi.org/10.1016/j.ccr.2012.05.01 5 Seigneur, M., V. Bidnenko, S.D.",OADS,/arxiv_data1/oa_pdf/94/3f/JCB_201406100.PMC4347643.pdf
"http://dx.doi.org/10.1016/   S0092-8674(00)81772- 9 Sidorova, J.M., N. Li, A. Folch, and R.J. Monnat Jr. 2008.",OADS,/arxiv_data1/oa_pdf/94/3f/JCB_201406100.PMC4347643.pdf
"http://dx.doi.org/   10.4161/cc.7.6.556 6 Sidorova, J.M., N. Li, D.C. Schwartz, A. Folch, and R.J. Monnat Jr. 2009.",Non-OADS,/arxiv_data1/oa_pdf/94/3f/JCB_201406100.PMC4347643.pdf
"http://dx.doi.org/10.1038/nprot.2009.5 4 Sturzenegger, A., K. Burdova, R. Kanagaraj, M. Levikova, C. Pinto, P. Cejka,   and P. Janscak.",Non-OADS,/arxiv_data1/oa_pdf/94/3f/JCB_201406100.PMC4347643.pdf
"http://dx.doi.org/10.1074/jbc.M114.57882 3 Thangavel, S., R. Mendoza-Maldonado, E. Tissino, J.M.",Non-OADS,/arxiv_data1/oa_pdf/94/3f/JCB_201406100.PMC4347643.pdf
"http://dx.doi.org/10.1128/MCB.01290-0 9 Wawrousek, K.E., B.K.",Non-OADS,/arxiv_data1/oa_pdf/94/3f/JCB_201406100.PMC4347643.pdf
"http://dx.doi.org/10.1038/nature0225 3 Yata, K., J. Lloyd, S. Maslen, J.Y.",OADS,/arxiv_data1/oa_pdf/94/3f/JCB_201406100.PMC4347643.pdf
